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INTRODUCTION TO CONTINUOUS ARTERIO-VENOUS 
HEMODIAFILTRATION (CAVHD) 
Chapter 1 
1.1 INTRODUCTION 
The kidney is an organ of vital importance in the human body. Its main function is to 
maintain and regulate the composition of solutes in the blood plasma, and indirectly also that 
of the interstitial and intracellular fluid. 
A total loss of the kidney function within hours or days is called acute renal failure (ARF), 
which often results fl.-om sepsis, a clinical syndrome accompanied also by massive edema, 
circulatOlY insufficiency, I'espiratOlY failure and sometimes neurological damage [1,2]. Acute 
renal failure and the associated water overload are common problems in critically ill patients 
and contribute significantly to mortality. It may be secondary to among other things such as 
hypotension, hypovolemia, trauma, drugs and disseminated intravascular coagulation. It may 
occur also in patients with multiple-organ failure. The resultant inability to remove toxic 
metabolites or to correct acid-base and elech'olyte abnormalities is commonly associated \\~th 
a fluid overload, with or without pulmonaI), edema, and an increase in interstitial water with 
a consequent reduction in tissue perfusion. Such patients are often hemodynamically unstable 
and characterized by a high catabolic rate [3,4]. The combination of low or unstable blood 
pressure and edema makes it quite diflicult to judge how much fluid should be withdrawn 
safely [4). Therefore, they need intensive dialysis and ultrafiltration treatment. However, the 
combination of ultrafiltration and intermittent hemodialysis (IHD) frequently leads to 
hypotension and neurological deterioration and may further jeopardize kidney fUllction [5]. 
Furthermore, rapid correction of the acidosis together with the rise of in flam rna tory mediators 
that result from the blood-membrane interaction may aggravate respiratory f:'lilure [6-11]. 
Consequently, in many patients with ARF 'conventional' form of hemodialysis and 
ultrafiltration techniques was contraindicated. Therefore, to treat patients with such 
complicated ARF a different form of dialysis therapy was needed with the following attributes 
[3,12,13]: 
eflicient removal of toxic metabolites presumably responsible for the uremic 
syndrome) 
correction of the patient's electrolyte abnormalities such as sodium for the treatment 
or prevention of hypotension and potassium for the treatment or prevention of 
hyperkalemia) 
correction of acid-base status by administering bufter-anions to control metabolic 
acidosis, 
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correction of patient's fluid balance by removing the excess body water and replacing 
the ultra filtrate with a clean substitution fluid, 
the ability freely to administer the parenteral nutrition and other hyper alimentation 
solutions, 
the ability to start the treatment anytime, 
gradual treatment so as to avoid sudden disturbances in the delicate equilibrium and 
fluid status of the patient. 
During the last decade, on considering these attributes, impressive advances have been made 
for the treatment of such complicated AItF in critically ill patients. This has led to the 
increased use of continuous rcnal replacement techniques in the intensive care unit as opposed 
to the use of intermittent hemodialysis and peritoneal dialysis [12,14]. Continuous arterio~ 
venous hemodiafiltration (CA VHD) is one of the continuous renal replacement techniques, 
which nowadays has become a widely used renal replacement therapy [3,13,15, 16]. 
1.2 HISTORICAL DEVELOPMENT OF CAVHD 
It was first demonstrated in 1913 that the dialysis of blood could remove small solutes that are 
normally excreted in urine [17]. The first dialysis machine was developed by Kollf [18] in 
1946. Its surh1.Ce area was large enough to be beneficial in treatment of patients with kidney 
hlilure. Later in the 19601s, blood access devices were developed, which allowed hemodialysis 
to be employed for the treatment of chronically in patients with permanent loss of kidney 
function (chronic renal t:lilure: CRF). In the carly years of dialysis, patients were treated for 
8 to 12 hours, two to three times a week. As early as 1960, Scribner et al [19] introduced a 
technique of continuous hemodialysis without the use of a blood pump, for the treatment of 
ARF. In 1964 however, the drawback of this development became clear when Peterson et al 
[20] observed acute encephalopathy during dialysis treatment. They explained this by the 
rapid fall in the solute plasma concentration due to diflhsion, leading to osmotic 
disequilibrium between plasma water and the brain tissue. Further, hemodialysis was refined 
by using controlled ultrafiltration, by bicarbonate as a buffer substitute rather than acetate, 
by high or variable sodium concentrations in dialysate and by cooler~temperature dialysate 
[21~24]. By virtue of these developments, most patients with CRF can now adequately be 
treated by II-ID in two or three sessions of 4 to 5 hours a week. In subsequent years IHD 
became standard for the treatment of acute or chronic renal failure in critically ill patients. 
However, dialysis induced hypotension and vascular instability together with sharp 
fluctuations in the plasma osmolality, pH and intravascular fluid volume, make the IHD 
poorly tolerated in unstable patients. 
In 1967, Henderson et al [25] descdbed the so~called pump~ddven hemofiltration technique, 
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where venous blood is pumped from the patient through an artificial kidney and subsequently 
back to the patient. By a hydrostatic pressure gradient across a semi-permeable membrane 
(cut-off point: 40.000 Daltons) an ultrafiltrate is produced fi'om plasma water. Solute mass 
transport is based on convection. The intravascular volume is preserved by replacing the 
ultra filtrate with a substitution fluid that has an electrolyte composition similar to that of the 
plasma. 'Vith hemofiltration the eflicicncy of the removal of urea was lower but 
disequilibrium was seldom seen and blood pressure was more stable. For hemofiltration, new 
highly permeable membranes were developed, which allowed passage of water and solutes 
of up to several thousand Daltons at very low pressures. lvloreover, BaLL et al [26] pointed 
out that the so~called 'middle molecules" which were believed to contribute to the uremic 
syndrome, were removed more efficiently with this technique. This middle molecule 
hypothesis also led to the development of peritoneal dialysis techniques. For the treatment of 
patients with complicated ARF, peritoneal dialysis is usually better tolerated but may Le 
contraindicated by intra~abdominal pathology, infection, technical difficulties or respiratOlY 
compromise [27-31). 
In 1977, Kramer et al [32] described a technique, called continuous arterio~venous 
hemofiltration (CA VH), which enables the control of uremia in critically ill patients with ARF 
without cardiovascular stability associated with conventional IHD. He used a small hemofilter 
and connected it to catheters in the femoral artery and vein to obtain a spontaneous blood 
flow driven by the arterial blood pressure of the patient only. To control the rate of fluid loss, 
he administered a substitution fluid. ''''hen small highly pem1eable hemofilters became 
generally available, many dialysis physicians relied on CA VH for the treatment of critically 
ill patients with ARF. In spite of very low blood pressures (50~ 70 mmHg), the gradual fluid 
withdrawal (10-14 Ilday) was very well tolerated by these patients [33,34]. As far as the 
h"eatment of uremia was concerned, the CA VH treatment proved to have limited to low urea 
clearance. The solute transport in CA VH occurs by convection and limited by the rate of 
ultrafiltrate production. "Vhen the rate of urea generation exceeds the rate of urea removal, 
a steady~state BUN level is not achieved. This may take place because of 1) high urea 
generation due to catabolism (For the highly catabolic patients, the rate of ultrafiltration was 
seldom enough to provide adequate clearance of uremic solutes (7~10 mllmin).) and/or 2) 
inadequate rate of ultrafiltration flow, particularly in hypotensive patients. It was particularly 
these hypotensive and unstable patients who needed a continuous form of renal therapy. If 
the patient were more stable, then a traditional fOl:m ofIHD could be implemented. Indeed, 
it was common practice for patients on CA VH to have IHD treatment as well until several 
adaptations of the CA VH technique were suggested. 
Kaplan et al [35] suggested the application ofa suction pump (usually 150-200 mmHg) to the 
ultrafiltrate compartment to increase the ultrafiltration flow rate. However an increased 
- 3-
Introduction to continuous arterio-venous hemodiafiItl'ation (CAVHD) 
filtration fraction (sometimes exceeding 50%) may favor hemofilter clotting despite adequate 
heparinization. Both "Vendon ct al [36] and Kaplan et al [37] relied on pumped veno-venous 
hemofiltration to increase blood flow rates (100-300 mllmin) through the hemofilter and so 
to increase the ultrafiltration flow rate. ',Vith this technique an ultrafiltration flow ratc of up 
to 50 Ucla)' and an urea clearance of34 mllmin may be produced. Further, Kaplan et al [38] 
proved the enhancement of the efficiency of CA VH by infusing the substihltion fluid in the 
arterial line (predilution), rather than in the venous line (postdilution). Infusing replacement 
fluid to the blood within the extracorporeal circuit via the arterial line just before the blood 
inlet port of the hemofilter (predilution) reduces the blood viscosity, hematocrit and plasma 
protein concentration and increases the flow and hydrostatic pressure across the membrane. 
In addition, predilution increases the availability of urea for convcctive transport by favoring 
its movement from the el),throcyte. All of this will increase the ultrafiltration flow rate [38,39]. 
Ronco et al [40] suggested additional dialysis with the same dialyzer. He first used a dialysate 
flow rate of 20 IIh for 2 hours a day and reasoned that at a high dialysate pressure no 
ultrafiltration wauld take place. Thc method was, of course, soon abandoned becausc of the 
considerable risk of'back filtration'. lvIeanwhile Gcronemus et al [41] suggested continuous 
hemodialysis rathcr than hemofiltration. At a dialysate flow rate of 1-2 IIh adequate clearance 
of urea was easily obtained. Unfortunately thdr dialyzer provided very low ultrafiltration flow 
rate. Later thcy suggested the use of highly permeable membranes. 
In 1984, Geronemus et al [42] described the technique of continuous arteria-venous 
hemodiafiltration (CAVHD). They emphasized the role of dialysate flaw in the enhancement 
of solute clearance by diffusion. Infusing a dialysate solution through the filtrate/dialysate 
compartment of the hemofilter countcr-current to thc blood flow cnhances the solute 
transport by diffusion. At that time, Van Geelcn and Vincent [15,16] in the intensive care unit 
of Erasmus University Hospital in Rotterdam were pioneering the technique ofCAVHD and 
they aimed far thc combination of convective and diffusive h-ansport. Solute transport by both 
difilision and convection provides a highcr clearance of urca (with a dialysate flow rate of 1 
1/h up to 25 mllmin against 10 mllmin in CAVH). \'Vithout removing large volumes of 
ultrafiltrate CAVHD has more effective control of uraemia than the CAVH alone. Increasing 
the dialysate flow rate up to 31/h may further increase the urea clearance up to 50 mUmin 
[43]. The dialysate flow rate (up to 4-5 IIh) is considerably less than the rate of P<1tient's blood 
flow through the hemafilter. Complete equilibration of small solutcs should occur between 
blood and dialysate if the blood flow rate is higher than the dialysate flow rate (44). CA VHD 
combines the advantages of CA VB and slow hcmodialysis, and may be performed by 
intensive care unit stalfwithaut the need for dialysis machines and traincd dialysis nurses. The 
technique ofCAVHD was soon to become the first choice treatmcnt of acute renal failure in 
the intensive care setting [3,4,15,16,44-46]. 
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1.3 PHYSICAL PRINCIPLES OF SOLUTE TRANSPORT IN CA VHD 
Continuous arteria-venous hemodiqjiltratioll is the combination of continuous arteria-venous 
hemqfillralioll with slow hemodia[ysis. In CA VHD, solute transport occurs simultaneously by 
combined effects of dialysis and hemofiltration. 
arierial blood ,----------, 
HD 
oullet :;:;;1 _____ ---' 
replacement fluid 
(predilu/ion) 
arterial blood 
CAVHD 
oullet dialysate/ultra filtrate 
replacement fluid 
(predilu/ion) 
replacament fluid 
(or postdilution) 
venous blood 
arterial blood 
inlet dialysate 
CAVH 
i replacement fluid 
; (or postdilution) 
! 
venous blood 
inlet dialysate 
venous 
blood 
ultra filtrate 
Figure 1.1: Principles of the conventional intermittent hemodialysis, continuous arterio-
venous hcmofilh'ation and continuous arteria-venous hcmodiafiltration. 
In Figure l.1, the physical principles orCA VHD, CAVH and conventional hemodialysis are 
depicted. \,Vith CA VH, blood is led through a flat sheet or a capillary hemofilter. The 
hemofilter consists of a blood and an ultrafiltrate compartment, which is separated by a 
membrane. The membrane is permeable to solutes of up to several thousand Daltons. Blood 
flow is driven from the difference between the patienes arterial and venous systemic pressures. 
Transmembrane pressure difference (Ti\ IIP) across the hemofilter membrane results in the 
movement of plasma water from blood into the filtrate compartment. As water moves across 
the hemofilter membrane, it "drags" solutes such as urea and creatinine, with it. This process 
is called u/lrq/i//ratioll for water and cOlwee/ion for solute transport. Filtered water together with 
non-protein bound solutes with low and middle molecular weights (r\1n-\~ is called ultrafilh·ate. 
Thus, the composition of ultra filtrate is similar to that of the plasma water. The quantity of 
solute movement by convection depends on rnolecular size, membrane hydraulic 
permeability, TtvlP and the rate of ultrafiltration flow. For solutes that are far below the 
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molecular 'cut-oir of the membrane, the rate of ultrafiltration alone determines the convective 
mass transport rate. 
The ratio of solute concentration in ultrafiltrate to that in the plasma water retained is called 
solufe Siflrillg cotjjicient. The sieving coefficient depends on the particular membrane (diameter 
of a membrane pore)} the molecular size and protein-binding properties of the solute. Sieving 
coefficient of uraemic solutes such as urea and creatinine equals onc and that of the blood 
cells and proteins equals zero, Proteins and blood cells are too large to cross the membrane 
and remain within the blood compartment and return through the venous end ofhemofilter 
to the systemic circulation. Cations such as sodium and potassium have a sieving coefficient 
of slightly less than one and anions have values greater than one. This is caused by the fact 
that the negatively charged proteins attract cations, resulting in a decreased transmembrane 
movement, and repel anions, causing to an increased transmembrane moveme.nt (Gibbs-
Donnan effect). 
Ultrafiltration does not affect the concentration of solute in plasma water. To inhibit 
coagulation heparin is added continuously to the blood when it enters the extracorporeal 
circuit. To prevent the patient fi·om too volume depleted because oflarge amounts of plasma 
water removed as ultrafiltrate (IO-ISI/day), a substitution fluid is administered to the blood 
either before the blood inlet port or after the blood outlet port of the hemofilter. Replacement 
of the ultrafiltrate with a clean substitution fluid decreases the concentration of both solutes 
and proteins in plasma water, decreases the hematocrit and blood viscosity, and increases the 
rate of blood flow and hydrostatic pressure across the hemofilter membrane by dilutional 
effects. 
In contrast to CA VH, in hemodialysis, diffusive transport is the major principle underlying 
blood purification, especially for the elimination of substances in the low molecular weight 
range, e.g. of urea and creatinine. DiHilsion is a passive and rapid transport process. 
Transmembrane concentration gradient, thus the driving force foJ' the solute diffusion across 
the membrane causes the solutes to diffuse fi.-om plasma water through the hemofilter 
membrane into the dialysate fluid that has an ideal plasma water composition and provides 
the osmotic gradient for diffusion. By running the dialysate fluid through the filtrate/dialysate 
compartment of the hemofilter counter-currently to the blood flow, solute transport by 
convection is enhanced by diffusion. The rate of diffusive mass h'ansport is mainly detemlined 
by the molecular size of solute, the type of particular membrane (surface area, diffusive 
permeability) and the rate of dialysate flow. Solutes with a small fiH'V such as urea (60 
Daltons) and creatinine (l13 Daltons) are removed by diffusion (dialysis), whereas for solutes 
with a l\-I\V greater than 500 Daltons difihsion is less efficient and their removal occurs 
predominantly by convection (hemofiltration). 
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1.4 AIM AND OUTLINE OF THE THESIS 
Continuo~s arterio~venous hcmodiafiltration (CA VHD) has become a widely used renal 
replacement therapy for patients with acute renal failure (ARE). It is a new intensive care 
method of complete renal replacement therapy in the critically ill and unstable kidney patient. 
Despite impressive advances in the intensive care hemodialysis therapy, mallY investigators 
have studied the CA VHD as a continuous renal therapy only from the clinical point of view. 
In 198'~ Van Geelen and Vincent [15,16] in their first experiments with CAVHD, sh'cssed 
the importance of simultaneous convective and diffusive solute transport. Nevertheless, there 
was then virtually no insight in both the dctcnninants of solute and volume transport and the 
relationships between the hemofilter characteristics and operational and clinical conditions 
in CA VHD. For example, it was not known to what extent the CAVRD treatment had 
influence on the disappearance rate of drugs and how slow the dialysate flow rate in the 
presence of ulh'afilh'ation must be to be able to control the patienfs uraemic state. Therefore, 
a study was begun of the physical and mathematical aspects of solute and volume transport 
in CAVHD, so as to be able to optimize the CA VHD treatment. 
The aim of this thesis is to investigate the determinants of blood, ultrafiltration and dialysate 
flow rates on the uraemic solute and drugs clearance, to describe the physical transport 
processes in CA VHD, to formulate the physical relationships between hemofilter 
characteristics and operational quantities, and to access the efficacy of CA VHD compared 
to lBD as far as its side~effects such as hypotension are concerned. This thesis is also to be 
beneficial in the sense of the fact that the dialysis physician should have a functional 
knowledge of the physical principles involved during treatment with a hemofilter. Such 
knowledge allows him to more accurately predict the results of therapy and to optimize the 
treatment protocol. In addition, he must interpret manufacturers' specifications and critically 
evaluate new devices offered for CA VRD. In order to follow the important physical concepts 
involved a certain amount of mathematical manipulation is required, but more rigorous 
mathematical and clinical engineering treatments are reduced to the expressions of clinical 
importance, such as solute clearance, 
Outline of the thesis 
In Chapter 2, the latest developments about the problems encountered in intermittent 
hemodialysis are reviewed from a literature study. Further, the indications and 
contraindications of CA VHD treatment, clinical equipment and its preparation are outlined, 
In Chapter 3, an analysis of determinants of blood and ultrafiltration flow rates is done by 
comparing the clinical observations with the theoretical prediction. In patients treated with 
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CAVHD, serial measurements of blood flow rate, blood pressure and ultrafilh"ation rate were 
performed, so as to estimate the hcmofilter resistance to blood flow and its hydraulic 
permeability. The aim of these studies was to examine the feasibility of predicting hemofiltcr 
performance under clinical conditions. 
In Chapter 4, the results of resistance to blood flow and membrane permeability index 
measured in a laboratory setting arc given. In laboratory setting, for some CA VH(D) capillary 
hemofilters, the resistance to flow was measured with fluid solutions of different viscosity. The 
hemofilters were perfused with saline, sucrose solution, pig blood and human blood as 
perfusion fluid. The effect of hemofilter resistance on the hydraulic performance 
(ultrafiltration) was also investigated by measuring the membrane permeability index and the 
resistance to (human) blood flow simultaneously over a survival time of about 220 hours. The 
aim of these studies was to examine the feasibility of predicting the hemofilter performance 
under laboratol), conditions. 
In Chaptel' 5, a general description of solute and volume transport in CA VHD is given. 
Existing models of conventional hemodialysis are not likely to be useful for the analysis of 
solute transport in CAVHD, since the solute transport in CAVHD differs from that in 
intermittent hemodialysis and hemodiafiltration in several respects. In view of the 
shortcomings of previous models, we developed a new mathematical model of CA VlID. This 
model takes into account the variation of concentration in the blood and dialysate boundary 
layers as well as inside the membrane in the presence of simultaneous diffusive and conve.ctive 
solute transports. The model equations require numerical solutions. 
In Chaptel' 6, analytical solutions to uraemic solute and volume transport in CA VHD are 
presented to calculate the difiusive mass transfer coefficient (I<U) for a solute when blood, 
filtrate and dialysate flow rates and solute concentrations are known. ''''e made some 
assumptions. Then, we introduced analytical solutions to solute and volume transport in 
CA VHD, so as to obtain expressions of the overall diffusive mass transfer coefficient, 
depending on the ultrafiltration volume flux profiles under the following conditions: 
Ko for zero ultrafiltration volume flux (1\.::::0), 
• Ka for a constant (mean) volume flux G,.::::Ja::::Q./S), and 
Kd for a linear decreasing volume flux (J\"::::a+px). 
Further we derived expressions of solute clearance in relation to the overall mass transfer 
coefficients Ko, I~ and I<u. By virtue of the expressions of the overall mass transfer 
coefficients related to solute clearance, the model is well suited for the analysis of solute 
transport by simultaneous convection and diffusion in CA VRD. This was the first detailed 
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analytical mathematical analysis of solute and volume transport in CA VHD and can easily 
be implemented in any spreadsheet program. 
In Chaptel' 7, the model is applied to clinical data obtained with 0.6 m2 AN-69 capillary 
hemofilters. The model equations governing the overall mass transfer coefficients (K", Ku and 
K;I) are evaluated by applying them to data of urea clearance measurements. Our model is 
a useful addition to the existing models of hcmociiafiltration, especially because it allows 
calculation of the diffusive mass transfer coefficient from the clinical data orCA VRD. It may 
be used both as a means to further our insight in the determinants of solute transport in 
CA VHD and to adjust clinical settings, e.g. dialysate flow rate, based on the predicted 
clearance of uraemic solutes. 
In Chapter 8, we studied the determinants of uraemic solute clearance in CA VHD. 
Clearance and its difillsive and convective components of uraemic solutes such as urea, 
creatinine and phosphate were determined in the region of relative low dialysate flow rates 
(OnJ at vaIying blood (Q,J and ultrafiltration flow rates ((1). The degree of conditions in 
which blood-dialysate solute equilibrium can be achieved was investigated. The diffusive 
permeability coefficients (I<,::::SKd) of urea and phosphate were related to diffusive 
permeability coefficient of creatinine. Further, by running a simple sensitivity analysis on the 
overall diffusive permeability coefficient, we analyzed the dependence ofI~ on the flow rates 
and on the strength of concentration driving force at the blood inlet of the hemofilter. The 
sensitivity analysis provides information about the reliability of predicting the K, from flow 
rates and solute concentrations. 
In Chapter 9, we describe a numerical computational method for solving the equations 
governing the mass balance in Chapter 5. The method was applied to the clearance data of 
uraemic solutes and some antibiotic drugs up to 1500 Daltons and to the data ofhemofilter 
hydraulic condition measured during CAVHD, so as to determine the relative weighting 
factors of blood (fo) and dialysate (fd) solute concentrations contributing the convective 
uraemic solute transport and the resistances (Rb + ~ and R d) to diffusion from the overall 
diffusive mass transfer coefficient (KJ within the operational limits of CA VHD. Depending 
on the hemofilter hydraulic condition (~H) and the dialysate flow rates (QIJ, the resistance 
(R,,+RnJ of blood and membrane and the resistance (l~) of dialysate to diffusion were 
determined by 'Vilson's plots. Further, by making use of the capil1my pore theOlY, the 
diffusive permeation coefficients (~) of some antibiotic drugs were related to that of the 
creatinine so as to predict the clearance of antibiotic drugs from the clearance of creatinine 
under the same operational conditions and hemofilter characteristics (a prediction model). 
Predicting the clearance of drugs from the clearance of creatinine is sufficiently accurate to 
be used in the clinic. 
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In Chapter 10, a simulation study was performed to investigate the effect of dialysis 
duration, the rate of urea removal, the flow rate of ultrafiltration and the dialysate sodium 
concentration on the fluid shift, which occurs during intermittent hemodialysis or 
hemodiafiltration therapy. Hereby we determined quantitatively the necessary sodium 
concentration in the dialysate solution to diminish the intercompartmental fluid shift in the 
presence of ultrafiltration. "Ve concluded that CAVHD is a better alternative technique for 
the treatment of patients with serious hemodynamic instability than the intermittent 
hemodialysis or hemodiafiltration. 
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An overview of clinical practice and equipment 
Chapter 2 
2.1 INTRODUCTION 
Intermittent hemodialysis (IHD) is a form of renal replacement therapy, which was developed 
for the h'catment of patients with chronic renal failure. Patients are dialyzed 2 or 3 times a 
week, for 3 to 6 hours per dialysis session. In these few hours, solute clearance (the solute 
removal rate per inlet solute concentration in units of mllmin) has to be high to tide over the 
interdialytic time interval. The high clearances are obtained by a large surface area, a blood 
flow rate of Qoo=200 to 300 mllmin and a dialysate flow rate ofQIi=500 mllmin. During 
dialysis, plasma water is withdrawn to an amount adjusted to the intcrdialytic body weight-
gain (B\VG) of the patient. Acute renal failure (ARF) is a potentially reversible condition. After 
acute tubular necrosis, if the patient's general condition improves, one may expect recovelY 
of kidney function after a period of two to six weeks [1]. In the period of these two to six 
weeks, the clinical condition of critically ill patient is fi·equently complicated by multiple organ 
failure with hemodynamic, respiratory or neurological instability. Treating such a patient with 
intermittent machine hemodialysis is not tolerated. In this chapter we give a short overview 
of the clinical problems encountered during the trcatmcnt of patients with ARF with 
intermittent hemodialysis, with emphasis on the possible consequences for critically ill 
patients. From literature, we review the indications and possible contraindications and finally 
the guidelines of initiating the clinical equipment of a CA VHD system. 
2.2 CLINICAL PROBLEMS WITH INTERMITTENT HEMODIALYSIS 
Dialysis-induced hypotension 
In IHD therapy, the most frequent complication is dia[ysis-induced hypotension [2]. Clinical 
studies show that rapid fluid removal during dialysis often leads to arterial hypotension. In the 
early years of hemodialysis, this was attributed to hypovolemia caused by a fluid removal rate 
that exceeds the rate of fluid mobilization from the interstitial space [3]. However, in 1978, 
Bergstrom et al [4] showed that rapid fluid removal was better tolerated if it were done 
without simultaneous dialysis. During simultaneous hemodialysis and hemofiltration, removal 
of water was easier to perform than during hemodialysis alone [5,6]. Furthermore, it was 
proved that even with isovolemic hemodialysis a reduction in blood pressure could be 
obsetved [7], suggesting that solute transport during dialysis interferes with the mechanisms 
of blood pressure control and therefore contributes to the side effects of the dialysis treatment. 
Some investigators explained this phenomenon by stating that: 
The rapid fall in plasma osmolality causes a fluid shift fi-om the extracellular into the 
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intracellular compartment, the so· called disequilibrium syndrome [4,8,9]. This 
internal fluid shift together with external fluid removal by ultrafiltration decreases 
intravascular volume [10]. 
The response of the autonomic nervous system alters during dialysis treatment [11,12] 
because of either the autonomic neuropathy or the fall in plasma osmolality. 
Sodium concentration in the dialysate solution is not optimal. Schultze et al [13] have 
demonstrated that when using a dialysate containing sodium of 126 mmol/l, the 
patient's mean arterial blood pressure 0~dAP) dropped 30 mmHg and plasma 
prostaglandins (PGEJ and plasma renin acth~ty rose significantly in comparison with 
a dialysate containing sodium of 140 mmolll. By using the dialysate containing 
sodium of 140 mmolll, the drop in blood pressure was only 13 mmHg. On the other 
hand, the finding that sodium balance is identical during hemofiltration (HF) and 
hemodialysis argues against prostaglandins playing an important role in vascular 
stability during HF. 
Interacting the blood with membrane leads to complement activation, which probably 
through the production of arachidonic acid metabolites, causes vasodilatation [13,14· 
16]. 
In a simulation study we also analyzed the influence of dialysate sodium 
concentration, the rate and amount of ultrafiltration, duration ofa dialysis session and 
urea clearance on the h'allscellular fluid shift during treatment with modeled dialysis 
sessions of 1 to 8 hours. The simulation results showed that the magnitude of fluid 
shift from extracellular into the intracellular fluid compartment decreases with slow 
dialysis, high sodium concentration in the dialysate fluid, low rate and amount of 
ultrafiltration and low rates of urea removal (See Chapter 10). 
Usually, the risk of dialysis·induced hypotension poses no severe restrictions to the treatment 
of patients with chronic renal failure. In hemodynamically unstable patients, however, the risk 
of hypotension with H-ID is often unacceptable. In these patients, even with slow dialysis at 
a blood flow rate of 180 mllmin, a recirculating dialysate stream and an ultrafiltration flow 
rate of only 200-300 mllh, hypotension fi:equcntly occurs [17]. 
Hypoxemia 
1f;poxemia is another complication ofIHD therapy. This can be explained by several causes: 
In using the acetate buffered dialysate, the loss of CO2 into the dialysate and a decreased 
respiratory quotient that results from acetate metabolism will both lead to an insufficient 
respiratory drive and hypoventilation [18,19]. A rapid increase in blood pH may cause 
hypoventilation, also with bicarbonate buffered dialysate [18]. The membrane bioillcompa-
tibility gives rise to the secretion of inflammatory mediators that may lead to pulmonary 
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vasoconstriction [16,20-22]. By using dialysate solution containing bicarbonate and more 
biocompatible membranes (such as AN-69, polysulfone) rather than cuprophane, these 
ventilatOlY problems may largely be prevented [20,22]. 
Neurological darllage 
IHD Illay cause neurological deterioration. Patients may become unconscious as a result of uremic 
encephalopathy itself. The patient's uraemic state also has a predisposition to the 
development of seizures [23]. Hemodialysis may, paradoxically, impair the neurological 
condition as a result of sudden changes in pH and osmolality. Kennedy et al [24] and La 
Greca et al [25] have shown that during dialysis U1'ea levels in cerebrospinal fluid decreased 
morc slowly than those in plasma. Aricff et al [26] show that in uremic dogs rapid dialysis 
causes brain edema and seizures. Slow dialysis, although resulting in a similar reduction in 
urea concentration, was not associated with brain edema. The brain edema was caused by a 
fluid shift resulting fi'om an osmotic disequilibrium between plasma and cerebrospinal fluid . 
. Interestingly, it could be shown that the change in osmolality did not result from changes in 
urea concentration alone. The authors suggested that another, as yet undefined, osmotically 
active solute is present in the brain, creating an osmotic gradient between brain tissue and 
plasma. In a clinical study, Port et al [27] demonstrated that the first dialysis treatment caused 
disturbances in the electroencephalogram in virhlally all patients and subjective symptoms of 
disequilibrium in most of them. He compared two groups of patients, one with a normal 
dialysate sodium concentration and one \\~th an increased dialysate sodium concentration in 
order to prevent the h1.l1 in plasma osmolality. He found that by this intervention, neurological 
problems could be prevented. Davenport et al [28] showed that, in case of hepatic 
encephalopathy cerebral perfusion pressure falls during intem1ittent hemofiltration treatment 
but not during CA VH. 
In conclusion, rapid removal of solutes and fluids in intermittent hemodialysis has some 
disadvantages. These are indications that, in order to prevent neurological complications of 
dialysis, one should aim for slower solute transport rates. Therefore, in patients with 
neurological problems, continuous treatment methods are to be preferred. In general, these 
problems do not impede the treatment of chronic renal f.:1.ilure patients. ',Vith acute renal 
f.:1.ilure patients, however, hemodynamic, neurologic and/or respiratOlY instability, inherent 
to the cause of the renal failure, are the most frequent problems encountered. These problems 
call for a more gentle approach, i.e. by continuous methods, such as CA VH or CAVHD. 
2.3 INDICATIONS FOR CAVHD 
In section 2.2, it was stated that the patients with ARF must be treated \\~th a more gentle 
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approach, such as CA VHD. In the University Hospital Rotterdam, the official indications for 
CAVHD arc cases of renal failure complicated by circulatory, respiratory or neurological 
instability, and cases of renal failure in which daily dialysis treatment would be needed. In 
general, patients treated by CAVHD are patients who have had major surgery or patients 
with sepsis and multiple organ failure, including renal failure [1]. 
Circulatory instability 
The single and most important reason for treating patients with CA VHD is the renal failure 
in combination with circulatory instability. The combination of low or unstable blood 
pressure and edema makes it quite difficult to judge how much fluid can be withdrawn safely. 
In case of a compromised myocardial function, the vascular refilling rate during ultrafiltration 
will be very slow. If such patients would be treated with IHD, this would lead to osmotic 
disequilibrium by which vascular refilling is further impaired (See Chapter 10). 'Vith 
CAVHD, due to the low rates of uraemic solute removal, osmotic disequilibrium is prevented 
[29] and fluid removal occurs more gradually. Indeed, several studies have shown improved' 
vascular stability during treatment with CA VHD [30-3'}]. 
Respiratol'y failure 
(Threatening) respiratory f.1.ilure due to fluid overload alone is not necessarily an indication 
to use continuous instead of intermittent techniques. These patients are best treated with 
ultrafiltration. However, if a patient with renal failure is weaned from the ventilator with 
difliculty, CA VHD is to be preferred over IHD. The latter may lead to a diminished 
respiratory drive and may lead to pulmonalY vasoconstriction. The latter phenomenon is 
attributed to bioillcompatibility of the membrane [35,36], In CAVHD only the more 
biocompatible synthetic membranes are used. fi'Ioreover, by the longer duration of usc, 
protein adsorption to the membrane minimizes any bioillcompatibility effects [37-39). 
Neurological instability 
Neurological instability is another indication for CAVHD. Neurological disturbances during 
IHD arisc from an osmotic disequilibrium betwecn blood and cerebrospinal fluid [40-42]: 
Again, with CA VHD, by the lower rate of solute removal, osmotic disequilibrium is 
prevented. This was borne out by the study of Davenport et aI [43], who showed that in 
patients with hepatic encephalopathy cerebral perfusion pressure fell after intermittent 
hemofiltration but was preserved during treatment with CAVH. 
Need foJ.' daily dialysis tJ.'eatnlent 
Another indication to choose continuous instead of intermittent treatments is the need for 
daily dialysis treatment. Patients with ARF, especially those with sepsis, are in a hyper 
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metabolic state with fever, an increased cardiac output and an increased resting energy 
expenditure [44]. Therefore, there is an increased demand of both energy and proteins. The 
positive cumulative caloric balance is associated with improved overall sUlvival [44-46]. To 
obtain a positive calOlic balance, patients often receive total parenteral nutrition, which may 
be complicated by vcry high rates of urea production and fluid overload. Until recently, this 
necessitated daily hemodialysis and ultrafiltration. Nowadays these problems are casily 
managed by CA VHD [47-50]. Indeed, patients with multiple organ failure treated by CAVH, 
show a positive energy balance and higher survival rates compared to patients treated by 
intermittent methods [51]. Compared to IRD, the rate of uremic solute removal is lower in 
CA VI-ID, but at usual dialysate flow rates the total removal per day is similar. Furthermore, 
intermittent therapies cany the risk of fluid overload in the period between two treatments. 
This risk is avoided by CA VRD. "Vith both treatment modalities one-should realize that 
amino acids are removed to a certain extent [52-56] but the rate of removal is small when 
compared to the. rate of administration. Another example of a situation, which used to be 
dealt with by daily intense dialysis treatment, is kidney transplantation in a patient with 
primary hyper oxaluria. In these patients plasma oxalate levels should be kept below 20 
Jlmolll [57] until the graft functions well. This is virtually impossible with intermittent 
treatment. 'Vith CAVHD, at a dialysate flow rate of approximately 4-5 IIh, however, a 
constant plasma oxalate clearance of 40·50 mllmin can be obtained, which suffices to control 
hyperoxalemia. 
Multiple ol'gan failul'e ... 
It has been hypothesized that continuous techniques can eficctively remove inflammatory 
mediators associated with sepsis, the adult respirator distress syndrome (ARDS) and multiple 
organ failure [58,59]. This prompted Paganini et al [60] to study the eIlect of CA VH in 
patients with ARDS who had no renal h"lilure. In that study, a beneficial effect on the course 
of ARDS could not be demonstrated. It is likely, however, that for most peptides endogenous 
clearances are much faster than their removal by CA VH or CAVHD. Therefore current 
research still focuses on the precise pathophysiological mechanisms involved in the multiple 
organ h1.ilure syndrome. The trend is to look for ways to more selectively remove or neutralize 
the key pathogenetic h"lctors by affinity columns or specific antibodies or drugs. 
Logistic problems 
Logistic indications for treatment with CAVHD are especially justified if frequent dialysis 
treatment would interfere with other aspects of patient care and if the arterial blood access 
poses no particular problem. Frequent and prolonged investigations or operations can 
proceed without disconnecting the hemofilter. 
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2.4 CONTRAINDICATIONS 
In general view, CA VHD is contraindicated only if the extracorporeal circuit interferes with 
the mobilization of the patient or because of problems with the arterial blood access. Thus, 
when a patient, who has been treated with CA VHD recovers, one tends to continue the 
treatment by IHD [63]. In case of problems with arterial blood access, the use of pumped 
veno-venous hemodiafiltration should be considered. The main disadvantage of the pumped 
technique is that in this case more specialized personnel is needed to watch this system. 
Ivforeover, if the pump is equipped ,,~th all the necessary alarms and safeguards, this implies 
that the pump is frequently interrupted which may lead to clotting of the system. 
Dialysale fluid 
Pump 
Heater 
Dialysate 
Inlet 
I Dialysale 
..J., Oullel 
Colleclion bag (urometer) 
Blood ouliel 
Blood inlet 
Replacement nuid 
(Predilution) 
Pump 
Venous blood 
.; 
Arterial blood 
Heparin infusion 
Figure 2.1: A schematic representation of a CAVHD system [63]. 
2.5 CLINICAL EQUIPMENT OF CAVHD 
The extracorporeal circuit used for CA VHD is shown in Figure 2.1. The patient is connected 
via a flexible tubing from the artelial access to the arterial port of the hemofilter. Blood from 
the arterial line circulates through the hemofilter, and returns to the patient from the venous 
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port. Blood pumps are not required. Heparin is infused into the arterial line. Dialysate is 
administered either by gravity or infusion pump counter-current to blood flow. Dialysate and 
additional ultrafiltrate are collected in a graduated ultrafiltration or dialysate collection bag. 
A substitutio-n fluid is administered into the arterial line (predilution) or into the venous line 
(postdilution). A list of the necessary equipment for CA VI-ID is given below: 
• catheters for arterial and venous access (and the disposables used for their 
introduction), 
a small surface high-flux hcmofiltcl', 
• arterial/venous blood tubing set with at least an entrance port in the arterial blood 
line for heparin administration and preferably an additional arterial and/or venous 
port for administration of substitution fluid, 
• ultrafiltration line, infusion line for substitution fluid, infusion line for dialysate fluid, 
graduated ultrafiltration collection bag or urometer, 
heparin pump, 
• pump for substitution fluid, which can deliver up to 1000 mUh 
dialysate pump which can deliver up to approximately 5 lIh, 
weighing device, dialysate heater, 
• heparin, substitution fluid, dialysate fluid, 
two liters of rinsing fluid: NaCl 0.90/0, containing heparin 5000 V/1. 
Blood access catheters 
Vascular access is achieved by means of an arterial shunt, either via femoral arteq' and vein 
catheters inserted percutaneously with a Seldinger wire technique or surgical insertion of a 
Scribner forearm or leg shunt [64]. In CA VHD, blood flows spontaneously. Low blood flow 
rates may lead to excessive hemoconcentration and to early clotting of the hemofilter. 
Therefore, Geronemus and others [61-65] prefer the use oftow resistance femoral catheters 
which allow high blood flow rates [66], but have reported occasional problems with bleeding 
and hematoma formation at the site of insertion. Reported complications of arterial 
cannulation include dissection, thrombosis, false aneUlysm formation, fistula formation, 
infection, and superficial 01' retroperitoneal bleeding. However, Kramer et al [67] have 
demonstrated that these complications were considerably reduced when specially designed 
short catheters were used exclusively. CAVH-catheters are best placed in the femoral artery 
and vein. These vessels are usually wide enough to accommodate the catheters and the 
introduction procedure is simple. If the femoral vessels cannot be used, one may consider 
using the axillary or brachial artelY and the jugular or subclavian vein for access. If a patient 
has a vascular prothesis of the femoral artery located less than 20 em above the groin, the use 
of the f~moral artery can be hazardous. Sometimes, due to extensive arteriosclerosis, 
cannulation of the femoral artery is impossible. In such cases, the axillary or brachial artery 
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or, if blood pressure is high enough, a Scribner shunt may be used as an alternative vascular 
access. Scribner shunts may be placed in the lower leg or in the forearm. In recent series, with 
the use of special CA VH~catheters, the incidence of damage to the femoral artery was 
reported to be 2% [1,68]. Furthermore, in a retrospective analysis, Swann et al [69] found no 
evidence for either sepsis or increased morbidity related to catheter infections. 
HenlofiIter 
For CA VHD one needs a small surface highly permeable hemofilter with a low resistance to 
blood flow. High flux characteristics usually coincide with good biocompatibility [70]. 
For optimal function a high diflhsive permeability is also required. Protein adsorption to the 
membrane surface causes a decrease of membrane permeability in time. In view of the long 
duration of use, obviously, protein adsorption is undesirable. The typical hemofilter used for 
CAVH or CAVHD has short capillaries with a diameter of between 220 and 280 11m and a 
membrane surf..1.ce area of between 0.16 and 0.7 m'2. In CAVH high~flux membranes are used 
in order to obtain adequate convective clearance. In CA VHD clearance occurs more by 
diffusion than by convection. The rate of ultrafiltration must still be high enough to be able 
to withdraw several liters of fluid per day. "Vhen using a high flux membrane, a total 
membrane surface area of 0.6 m2 is enough to obtain an ultrafiltration rate of300 to 1000 
ml/min. A much larger membrane surface area is undesirable for two reasons: 1) It leads to 
an excessive ultrafiltrate production and thereby necessitates substitution infusion rates that 
are above the range of the intravenous infusion pumps that are generally available. 2) It 
implies more extensive contact between blood and membrane material and, hence, a greater 
risk of clotting. 
The life span of each hemofilter is limited by a reduction in efl1ciency over a period of 
continuous use or by clotting of the extracorporeal circuit. The hydraulic efficiency of the 
hemofilter may be monitored by regular comparisons of the membrane hydraulic 
permeability coefficient or ultrafiltration coefHcient, which we call the hydraulic permeability 
index. Also regular monitoring the diflhsive mass transfer coefficient of urea will reflect the 
diffusive pelformance of the hemofilter during the treatment. If the membrane permeability 
becomes POOl', as reflected by an ultrafiltration rate or less than 200 mUh, the hemofilter may 
be changed. The average life span of a non~c1otting hemofilter is about 2 days but may be as 
long as 5 days [62]. 
Dialysate fluid 
In CA VHD sterile dialysate IS necessary in order to prevent back~transport of possible 
contaminants) such as pyrogen, from dialysate to blood [71~73]. It is easiest to use a 
commercially available hemofiltration substitution fluid as dialysate fluid, which come in bags 
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of up to 5 liters. Dialysate fluid for peritoneal dialysis is less suitable for usc in CA VHD, 
mainly because of its low sodium content and high content of glucose (See Table 2.1). After 
a few days oftrcatll1cnt with CAVHD at a dialysate flow rate of 1 lIh, Vos [63] reported that 
they have frequently encountered hypokalemia, hypophosphatemia and alkalosis. In their 
view therefore, the composition of an ideal dialysate solution should be so as to prevent 
electrolyte derangements during the stable phase of CA VHD treatment. At the start of 
treatment, when serum potassium and phosphate are high and bicarbonate is low, the same 
dialysate fluid may still be used albeit at a higher dialysate flow rate. They would not advocate 
the use of a range of different dialysate solutions, both because it is impractical and because 
it offers no guarantee that individual modifications or supplementation are no longer needed. 
Until recently, all solutions contained either lactate or acetate as a buffer substitute, since the 
addition of bicarbonate would be precluded because of precipitation with calcium and 
magnesium. Presently, we use for dialysate a fluid to which bicarbonate is added just before 
use. ''''hen used within 24 hours, precipitation of calcium carbonate is negligible. ',Vith 
bicarbonate containing fluids, the possible harmful enects of acetate and the inconvenience 
of spurious elevation of blood lactate is eliminated. Furthermore, Jenkins et al [74] have 
demonstrated that in children on CAVHD who havc persistent metabolic acidosis, changing 
from lactate~buflcred dialysate to bicarbonate-bulTered dialysate considerably improves the 
metabolic acidosis. 
Table 2.1: Composition of fluids which can be used for dialysate fluid in CA VHD 
(mmolll) [63] 
Dialysate fluid Na+ K+ Ca2+ Mg" Cl- Lact Ac· HC03- Glucose 
Fres. HFll 140 1.63 0.75 101 45.0 0 0 10.9 
Fres. HF21 135 2 1.88 0.75 109 33.8 0 0 8.3 
Fres, HF02 140 0 2.00 1.00 III 0 35 0 0 
Schiwa SH-44 HEP 140 2 1.75 0.50 112 2.9 0 31.4 5.6 
Schiwa SH -35 HEP 140 0 1.75 0.50 110 2.9 0 31.4 5.6 
Schiwa SH-36 HEP 140 4 1.75 0.50 114 2.9 0 39.7 5.6 
Schiwa SH~41 HEP 141 0 0 0.72 108 0 0 34.3 5.6 
HospalLO 140 0 1.75 0.75 100 45.0 0 0 0 
Hospal L2 JoI2 2 2.00 0.75 110 40.0 0 0 0 
Hospal LC4D 140 
" 
2.00 0.75 110 40.0 0 0 6.1 
Cambro Hemofiltrasol 21 140 1.60 0.75 100 45.0 0 0 11.1 
Cambro Hemofiltrasol 22 140 0 1.60 0.75 100 45.0 0 0 11.1 
Cambro Hcmofiltrasol 23 140 1.80 0.75 100 45.0 0 0 11.1 
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Substitution fluid 
For substitution fluid one may use simple Ringerts lactate. In case of hyponatremia, the 
addition of 1 gr NaCI to 500 ml ofRingerts lactate so as to increase its sodium concentration 
to 180 mmol/l (in case of predilution) will correct the hyponatremia. Alternatively, if the 
patient is no longer acidotic, one might consider the use of isotonic saline for substitution fluid. 
Substitution can be given either by infusing the fluid on the arterial line (predilution) or on the 
venous line of the hemofilter (postdilution). Predilution has several advantages [75,76]. By 
predilution the hematocrit and the plasma protein concentration are decreased, which leads 
to a decrease of the blood viscosity and an increase of blood flow rate. The flow rate of the 
substitution fluid must be acljusted hourly to the rate of ultrafiltration so as to achieve the 
desired fluid balance. 
Pumps and weighing devices 
For safety reasons the use of a pump in the blood linc is not advised. If onc were to use a 
pump in the blood line, this would at least necessitate the use of a bubble trap and a device 
for monitoring the pressure in the arterial blood line, immediately after the pump (in order 
to detect clotting of the hemofilter) and preferably also in the venous blood line. One might 
also argue that the extracorporeal system ought to be supervised by a renal nurse. For 
pumping dialysate fluid, a special pump, that may deliver up to 3~5 I/h, is useful but a simple 
screw clamp will also do. As dialysis fluid comes in big bags, it is necessary to use a weighing 
de\~ce to check the amount of dialysate delivered evel')' hour. The total amount of ultrafiltrate 
plus spent dialysate may be measured either by weighing or by using a calibrated container. 
''''hen substihltion fluid is given into the arterial line Cpredilutiont), an infusion pump, has to 
be used because of the high pressure. In view of the high ultrafiltration flow rate that occurs 
in the first few hours, this pump must be able to deliver up to 1000 mllh. 
Anticoagulation and clotting 
The main detem1inant of clotting in CA VHD is blood flow or the lack thereof. In CA VHD, 
one deals with an extracorporeaI system with low pressures and low blood flow rates. The 
interruption of flow by kinking of lines or catheters promotes clotting. Cooling of the blood 
in the connecting lines also increases viscosity and reduces the blood flow. It is therefore 
important to obtain a blood flow rate at all times as high as possible. For this reason, the use 
of low resistance circuit is beneficial. The main dcterminant of the level of anticoagulation 
necessary is the presence or absence of clotting of blood in the extracorporeal circuit. Clotting 
may be suspected if there is sharp fall in the ultrafiltration flow rate or if the blood lines 
become dark. The most useful policy against the clotting is to give the patient a bolus dose of 
500 units per hour of heparin prior to connection to the extracorporeal circuit. Thereafter, 
between 500 and 1000 units/hour of heparin is infused via a syringe pump into the arterial 
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line proximal to the hcmofiltcr. The dose may be changed to between 250 and 750 U/h as 
clinically indicated. ""hen platelet counts comes below 20'109 /1, no heparin is needed at all. 
One might consider regional heparinization, i.e. heparin in the arterial line and protamine 
in the venous line [77]. Recently .~vlehta ct al [78,79] have published a scheme for citrate 
anticoagulation in CA VHD. 
2.6 PRIMING AND INITIATING CAVHD SYSTEM 
It is extremely important to properly prime the hemofilter for CAVHD. The purpose of 
priming a hemofilter is to purge an ail' and, with some hcmofilters, glycerine, which is used 
to prevent dehydration of the membrane. The hemofilter is primed from blood side as well 
as fi'om the dialysate side if it is necessary. On the blood side, the priming is accomplished via 
a gravity flow of 2 I saline containing 5000 or 10000 VII ofhep.rin [61,62). The dialysate 
side is primed via the gravity flow of the dialysate fluid. Here follows a complete description 
of priming procedure [63): 
Attach the blood lines and the ultrafiltrate line to the hemofilter. The ultrafiltrate 
outlet has to be situated on the arterial site of the hemofilter. 
Place the hemofilter in a holder in the upright position, the venous port at the top. 
Connect the proximal end of the arterial line to the rinsing fluid bag and the distal end 
of the venous line to an empty sterile bag. 
Clamp the ultrafiltrate Hne and run 1 to 11f? liters of heparinized saline through the 
blood lines and through the hemofilter under gravity flow. 
fvIake sure that side ports have been rinsed as well and that all air has been eliminated. 
Then unclamp the ultrafiltrate line and damp the venous line. 
Run Ii? liter of heparinized saline through the system. Hereby forced ultrafiltration 
will occur and glycerine is rinsed out of the pores of the membrane. 
Finally unclamp the venous line and rinse the rest of the fluid through the system. 
After priming, the pumps, heater, urometer, heparin, substitution fluid and dialysate fluid are 
connected to the system and the hemofilter, filled with rinsing fluid, is connected to the 
catheters. After connecting the catheters, the hemofilter is placed in a vertical position at a 
level of the patient, about 50 cm above the ultraiHtratcl dialysate container in order to get a 
negative pressure in the dialysate compartment and thereby enhance the rate of ultrafiltration. 
It is customaty to position the hemofilter with the dialysate outlet up, in order to make sure 
that any air in the dialysate compartment leaves the compartment immediately. There should 
be no direct contact between the sterile dialysate exit port and the container in which 
ultrafiltrate and dialysate are conected. The hemofilter is left in place as long as it functions 
well. If ultrafiltration rate falls below 200 mUh, and kinking of the catheters or blood lines has 
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been excluded, the hemofilter is replaced. If the patient must be transported, it is easiest to 
temporarily disconnect the dialysate infusion line and fix the hemofilter onto the leg of the 
patient. 
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DETERMINANTS OF BLOOD AND ULTRAFILTRATION FLOW 
RATES. Clinical observations and theoretical predictions 
Chapter 3 
3.1 INTRODUCTION 
Continuous artclio·venous hemofiltration (CA VH) and hClllodiafiltration (CA VHD) are used 
in intensive care units for the treatment of patients with acute renal f..1.i1ure. Both techniques 
are based on spontaneous blood flow and spontaneous ultrafiltration. CA VHD works by 
achieving arterial and venous vascular access, and perfusing a small hemofilter taking the 
benefit of the patient's arterial blood pressure instead of a blood pump. At a rate depending 
on the desired overall fluid balance, substitution fluid is infused [I]. ~'lany nephrologists feel 
that CA VH(D) is the optimal form of renal replacement therapy in critically ill patients. 
However, failure of the technique may occur due to an inadequate blood flow rate, leading 
to excessive hemoconcentration and clotting. It is therefore important to obtain an adequate 
rate of blood flow through the hemofilter, so as to minimize the risk of excessive 
hemoconcentration and clotting. 
Theoretically, blood and ultrafiltration flow rates may be predicted on the basis of geometl)' 
of the extracorporeal circuit, membrane characteristics and blood viscosity. In their ill vitro 
simulation and mathematical model ofCA VH, Pallone et al [2] reported that they were able 
to predict the hemofilter pelfOlmance in a laboratory setting. The resistance to blood flow was 
in good agreement with their model predictions. However, Olbricht et al [3] found in a 
clinical study that the resistance to blood flow was 3 times higher than expected. 
The aim of the present study was to examine the feasibility of predicting hemofilter 
performance under clinical conditions. In patients who were treated with CA VHD, serial 
measurements of blood flow rate, blood pressures and ultrafiltration rate were performed so 
as to estimate the hemofilter resistance (Rr) to blood flow and its hydraulic permeability index 
(~\'II). The resistance of each component of the extracorporeal circuit was predicted from their 
geometry and blood viscosity and then compared with the measured values. The blood and 
ultrafiltration flow rates were recorded during the whole CAVHD treatment in order to 
observe the time courses ofi\H and Rr . The hemofilter resistance to blood flow was also 
measured in a laboratory setting (See Chapter 4). Clinical and laboratory data were then 
compared with the theoretical predictions. 
3.2 RESISTANCE TO BLOOD FLOW 
The cxtracorporeal circuit of CA VHD consists of components of arterial blood access 
(catheter and tubing), hemofilter and venous blood access (tubing and catheter). In the 
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follO\\~ng, the variables and constants relating to arterial access, hcmofiltcr and venous access 
are denoted by the subscripts aa,fand va respectively. The blood flow rate (Qrn.) circulating 
through the extracorporcai circuit depends on the intra-arterial (Pi,,) and intra-venous (Pi-..) 
blood pressures and undergoes a total resistance (Rt): 
Q
be 
= Piu - Pi\' 
R, 
(3.1 ) 
in which the intra-arterial pressure (Pi,,) is taken to be equal to the mean arterial pressure 
(MAP), measured from the femoral artery and the intra-venous pressure (Pi..) is taken as the 
mean venous pressure (~vlVP), measured from the femoral vein. 
Observed resistance of the extl'acol'pol'cal circuit to blood flow 
The total resistance (RJ is the sum ofRJa , Rrand R .. Il each representing the resistance of the 
arterial access, the hemofilter and the venous access respectively: 
(3.2) 
To calculate the total resistance (RJ in mmHg per milmin, the individual resistances of the 
extracorporeal circuit have to be calculated on dividing the pressure drop across the 
component by the blood flow rate: 
(3.3) 
(3.4) 
(3.5) 
in which Phi [mmHg] is the prefilterR , Poo [mmHg] the postfilter hydrostatic blood pressure, 
Qro [mIl min] the arterial blood flow rate, ~rcl[mllmin] the infusion rate of substitution fluid 
and Qr [mllmin] the flow rate of ultrafiltration. 
Predicting the blood flow rate cit'culating in the extracorporeaI circuit 
In the previous equations, the blood flow rate (Q,J entering the extracorporeal circuit is 
assumed to be measured. However, in most clinical applications ~'.1 is not measured and 
must be estimated fiom the overall circuit resistance (l~.,,) and the blood viscosity. Under the 
conditions of our study, with shear rates of 150 to 400 sec·], blood may be regarded as a 
Newtonian fluid [4]. Furthermore, within the fibers and channels the blood flow is laminar. 
Therefore, we also calculated the resistance to blood flow from the geometry of each 
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component using the Poiseuille Jaw. The total circuit resistance to blood flow is predicted as: 
(3.6) 
where R-aa,p; Rr,p and R-.l,p represent respectively the resistance of the arterial access 
components, the hemofilter and the venous access components, which are predicted from 
manufacturers' specifications and blood viscosity. Resistance of the arterial access (Raa,p) is 
calculated from [2]: 
R = 128 L 
oa,p 1C j (3.7) 
where the sum is over the number G) of arterial access components with Lola em] the length, 
daa[m] the internal diameter and llaa [mmHg min] the blood viscosity in the arterial access. 
The resistance to blood flow (ltr,p) for a capillmy hemofilter is calculated fi'om: 
64 (~b1 + 1)",)L[ 
Rf,p = 4 (3.8) 
" Nd[ 
where 1,- [m] is the length offibers, N the number of fibers, d f I}tm] the internal diameter of 
a fiber, 'I1bi and '1100 [mmHg min] the blood \~scosity at the blood inlet and outlet respectively. 
For a plate hemofilter the R{,p is calculated from: 
3 (~" + ~",)L, 
R[.p = _'-'-"'-----'""'c,---' 
4 Nc wclzbc 
(3.9) 
where 4 [m) is the length of blood channels, N, the number of blood channels, w, the blood 
channel width and hoc em] the blood channel haLf-height [5]. Resistance of the venous access 
(R".p) is calculated as: 
R = 128" 
I"a,p 1t Lj (3.10) 
where the sum is over the number G) of venous access components with L,'a em] the length, 
d..,. em] the internal diameter and '1100 [mmHg min] the blood viscosity at the blood outlet of 
the hemofilter that equals the blood viscosity in the venous access ('I1\.J in case of predilution. 
Normalized resistance to blood flow 
Parameters like the length, internal diameter, number of fibers or channels, channel width, 
channel half-height and membrane total surface area of the circuit components are mostly 
determined from manufacturers' specifications. From these specifications it is possible to 
calculate the individual circuit resistances to the blood flow and compare them with the 
obsetved resistances. 'Ve therefore defined normalized resistance to the blood flow 
(R,.,,[IO'/ml] on dividing the obselved resistance (RJ by the predicted blood viscosity (11;): 
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(3.11 ) 
where the subscript i represents the subscript aft for the arterial access) the subscriptJfor the 
hemofilter and the subscript va for the venous access. The normalized resistance to blood flow 
is the same as the resistance calculated from the geometty. 
Predicting the blood viscosity 
The blood viscosity (1)[,) depends on plasma protein concentration (Cp)' hematocrit (Ht) and 
temperature (T). In narrow tubes blood viscosity may decrease according to the Fahreaeus~ 
lindqvist effect. "Vith a diameter of200 to 240 ).un, however, the decrease in blood viscosity 
is less than 5% and may therefore be neglected [6J. \Ve calculated the blood viscosity from 
an empirical formula as described by Pallone et al [7]: 
~ 0 I 449 ~ e,·303 '>0) 
'1 b • '1 b,37 (3.12) 
where 11[',37 is the blood viscosity at 37 °e and the constant 1.449 represents the ratio of water 
viscosity at 20 ° C to that at 37 ° C. The term y(T) represents: 
'(I) 0 1.327'(20 - I) - 0.OOI05·(T- 20)' 
) T+ 105 
in a range of20~T~ 100°C. The blood viscosity at 37°e is given by 
11, 31 0 ~ 37(1 + 2.5Ht + 0.0735Ht') 
• p. 
The plasma viscosity at 37 ° C is given by: 
C 
IIp,37 == 1l1l',37 + (fJpn - 11 w,37) cP 
p" 
(3.13) 
(3. H) 
(3.15) 
where the water viscosity (1111',37) at 37°C is 0.864xlO-7 mm Hg·min. The normal plasma 
\~scosity (11p,J is 1.54x I 0-7 mm Hg'min at a plasma protein concentration of Cpn ::::.7 g/ dl. The 
values ofll aa) llbi ancilloo' representing the blood \~scosit}, in the arterial access, the hemofilter 
blood inlet and the hemofilter blood outlet respectively are calculated from the boundary 
values of hematocrit and protein concentration (Hti ) Hto ) Cpi) Cpo). Blood viscosity in the 
arterial access (ll.:J is calculated from eq.(3.12) by substihlting arterial hematocrit (HtJ in 
eq.(3.1+) and arterial plasma protein concentration (C.J in eq.(3.15) and a blood temperature 
of3JOe in the patient in eq.(3.13). The blood temperahlre in the extracorporeal circuit has 
to be measured. Blood viscosity (11bU at the blood inlet is calculated from eq.{3.12) by 
substituting the plasma protein concentration (Cp;) at the blood inlet in eq.(3.15) and the 
hematocrit at the blood inlet (Ht;) in eq.(3.1 +) from: 
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(I - HI,) Cp,Q"" 
(1 - HI,) Q"" + QWd 
Hla Q"" HI = 
f Qba + Qpfed 
Chaptel' 3 
(3.16) 
(3.17) 
Likewise, the blood viscosity (1]",) at the blood outlet is calculated from eq.(3.12) by 
substituting the plasma protein concentration at the blood outlet (Cpo) in eq.(3.l5) and the 
hematocrit at the blood outlet (Hto) in eq.(3.14) from: 
C = (1 - HI,)Cp,Q", 
P' (I - HI,)Q"" + Qp"d - Qf (3.18) 
(3.19) 
Observed resistance versus predicted resistance 
From a theoretical point of view, the obsctvcd resistance must be equal to the resistance 
calculated fi'om the circuit geometty and blood viscosity. In practice however, because of 
uncalculated pressure losses, geometrical differences, and the way of calculating the blood 
viscosity, the predicted resistance of each circuit component differs from the measured 
resistance. The ratio of the measured resistance (R;) to the predicted resistance (Rj,J is denoted 
with (tj: 
", (3.20) 
where the subscript i represents the subscript aa for the arterial access, the subscript/for the 
hemofilter and the subscript va for the venous access. 
3.3 MEMBRANE HYDRAULIC PERMEABILITY INDEX (MI) 
Membrane hydraulic permeability index (MI, [mllll"mmHg) or the ultrafiltration coefficient 
is used to indicate the hydraulic pel{ormance of the hemofilter during a CA VHD treatment. 
''''e defined the membrane permeability index as the product of the hydraulic permeability 
coefficient (1"" [ml/(m"mill"mmHg) and the total surface area of the membrane (S, [m'). 
:MI is calculated from the measured rate of ultrafiltration flow and the mean transmembrane 
pressure difference (TMP m' [mmHg) as: 
(3.21) 
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The membrane hydraulic permeability coefficient~) is calculated from eq.(3.21) as: 
L = QJ 
P S'TMP 
m 
The mean transmembrane pressure diflerence (T~IIP m) was calculated as: 
1 
TAt/Pm = 2 (Pbi + Pbt) - Pd - IIpm 
(3.22) 
(3.23) 
where Pd [mmHg], the pressure midway in the ultrafiltration /dialysate compartment, was 
calculated fi-om the height of the fluid column (hJ in the ultrafiltration line: 
h, P =--
d 1.36 (3.24) 
where 1.36 is a cOIlversion factor from cmH20 to mmHg. Further, IIpm , representing the 
mean oncotic pressure caused by the plasma proteins, is calculated according to the equation 
of Landi, and Pappenheimcl' [8): 
npm = 2.1Cpm+0.16C:'II+O.OO9C},1I 
where Cpm [g/ dl] is the mean concentration of plasma proteins: 
1 
Cpm = 2( Cpj + Cpo) 
(3.25) 
(3.26) 
with the protein concentration at the blood inlet (Cpi) and that at the blood outlet (Cpo), The 
Bernouilli efiects were thus neglected. Equation (3.25) had previously been found to fit 
experimental data closely over the range 0 to 25% of protein [9,10]. ''''hen we compared the 
measured values with the calculated, the difference was always less than 5 mmHg [II]. 
3.4 METHODS 
Clinical protocol and Ineasnrelnents 
In this ShIdy we determined the resistance to blood flow of the extracorporeal device as well 
as the hydraulic permeability of the hemofilter membrane in intensive care patients treated 
with CAVHD. Twenty patients were treated with CAVHD for acute renal failure and sepsis 
and/or circulatory or neurological instability (See Table 3.1). The CAVHD circuit was 
installed as depicted in Figure 3.1 (for details, see Chapter 2). A hemofiltration Sllbstitution 
solution (HF-II, Fresenius, Germany) was used as dialysate fluid. ~or both vascular and 
venous blood access we used: 
• CAVH-catheters 11.4 em long with an internal diameter of 2.7 mm (!v18CAVH4, 
~IIedcomp) in the femoral vessels, Shaldon catheters 15 cm long with an internal 
diameter of 2.3 mm, and Scribner shunts, 
• arterial standard polyvinylcholoride (PVC) hIbing 0.9 m long with an internal 
diameter of 4.36 mm, venous standard PVC tubing 1 m long. 
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Three types ofhemofiltcrs were lIsed (See also Table 4.1 in Chapter 4): 
• a polyacrylonitrilic (AN-69) plate hemofilter (15 compartments, length 26.8 eIll, width 
6.7 em, channel height 200+0.26·T~vlPm pm, membrane surface 0.43 m2; 
SCU/CA VHD, Hospal, France), 
• a polyaclylonitrilie (AN-59) capillary hernolilter (5000 fibers, total length 15 em, 
including 2 em \\~thin potting, internal diameter offibers 240 f-tm, and 220 llIn ,,~thin 
potting, membrane surface 0.6 m2; .~...ttlltiflow-60, Hospal, France) and 
• a polysulfone (PS) capillary hcmofilter (4600 fibers, total fiber length 8.5 em, internal 
diameter of fibers 200 ,.un, membrane sUrh1.ce 0.23 m2; Spiraflo HFT02, Sarin 
Biomedica, Italy); all specifications according to manufacturers. 
dialysate 
fluid 
subslitution fluid 
-TPN 
- blood, etc. 
Figurc 3.1: A schematic representation of a CA VHD system. 
Hemofilters were prepared by rinsing the blood compartment with 2 liters of saline containing 
heparin 5000 U/I, al1O\\~ng filtration to take place. Hemofilters were placed in the upright 
position, with the ultrafiltrate outlet up. Ultrafiltrate column height was about 60 cm. 
Standard anticoagulation consisted of heparin 500 U Ih, infused into the arterial line of the 
hemofilter. No loading dose of heparin was given. No protamine was used. Three patients 
received no heparin because of excessive bleeding, thrombocytopenia or hepatic failure and 
coagulation disorders. Ringer's lactate as substitution fluid was infused into the arterial line 
(predilution). The amount of substitution fluid was adjusted hourly to the net ultrafiltration 
flow rate. Reasons for hemofilter replacement were clotting of the hemofilter or an 
ultrafiltration flow rate <200 mUh. Furthermore, hemofilters were removed when dialysis was 
- 35 -
Clinical observations and theoretical predictions 
no longer necessary or when clinical improvement allowed mobilization to treat the patient 
further with the conventional intelmittent hemodialysis. Average hcmofilter 'survival' time was 
3 days. 
Electronic pressure transducers were connected to the arterial and the venous lines to measure 
the prc-(Pbi, [mmHg]) and postfilter (Phol [mmHg) hydraulic pressures. Both pressures were 
measured using the same pressure transducer. In the patients, we also measured intra-arterial 
(pia,[mmHg) and intra-venous (Pi",., [mmHgJ) pressures by the same pressure transducers after 
clamping the line for 10 seconds. Blood flow rate through the arterial catheter (Qm, [mllmin]) 
before perfusing the prcdilution fluid was determined in duplicate by measuring the time 
required for an air bubble displacement over 13 ml of tubing. The flow rate of substitution 
fluid (C4rcdJ[mllmin]) was measured by weighing device. Arterial hematocrit (HtJ and plasma 
protein concentration (CpaJ [g/ dl]) were measured to calculate the blood viscosity (llbJ 
[mmHg'min]) and the oncotic pressure (IIp,[mmHgJ). Ultrafiltration flow rate (Q" [~l/minl) 
was determined by timed collection of ultra filtrate from the ultrafiltrate line over five minutes 
after switching off the dialysate pump. 
In a separate study we took blood samples for viscosity measurements fi:om 10 patients, aged 
38 to 66 years, who had been treated in the intensive care department for at least three days. 
Viscosity measurements were performed using an apparatus that measures the flow rate of 
blood at 37 0 C through a glass capillary with a known resistance. The internal diameter of the 
capillal)' is 1.05 mm and the velocity is approximately 30 mm/sec, yielding shear rates similar 
to those within the fibers of the hemofilters. 
3.5 RESULTS 
Statistics 
The clinical data are presented as means ± 1 S.D. The time dependent decrease ofhemofilter 
permeability was analyzed by regression analysis. Previous experiments showed that a good 
fit was obtained by linear regression of the membrane index ~H) or hydraulic permeability 
~) as a logarithmic function of treatment time (t, [hours]) [1]. This regression analysis was 
performed for each individual hemofilter. An approximately equal number of data points 
were obtained before and after 12 h of use. Slopes and extrapolated values at 12 h of use were 
compared by Wilcoxon's Rank test (see Table 3.5). 
Resistance to blood flow 
Causes of renal failure and the mean arterial blood pressure values (lvlAP) on starting 
CAVHD treatment are given in Table 3.1. The mean arterial pressure was below 70 mmHg 
in a third of the patients. Hematocrit and plasma protein concentration werc determincd to 
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calculate the blood viscosity at 37°C from diflercnt patients according to eq.(3.12). The 
component resistances R.u, Rrand R\>a were calculated from the measured pressure differences 
and the blood flow rates according to eq.(3.4), eq.(3.3) and eq.(3.5) respectively. In Table 3.2, 
the values of measured resistance (values as means ±SD) are given for the different 
components of the extracorporeal circuit. 
Table 3.1: Patient characteristics [11]. IvIAP: :Mean arterial pressure on starting the 
CA VHD treatment. 
~e Cause of renal failure MAP Age Cause 
41 sepsis, hepatoreal syndrome 107 44 cardiogenic shock 
59 sepsis, rapidly progressive glomerulonephritis 70 71 cardiogcnic shock 
60 rapidly progressive glomerulonephritis 107 64 cardiogenic shock 
70 rapidly progressive glomerulonephritis 75 52 cardiogcnic shock 
29 thrombotic thrombocytopenic purpura 120 34 sepsis 
25 trauma, shock, rhabdomyolyis 115 75 sepsis 
62 sepsis, interstitialncphritis 64 64 sepsis 
61 open hart surgery, shock 65 30 sepsis 
49 tumor infiltration in the kidney 135 69 Sepsis 
68 aortic surgelY 108 64 legionella nephritis 
MAP 
58 
69 
78 
67 
66 
96 
68 
105 
84 
106 
On starting the CA VHD treatments, the CAVH-catheters had a resistance to blood flow of 
only 0.10 mmHg/(mllmin), while for the Shaldon cathete" 0.16 mmHg pel' mllmin and for 
the Scribner shunt this value was 0.36 mmHg per mllmin. The average hemofilter resistance 
to blood flow was behveen 0.24 and 0.35 mmHg per mllmin. Using CA VH-catheters, the 
overall resistance (RJ during CA VHD treatment was approximately OA5 to 0.55 mmHg/ 
(mil min). This resulted in blood flow rates of 164±59 mllmin (range 63-284 mil min). In 
Table 3.2, the observed resistances were compared with the resistances predicted from the 
component geometty and calculated blood viscosity. The values of the resistance of the circuit 
components we observed were two to three times higher than the values calculated from the 
circuit geometty and blood viscosity. \'Vith the CAVH catheters+tubing and the Al'l-69 
capillaly hemofilter, as can be seen from the ratios (a;) of the observed resistances to the 
predicted resistances in Table 3.2, the ratio of the total observed resistance to the total 
predicted resistance (R/~,p=2.45) results in an overestimation of the blood flow rate (~in 
eq.(3.1)) by 145%. The discrepancy between the observed and predicted values of circuit 
resistance to blood flow may partly be explained by underestimation of blood viscosity. To 
determine the blood viscosity in the hemofilter, we measured the actual blood viscosity from 
the blood samples of 10 intensive care patients. Actual blood viscosity was measured at 37 0 C 
and at shear rates similar to those in the hemofilter and it ranged from 2.27xIO·7 to 3.17xlO-7 
mmHg·min. This was 1.43 times (range 12.-1.5) higher than those calculated by eq.(3.12). 
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Thus, the measured blood viscosity (See Table 3.3) was 1.43 times higher than the value 
calculated according to Pallone et al [7]. After correcting the blood viscosity by a factor of 
1.43, the size (R/Rt,p::::1.70) of the overestimation was 70%. 
Table 3.2: Observed and predicted resistances to blood flow in mmHg'min/ml of the 
circuit components at the start orCA VHD treatment of dilTerent patients. Rn,i (l 05/ml] is 
the resistance calculated from geometl),. ( t: Values after being corrected with 1.'13 for the 
predicted blood viscosity. I: Poi)'sulfone 
~omponents of the extracorporeal observed predicted 1~,1 obs.!pre. 
circuit resistance resistance (X, n 
arterial tubing 1.0 
access CA VH catheter + tubing 0.10 ± 0.04 0.05±0.01 1.9 2.0 (1.4t 39 
Schribner shunt + tubing 0.36 ± 0.07 6 
Shaldons catheter + tubing 0.16 ± 0.05 0.08±0.01 3.2 1.9 (1.3) 6 
filter AN-59 plate hemofilter 0.25 ± 0.06 0.09±0.01 3.1 2.8 (1.9) 16 
Ai"l"-69 capillary hemofilter 0.24 ± 0.11 0.08±0.02 3.1 2.9 (2) 17 
IpS capillaty hcmofilter 0.35 ± 0.14 0.14±0.Ql 4.7 2.4 (1.7) 17 
venous tubing 1.I 
access tubing + CA VH catheter 0.10 ± 0.04 0.05±0.01 2.0 1.9 (1.3) 39 
tubing + Schribner shunt 0.36 ± 0.13 6 
tubing + Shaldons catheter 0.16 ± 0.05 0.09±0.01 3.3 1.9 (1.3) 6 
Table 3.3: Blood viscosity measurements [II]. 
Nr. Ht Cp [gIl] llt,[10·7 mmHg'min] obs'!pred. 
I 0.21 55 2.84 1.33 
2 0.31 49 3.55 1.49 
3 0.25 55 2.66 1.17 
4 0.21 53 3.23 1.54 
5 0.26 36 3.06 1.53 
6 0.33 -15 3.69 1.55 
7 0.3 75 3.93 1.41 
8 0.34 54 3.96 1.54 
9 0.26 54 3.05 1.33 
10 0.24 56 3.11 1.38 
average±SD 0.27±0.05 53.2±9.3 3.31± 0.43 1.'13± 0.12 
Hemofilter resistance to blood flow during the CA VHD treatment 
Figure 3.2 shows the resistance to blood flow for an AL'l-69 capillary hemofiltcr during the 
treatment of one patient. Generally, there was no appreciable change in the hemofiltcr 
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resistance with time. In a few cases, a sudden increase in the resistance to blood flow heralded 
clotting of the hemofiltcr. A few hours before the hemofilter had become clotted completely} 
a sharp drop in the blood flow rate was obSClved. 
1.0 20 
0 I 
O.S r 16 
0 
0 
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c ) ~ 0 MI '" O.S 12 ~ ~ 0 0 E 0 • 00 0 ~'" '" E 0 .§. 0.4 \R' , S .§. ,z • . • ;; • , • • I 7.7~ , , , , , 0.2 , , , 4 
0.0 0 
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treatmont limo t (hours) 
Figure 3.2: Recording the hydraulic permeability index (rvH) and the 
hemofilter resistance (RJ to the blood flow. 
The average hemofilter resistance to blood flow was between 0.24 and 0.35 mmHg·min/ml. 
To compare the measured resistance of an AN-69 capillary hemofilter ",th the predicted 
values during the treatment, hematocrit and plasma protein concentrations were determined 
to calculate the blood viscosity at 37°e from four different patients. In Table 3.4, the 
observed and predicted values of the resistances of extra corpo real circuit are shown under 
different conditions, where the observed values ofhemofilter resistance (Rf) higher than 0.4 
mmHg/(mllmin) were not taken into account because of clotting. 'Ve found that the ratio of 
measured averaged resistance to that of predicted average resistance varied per patient. The 
average individual correction factors were calculated as eta = 1.0 for the arterial access, ct v=O.9 
for the venous access and ctr=2.8 for the hemofilter. The average ratio R/Rt,p was 1.5, 
resulting in 50% overestimation of the blood flow rate (Q,a = 297 mllmin). The over~ 
estimation of blood flow rate is mostly resulted from the underestimation of blood viscosity 
in the hemofilter. After correcting the blood viscosity by a factor of 1.43, the size 
(I~./I~p= 1.06) of the overestimation was 6%. From the measurements ofhemofilter resistance, 
recorded from different patients during about 5 days at arbitrarily chosen time intervals (See 
Figure 3.3), the correction f.:'lctor (ctr/1,43=Rr/Rf,p) was determined in relation to various 
hemofilter resistance (Rf). "Ve found that etf is related to Rr according to the regression 
equation: rx/ 1.43=R,/Rrp=R/0.09 (R'=0.96, n=50) for 0.04sRrsO.6 mmHg·min/ml. From 
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this regression equation follows that the average value of the predicted hemofilter resistance 
was Rr,p =0.09 mmHg·min/ml. 
Table 3.4: Predicted and measured resistances to the blood flow from different patients with an 
extracorporeal circuit consisting of the CAVH catheters+tubing for both the arterial and venous 
access components and the AN-69 capillary hemofilter. Resistances are all in [mmHg per blood 
flow rate of 100 mllmin]. n (number of data points):::: '~for each patient. 
Patient nr. ---io 
Q" [ml/min] 
Q, [1llI/min] 
Q,«d [mI/min] 
C p, [gIl] 
Ht, 
P;, [mmHg] 
R"",p 
R., 
~ . ..,? 
I~, 
Rr,p 
R, 
«,,=Rou/Ra3,p 
", = R"/R, .. p 
ar=R/Rr,p 
al::::RI/~, 
6 
I 
154.9±4.9 
1O.4±2.7 
IO.B±2.9 
56.6±7.3 
O.25±O.O5 
62.3±1.5 
B.3I±O.79 
6.39±1.76 
B.29±0.7B 
7.25± 1.47 
6.BB±0.59 
16.57±3.I·J 
0.77 
0.B7 
2.41 
o 
o 
o 
o 
I 2 I 
294.5±33.2 
14.I±2.4 
14.3±2.B 
47.0±5.3 
O.26±O.O5 
93.2± 17.2 
7.BO±O.B3 
6.4B±O.80 
7.BI±0.B4 
6.4I±0.74 
6.54±0.69 
16.96±2.55 
0.B3 
0.B2 
2.59 
o 
o 
o 
• 
3 I 4 
152.I±IO.I 192.4±35.5 
8.4±3.2 9.3±2.3 
6.3±2.9 4.0±O.B 
B1.7±O.3 67.6±3.4 
O.23±O.O2 O.32±O.OI 
BO.O±1.4 93.0±I6.B 
9.30±O.30 9.7B±O.32 
12.5<1±O.I7 9.72±2.10 
9.4<1±O.32 IO.I3±0.56 
IO.I5±3.45 B.33±I.IB 
7.B5±0.20 B.42±0.37 
24.37±1.56 25.25±4.2B 
1.35 0.99 
LOB 0.B2 
3.10 3.00 
o 
o o 
o 
o 0 
o 
",11.43 = R,to.o9 
R2 = 0.96 n=50 
I average 
19B.5±20.9 
IO.6±2.4 
B.9±2.4 
63.2±4.1 
O.27±O.O3 
B2.I±9.2 
B.BO±O.56 
B.7B±1.21 
B.92±0.63 
B.OH 1.71 
7.42±0.46 
20.99±2.90 
1.00 (O.70r 
0.90 (O.64t 
2.B3 (1.9Br 
1.50 (1.06t 
o +------.-----,------.------r----~r_--__, 
0.0 0.1 0.2 0.3 0.4 0.6 0.6 
measured hemofllter resistance Rf [mmHg/(ml/min)) 
Figure 3.3: Correction factor (a/1.43) in relation to the observed hcmofilter resistance 
(Re!. 
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From Tables 3.2 and 3.4 and Figurc 3.3 can be seen that in CA VHD the method of 
predicting the hemofilter resistance to blood flow from the geometry and from the calculated 
blood viscosity from hematocrit, plasma protein concentration and temperature is not reliable. 
This is partly due to an underestimation of blood viscosity (1.'1·3 times the measured blood 
viscosity), partly due to the fiber swelling and may be due to the protein adhesion on the 
membrane during the prolongcd use ofhemofilter and clotting. 
Decline of ultrafiltration flow rate and n1.enlbl'anc index over time 
In Figure 3.4, the rate of ultrafiltration flow (Q) and the rate ofreplacerncnt fluid infusion 
(~lIctJ arc shown during the treatment. From Figure 3.4, it is apparent that ultrafiltration flow 
rate decreased over the treatment time (t) as: 
Q/t) = 15 - 2.lIn(t) (3.27) 
for t.:-::: 115 hours (R2:::O.95, n:::31), while blood flow rate and mean transmembrane pressure 
difference cr~'lPl;l ) remained constant (See Figure 3.5). This shows that the membrane 
hydraulic permeability index (1vlI) decreased in time. 
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Figure 3.4: Recording the infusion rate of substitution fluid (Or",J and the rate of 
ultrafiltration flow (Q), which was measured by timed collection. 
In Figure 3.2, the membrane hydraulic permeability index (~rlI) and the hemofilter resistance 
to blood flow are shown. The l\H decreased over the treatment time according to: 
ME(t) = 18.8 - 2.8In(t) (3.28) 
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for t~ 115 hours (R2=O.94, 11=31), while the resistance remained constant (24 mmHg per 
100 mllmin) until the hcmofilter had become clotted. ',Vhen the ultrafiltration flow rate was 
less than 5 ml/min, the hcrnofilter resistance showed an increase indicating that the hemofilter 
had become clotted. After a few hours, the hemofilter was completely clotted and eventually 
replaced with a new one. 
150 
0" 
OJ 125 
'" E 
E 
...... 100 ~ '. 
" MAP r 
oC 75 o 0 0 
:! 0 
'2 
". 
50 ~ 
oS TMPm 
• a 25 
o +---~----~----~--~----~----, 
o 20 40 60 80 100 120 
treatment time t [hours] 
Figure 3.5: Recording the patient's arterial blood now rate (QJ, mean 
arterial pressure (MAP) and hemofiltcr mean transmembrane pressure 
(TrvIp.J during a CA VlID treatment of 120 hours. 
Figure 3.2 shows that the membrane index :r..,11 was not affected by the hemofilter resistance 
until the hemofilter had become clotted. The survival time of this hemofilter was 5 days or less 
than 5 days due to early clotting of the hemofilter or other technical failures. 
Decreasing the IvII in time is presumably due to the decrease in the hydraulic permeability 
coefficient~. This phenomenon has also been demonstrated by others [1,9,12]. It has been 
shown that during continued use of a membrane, a decline in the hydraulic permeability 
occurs because of protein adhesion [10,13]. In Figure 3.6, the average rate of decline of 4 
with three difierent hemofilters is shown. Hydraulic permeability of both the Ai\fR 69 
membranes was less than that of the polysulfone membrane (See Table 3.5). 'The decline in 
~ was least apparent with a small polysulfonc capillary hemofilter. The rate of the decrease 
in Iv was faster with the plate hemofilter than \\~th the capilIal)' hemofilter. In Table 3.5, the 
hydraulic permeability coefficients of three types ofhemofilters are shown in units of 
cm/(mitl'mmHg) after interpolation for t:?12h. 
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Table 3.5: Hydraulic permeability coefficient (4. [cm/(min mmHg)]) 
of three types ofhemofilters [11]. J}: Value obtained by interpolation, 
2) : Slope b irHhe formula 4(t)=a-bln(t). 
At'l'-69 capillary At'l"-69 plate hemofilters PS capillaty hemofilters 
hemofilters 
L, rafter 12h 
2.69 
3.66 
2.57 
2.14 
2.90 
2.60 
2.81 
0.39 2.81 0.67 
1.55 
0.60 
0.34 
0.73 
0.98 
0.87 
0.56 1.62 
5.70 1.79 
2.34 0.84 
2.26 1.05 
2.87 2.01 
2.02 1.53 
2.97 1.26 
3.35 1.05 
2.85 1.10 
3.23 1.08 
0.92 1.03 
L,'after 12h 
6.47 
5.94 
4.11 
6.27 
4.50 
6.53 
0.55 
1.30 
0.05 
0.70 
1.27 
0.53 
_________________________________ L·J} _______ 4,~;l _______________________ . 
average: 2.77 0.72 2.58 1.35 5.03 0.69 
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The average 4-values of2.77 and 2.58 for the AN-59 hemofilters were both lower than the 
value of 5.03 for the polysulfone (PS) hemofilter (p<O.O I). The slopes 0.72 and 0.59 for the 
capillary filter~ were both lower than the slope of 1.35 for the plate hemofilter (p<0.05). 
0 .• I 
~§ 0.6 ~x 
• E E E .. 
Po[ysulfone capillary hemofilter 
!l .• 0.' 
• E c"'" • f E 
".E. Ll" • 0 0 
AN·69 capillary hemofllter 
E 0.2 0 0 0 
000 
0 
••• ~::::::~:=;o .. 
o AN-69 plate hemofHter 
o+---------,---------,---------~--------~ 
o 30 60 90 120 
treatment time (I) (hours) 
Figure -3.6: Membrane hydraulic permeability coefficient 4 with treatment 
time (t). 
- 43-
Clinical observations and theoretical predictions 
3.6 DISCUSSION AND CONCLUSION 
Blood flow I.'ate 
Pallone and Peterson have shown that, for capillary and flat plate hemofiltcrs, the resistance 
to flow may be predicted from the hemofiltel' geometry [2,7]. Their prediction ·was based 011 
Poiseuille's law. In their calculations it was assumed that blood behaves as a Newtonian fluid 
and that the blood flow through the hemofilter is laminar. Furthermore, they used data from 
the literature that allow the calculation of blood viscosity from hematocrit, protein 
concentration and temperature. In our study we used the same methods. "Ve found that the 
hemofilter resistance to flow was two to three times higher than the predicted value. A similar 
finding has recently been reported for a number of other hemofilters [3]. To explain this 
discrepancy we considered clotting of fibers, underestimation of blood viscosity as we have 
shown in this chapter, turbulent flow and/or additional pressure losses due to the sudden 
changes in the blood path diameter and deviations of the internal diameter of the fibers. To 
determine the eflect of these factors on the observed hemofilter resistance to the blood flow, 
we decided to measure the resistance of a number of different hemofilters in a laboratory 
setting (See Chapter 4). The measured circuit resistance to blood flow showed a discrepancy 
when we predicted it iI-om manufacturers' specifications and blood viscosity. The discrepancy 
between the predicted and the actual hemofilter resistance was partly due to an 
underestimation of blood \~scosity and partly due to an increased resistance in the hemofilter 
as a result of, probably, a small decrease in the fiber diameter. Also, small pressure losses 
along the extracorporeal circuit due to deviations Ii-om ideal cylindric geometry (constriction 
and widening in the hemofilter potting and access components) contribute to the discrepancy. 
Clearly, the blood viscosity which is estimated according to Pallone's expression, eq.(3.12), has 
to be corrected by a factor 1.43 per each nUllHg/(mlimin) of the hemofilter resistance. 
Estimating the blood flow rate from patients output such as arterio~venous pressure diflerence, 
protein concentration, hematocrit and hemofilter manufacturer specification is not reliable, 
as far as the hemofilter is concerned. Ideally, the blood flow rate should be measured 
continuously. It is technically feasible to measure blood flow by means of the echo·Doppler 
principle, using a flow probe around the blood line, but the necessary equipment is not yet 
widely available. As an alternative, injecting a 0.3 1111 air bubble into the blood line may help 
to determine the blood flow rate. In the laboratory setting, we have measured the blood flow 
rate by using the echo· Doppler principle as well (See Chapter 4.). 
Ultrafiltration flow 
The fall in the ultrafiltration flow rate over time may be explained both by changes in the 
membrane permeability, presumably resulting from protein adsorption to the membrane, and 
by a fall in the available membrane SUrh1.Ce area, e.g. due to unsuspected dotting offibers. For 
reasons given above, unsuspected dotting of fibers is unlikely to occur under clinical 
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conditions. Therefore, the decrease in membrane permeability with time is more likely to be 
due to ongoing protein adsorption. "Ve should note that according toJcnkins et al [12] the 
hemofilter hydraulic permeability may decline even after contact with water alone. To our 
knowledge, however, others have not reproduced this finding. For the AN-69 capillary 
hcmofiltcr we did not observe a fall in the hydraulic permeability coefficient CLr) between 1 
and 48 hours of saline perfusion, but we did observe a fall in ~ with plasma and blood (See 
Chapter 4). During continuous treatments the net ultrafiltratc production is measured every 
hour and the substitution infusion rate is adjusted accordingly. A sufficient net ultrafiltration 
rate is an easy indication that the system functions well. A very low ultrafiltration flow rate 
may be an indication that blood flow has stopped due to clotting at the venous end of the 
hemofilter. ""hen the rate of ultrafiltration has become less than 200 mUh or when clotting 
of the hemofilter has occurred, the hemofilter must be replace. If the catheters are flushed, 
changing ofhemofilters may generally be deferred so as to take place during working hours. 
Clinical itnplications 
In critically ill patients, in whom CA VH(D) is indicated, blood pressure tends to be low. A low 
resistance to blood flow of the extracorporeal circuit is therefore mandatory. In this respect 
CAVH catheters are clearly to be preferred to Scribner shunts. The use of a Scribner shunt 
instead of catheters doubled the overall resistance of the extracorporeal system. In our view, 
Scribner shunts should be regarded as unsuitable for CA VH(D). The resistance to blood flow 
of the hemofilters studied was low enough to ensure an adequate blood flow rate in most 
cases. To obtain a reasonably accurate prediction of blood flow rate under clinical conditions, 
data ofhemofilter resistance and a more accurate estimation of blood viscosity in a laboratory 
setting were needed. 'Vith regard to the three hemofilters studied, the ultrafiltration rate was 
always high enough for correction of over-hydration. On the other hand, because of the time 
dependent fall in membrane permeability, the ultrafiltration flow rate will soon become too 
low for adequate solute removal through convection alone. In case ofCAVH this necessitates 
frequent changes of the hemofilters. In case ofCAVHD the fall in ultrafiltration flow rate will 
result in a fall of solute removal by convection and also by diffusion since the number of 
membrane pores, with which the rate of solute removal by diffusion increases, will be 
decreased due to the same factors influencing the fall in the ultrafiltration flow rate. 
Feasibility of predicting hemofiItel.' performance 
The feasibility of continuous therapies such CA VH and CA VHD depends strongly on the 
hemofilter performance that may fail due to technical f.:'lilures, usually because of inadequate 
blood flow. Inadequate low rates of blood flow can lead to excessive hemoconcentration that 
in turn results in an increase in the hemofilter resistance, causing early clotting of the 
hemofilter. Estimating the adequate blood flow rate to achieve a desired rate of patient's fluid 
loss and toxin clearance depends not only on the patient's output but also on the 
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mathematical modeling that describes the solute and fluid transport across the hemofilter. 
Apparently, predicting the blood flow rate fi'om manufacturer specifications is not reliable and 
has to be measured continuously. 'Vhen this model is applied for predicting the blood flow 
rate, the correction factor 1.43 for the blood viscosity has to be taken into account. 
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DETERMINANTS OF BLOOD AND ULTRAFILTRATION FLOW 
RATES: Laboratory observations and theoretical predictions 
Chapter 4 
4.1 INTRODUCTION 
Patients with acute renal failure treated \\~th continuous arterio-venous hcmodiafiltration 
(CA VHD) are characterized ,,~th their circulatory instability, leading to low and/or unstable 
blood pressures. The combination of a low and unstable blood pressure makes it quite difficult 
to judge how much fluid can be withdrawn safely. Besides this, f:'lilure of the technique may 
occur because of an inadequate blood flow rate, leading to excessive hemoconcentration and 
clotting. In Chapter 3 we introduced a methodology [1] to predict the blood flow rate under 
different clinical conditions and hcmofilter characteristics. \\Fe related the blood flow rate to 
the resistance exerted by the extracorporeal circuit, based on geometry and blood viscosity. 
'Vith three kinds ofhemofilters (A1"1-69 capillaty, AN-69 plate and PS capillary), we showed 
that the observed hemofilter resistance to blood flow was about 3 times greater as that 
calculated fi'om geometry and predicted blood viscosity (See Chapter 3). Also the resistance 
was showed to remain constant during the whole treatment time until the hemofiiter began 
to clot. To obtain a reasonably accurate prediction of blood flow rate under clinical 
conditions, a more accurate estimation of the hemofilter resistance to blood flow in a 
laboratory setting was needed. 
In this chapter, the resistance to flow was measured with fluid solutions of different viscosity 
for some CAVH(D) capillary hcmofilters (See Table 4.1). The hemofilters were perfused with 
saline, sucrose solution and pig blood as perfusion fluid. The viscosity values of saline and 
sucrose solutions were taken from published data and that of the pig blood was measured. 
Using the viscosity values provided, we compared the resistance of each hemofilter with the 
theoretical predictions. The effect of hemofilter resistance on the hydraulic performance 
(ultrafiltration) was also investigated by measuring the membrane permeability index (~dl) and 
the resistance to (lmman) blood flow simultaneously over a survival time of about 220 hours. 
4.2 METHODS 
Predicting herrlOfiIter resistance fronl housing and membl.'ane geOllletry 
A typical capillary hemofilter is schematically depicted in Figure 4.1. Although the hollow 
fibers seem like a bundle of horizontal straight tubes lying parallel to each other, they differ 
very much from the straight tube configuration. However, in many studies it has been 
assumed that a hollow fiber can be considered as a straight porous tube configuration. In flow 
systems, such as the capillary hemofilters encountered in both in vitro and in vivo studies, the 
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pressure drop results mainly from the friction of the flowing fluid with the surface of tubing 
and to some extent from some additional irregularities such as bends, valves, fittings, 
bifurcation, sudden expansions and constrictions. 
arterial 
blood 
hollow fibers 
.... 1iIIIIt!!.~::::1I~1IIIi~1IIII1IIII1IIII1IIII1IIII .. 1IIIIj fiber wall (membrane) 
Figtu'e 4.1: A schematic representation of an idealized capillary hemofilter 
configuration. 
For a steady flow of incompressible fluid in horizontal tubes with irregularities, the pressure 
loss is calculated as [2]: 
(4.1) 
where p is density of the fluid, fr the friction factor, Vm the average longitudinal velocity of the 
f1O\\~ng fluid, L the length of a segment, d the internal diameter, c,. the friction loss factor of 
the irregularity. The first term on the right-hand side ofeq.(4.1) represents the pressure loss 
due to fi'iction forces of i straight tube sections, the second term represents the pressure loss 
due to j irregularities. The average velocity, assuming a parabolic velocity profile, is calculated 
from the fluid flow rate (QJ dividing by the cross-sectional area of the tubing: 
4Q. 
1td' 
(4.2) 
The friction factor fr depends on the Reynold number (RJ. For a laminar flow (Re-<2100): 
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(4.3) 
and for a tlll'bulent flow (R,>2100): 
It " 0.0791R,-o.25 (4.4) 
The Reynold number is given by: 
R - dv P e - 111-
~ 
(4.5) 
where 11 is the fluid viscosity. The values of c,. for some obstacles can be found in standard 
handbooks and texts [3-4]. For a sudden expansion: 
S 
e,. " (1 -...!.)' (4.6) 
Sb 
and for a sudden constriction: 
e, " 0.45(1 S, - -) 
Sb 
(4.7) 
where Ss and Sb are the crossMsectional areas of narrow and wide parts of tubing respectively. 
Substitution of eqs.(4.2), (4.3) and (4.5) in the fil~t term on the right-hand side of eq.(4.1) yields 
the Hagen-Poiseuille's relationship: 
" 1 2 L PL., (!r'ivm4d)' = RfPQb (4.8) 
with 
(4.9) 
where N is the number of tubes (fibers) lying in parallel and Rrp is the resistance due to friction 
forces only, called the Poiseuille's resistance to the flowing fluid in a straight htbing. On 
substituting eq.(4.2) in the second term of the right-hand side of eq.(4.1) and dividing by <1" 
we find the resistance to flowing fluid due to irregularities: 
" 8 P e, L.,' (--)j Qb = !zQb 
'J n2d4 
The total resistance to flowing fluid becomes: 
Rf " Rfp + hQb 
(4.10) 
(4.11 ) 
where Rrp is the Poiseuille's resistance for laminar flow and has to be considered as the 
resistance to flowing fluid without irregularities. hQ, is the resistance because of the 
irregularities and flow rate. According to eq.(4.11), the resistance to flowing fluid varies with 
a fluid flow rate (QJ with the variation coefficient (h), representing the change in Rr pel' unit 
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flow rate (slope). Eq.(4.l1) is valid for laminar flow. For turbulent flow, the total resistance can 
be derived on the same way as eq.(4.11) using the friction factor frin eq.(4.4). 
Labol'atory protocol 
Vsing sal inc as perfusion fluid, we first tested the method of calculating the resistancc to flow 
by measuring the flow rate and pressure drop over a 1.52 m long glass tubing with an inner 
diameter of 4.1 mm and also for a 2.23 m long standard polyvinyl chloride (PVC) blood 
hlbing with an inner diameter of 4.36 mm. Then the resistance of some CA VI-I(D) capillary 
hcmofiltcrs (Sce Tables 4.1 and 4.2) were studied at difierent flow rates. 
pressure meter transducer 
flow probe 
1 
Figure 4.2: Experimental set-up to measure the hemofilter permeability index 
(MI) and resistance to flow (Rf). 
The resistance of AN-69 capillary hemofilters was determined also with sucrose solution and 
pig blood as perfusion fluid. Eight AN-59 capillary hemofilters were used. They were all first 
perfused with saline, then two hemofilter were perfused with a sucrose solution and three 
hemofilters were perfused with pig blood (see Table 4.2 for further specifications). Hemofilters 
were prepared by rinsing the blood compartment with 2 I of saline containing heparin 5000 
VII, allowing filtration to take place. After that, the dialysate compartment was dosed. Blood 
tubing \\~th an inner diameter of 4.3 mm, containing side ports was used and adjusted so we 
could measure the pressure in the perfusion fluid 2 cm before and after the hemofilter. An 
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electromagnetic flow probe was inserted in the tubing so that mean flow rate could be 
measured continuously. Flow rates were measured also by an ultrasound Doppler velocity 
meter and by water column height. The experiments were performed at room temperature, 
with the experimental set-up shown in Figure 4.2. Hcmofilters were in the horizontal position. 
A RhodialR or BelcoR blood pump was used to generate pulsatile flow rates from 50 to 600 
mllmin. The hemofilter resistance to flow was thus measured at different flow rates. 
Furthermore, with all three solutions we once changed the set-up to create an open circuit 
with a container at a variable height, in which gravity generated a constant flow through the 
hemofilter and the pump was used to return the fluid to the container. Values of viscosity for 
the saline and sucrose solutions were taken from published tables [5]. The viscosity of pig 
blood with a hematocrit value of 0.23-0.25 was measured at room temperature with a 
Viscomat viscosity meter. 
Further, the hemofilter resistance (RJ and membrane permeability index (r\ifJ) of an HAN_59" 
capillaty hemofilter were recorded during about 220 hours under laboratory conditions, with 
an experimental set-up as is shown in Figure 4.2. From arterial line, the plasma protein 
concentrations were measured to determine the transmembrane pressure difference (T~."fP). 
To keep the hematocrit value constant during the experimentation, the ultrafiltrate was 
recirculated into the arterial line by using a blood pump. A specially designed electronic 
circuit was used to regulate the blood pump controlling the amount of ultrafiltrate to be 
recirculated into the arterial line. Ultrafiltration flow rate was determined by timed collection. 
The pre- and postfiltel' pressures were measured \\~th the same pressure transducers. 
4.3 RESULTS 
Resistance to flow 
"Ve plotted measured resistance ofhemofilters and tubing against flow rates. Linear regression 
analyses were used to calculate the slope (h) and the Poiseuille resistance (Rfp) at a zero slope 
or at a zero flow rate (~) according to eq.{4.11). The slopes were also calculated from 
eq.(4.10). The results of resistance measurements are given in Table 4.2, Figure 4.3 and 
Figure -1.4. For both glass and PVC tubing with saline as perfusion fluid, the resistance to a 
light pulsatile flow was in accordance with that predicted according to PoiseuiHe's law (with 
a relative error less than 10%). The flow rates at which turbulence may occur were calculated 
from eq.(4.2) and eq.(4.5). In a laminar flow region (Re<2100), an average value of the 
resistance {Rr} was calculated over the flow rates. 
Under the same laboratory conditions using saline as perfusion fluid, the resistances {Rf} of 
six hemofilters from five different manufacturers were measured and compared with the 
values calculated from eq.(4.9}. For all the hemofilters, the obselved values were higher (up 
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to 50%) than the calculated values. To explain this discrepancy, we measured the diameters 
of man)' arbitrarily chosen fibers (or the Hospal AN-fi9 hemofilter). From one fiber only, at 
least 10 diameters along the fiber length were measured. In total 308 of diameters were 
measured. Based on the results of the diameter measurements, the resistance was calculated 
again (See Table 4.2). The difference between the calculated and obsctved values afRe was 
2%. Only for Hospal AN-69 hemofilter, the resistance increased slightly ,vith the flow rate. 
The calculated slopes (the vaJiation in Rf per 100 m1lmin) were different from those obtained 
from the regression analysis. The calculated slope of Asahi 23320 hemofilter only was in good 
agreement with the obselved value. 
Table 4.1: Manufacturer data ofCAVH(D) capillal), hemofilters and calculated 
resistance to flow for blood, sucrose solution (or pig blood) and saline as perfusion 
fluid. I : wet condition, 2 : calculated fi'om measured resistance. 
hemofilter type dm d, Lr N S R,p R,p R,p 
blood sucrose saline 
Hospal ~\'lultiflow·60 AN-69 50 '240 15 6 0.6 10.7 8.6 3.8 
Amicon D·20 PS 75 250 12.7 5 0.4 9.3 7.4 3.3 
Amicon D-30 PS 75 250 21.2 5 0.7 15.5 12.4 5.5 
Cambro FH 22 PA 60 215 4.1 2.1 0.16 44.8 35.8 16.0 
Cambro FH 66 PA 60 215 17.2 6.2 0.59 18.5 14.8 6.6 
Fresenius A-V 400 PS 35 220 25.5 4.5 0.7 34.5 27.6 12.3 
Sorin HFT02 PS 40 200 12.0 4.6 0.24 20.3 16.3 7.3 
Renaflo HF250 PS 40 280 14.0 2.8 0.25 11.6 9.3 4.1 
Renaflo HF500 PS 40 280 21.5 3.35 0.5 14.9 11.9 5.3 
ABahi APF-03 PAN 35 250 18.5 3.4 0.39 19.9 15.9 7.1 
Asahi APF-6 PAN 35 250 18.5 6.4 0.6 10.6 8.4 3.8 
ABahi23320 PAN 200 22 6.5 "0.86 30.2 24.1 10.8 
Asahi 24527 PAl'! 200 22 6.5 '0.86 30.2 24.1 10.8 
AN·69: ACl),10nitrile-69, PS: Polysulfone, PA: Polyamide, PAN: Polyacylonitrilc,dm: fibcr wall 
thickness u.un] , <4: fiber internal diameter [J.tm], 4: fiber length [m], N: number offiberl-[xlO:J], 
S: effective membrane sUlface area [m'1, Rrp [mmHg/{lOO ml/min»): resistance to flow calculated from 
Hagen-Poiseuille's relationship. 
Viscosit}, [mmHg min]: 3.5'10-7 (blood wth Ht=O.25) 
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1.2'10" (saline) 
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Table 4-.2: Resistance to fluid flow for hlbing and some capillary hemofilters. 
Rr [mmHg/(lOO mIl min)] = Rrp + h Q, "oth h (slope) in units of% per 100 mllmin. 
calculated 
measured resistance tubing perfusion 
resistance R,(h=O)/R,p 
hemofilter fluid 
Rrp h R, (h=O) 3Rr h 
glass tubing saline 2.27 0.0 l.92 2.20±0.46 0.05 0.86 
PVC tubing 3.15 0.0 3.16 3.44±0.21 0.04 l.00 
-------------------------------------------------------------------------------------
Hospal AN·59 
" 
Sarin HFI02 
Asahi 23320 saline 
Asahi 24527 
Renaflo HF 250 
Diafilter 30 
ax AN-59 filters saline 
2x A1~-69 filters sucrose 
3x AN-59 filters pig blood 
3.97 
, '1.06 
, 5.54 
7.4 
10.92 
10.92 
4.01 
13.<11 
3.9 
9.1 
9.1 
11= I .25·lO·7 mmHg min (for saline), 
l.55 5.42 
0.9 8.H 
0.6 14.03 
0.6 12.27 
1.6 5.74 
0.5 20.21 
1.55 '5.5±0.9 
13.2±2.0 
23.3± 1.2 
5.87±0.25 
8.44±0.15 
13.87±0.24 
12.03±0.26 
5.76±0.16 
20.57±0.49 
4.1 
0.0 
0.7 
0.1 
OA 
1.2 
') .2± 1.8 
5.0±0.1 
0.5±0.8 
11=2.80'10 -7 mmHg min (for sucrose solution and pig blood with Ht=O.23 - 0.26). 
l.37 
1.33 
0.98 
1.14 
l.28 
1.12 
1.43 
1.51 
1.41 
1.45 
2.56 
I, fiber diameter 220 ~lm in the potting (L=2 em) and 240 11m in a fiber block (L=13 em) 
'. 
3. 
,. 
fiber diameter 231.6 ~ml (11=52) in the potting and 217.4 ~m (n=266) in a fiber block 
measured in a separate study (8-10% less than the manufachlrer specification), 
average value over the flow rates in a laminar flow region (See Figure 4.4), 
average value over the number ofhcmofilters used 
From the measurements of resistance to flow of a number ofHospal Al'\'-69 capillary 
hemofilters with saline (8 hemofilters) and sucrose solution (2 hcmofilters) we observed that 
both with sal inc and ,\~th the sucrose solution, the resistance was 40% higher than the values 
calculated according to manuf..1.cturer specifications. Similar values werc obtained with either 
pulsatile or constant flows. The resistance rose slightly with increasing flow rates. "Vith pig 
blood with Ht=0.23-0.26, the resistancc to flow was 156% higher than the calculated value, 
and it did not increase with the flow rates (Sec Figure 4.4). 
PerJueability index 
Perfusing the AN-69 capillmy hemofilters with saline, plasma and human blood, we studied 
the time courses of the hcmofilter resistance, Rlt), and the membrane permeability index, 
lvII(t) (known as ultrafiltration coefficient). Three AN-69 capillary hcmofilters were used. 
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Figure 4.3: Resistance to flow, measured over a standard PVC tubing and a glass 
tubing, in relation to flow rate. Turbulent flow occurs at Q, = 426 mlJmin for glass 
tubing and at Q,::: 432 mllmin for PVC tubing. 
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Figure 4.4: Resistance to flow of AN-69 capillal)' hcmofiIter, using saline, sucrose and 
pig blood. 
One hemofilter was perfused with saline during about 140 hours. Neither a decrease in .MI 
nor an increase in ~ was observed. A second hemofilter, perfused with plasma showed a 
decrease in ~H between 1 and 51 hours according to the follO\\~ng regression equation: 
MI(t) ~ 12.4 - I.lIn(l) (4.12) 
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with (R' =0.75, n=109). A third hemofilter, perfilSed with human blood showed a decrease 
in MI between 1 and 140 hours according to the following regression equation: 
M/(/) = 16.7 - 2.lIn(/) (4.13) 
with (R2 =0:74, n= 210). In' Figure 4.5, the recorded :MI and Rrobscrvations during about 
220 hours experimentation were shown. Up to about 140 hours of human blood perfusion, 
the Rr was about 0.16±0.01 mmHg·min/ml. Afterwards, the Rr increased up to 0.6 
mmHg'min/ml within 20 hours. The sudden increase ofRr was an indication of clotting. 
\Vithin hours was the hemofilter completely clotted. \'Ve also observed a similar sudden 
increase afRr under clinical conditions, see Chapter 3. 
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Figure 4.5: Membrane permeability index (1\'11) and the filter resistance {Rf} of an 
AN-69 capillmy hemofilter, perfused with human blood (Ht=O.25-0.3) in relation to 
time (t). 
4.4 DISCUSSION AND CONCLUSION 
Laboratory measurements showed that the resistance of tubing was in accordance with the 
calculated value, which argues against gross methodological mistakes. The resistance of the 
hemofilter, perfused with saline or a sucrose solution, was 40% higher than expected. 
Furthermore, it was to some extent flow dependent, suggesting that hlrhulence does occur, 
most likely at the hemofilter inlet. However, this can hardly explain why the extrapolated 
resistance at a virtually zero flow rate was increased with 40%. Also, when we applied 
Bernouilli's law (See Eq.(4.10)) to estimate the pressure drop that results from the sudden 
change in diameter at the hemofilter in- and outlet [6], we calculated a pressure drop of far 
less than 1 mmHg. On the other hand, a 40% increase in R f would be explained if the fiber 
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diameter would be a mere 8-10% lower than the given value. "Vhen hcmofilters were perfused 
with pig blood, the discrepancy between the observed and predicted resistance was 156%, 
which rose to a suspicion that the pig blood viscosity measured in laboratory was not the same 
with that in the hemofilter. "Vith human blood, the I~was 0.16 mmHg'min/ml when a high 
dose of heparin prevented clotting. This argues against a significant contribution of clotting 
of fibers to the hemofilter resistance. The predicted value ofRrwith Imrnan blood was 0.08 
mmHg 'min/ml (in Chapter 3). On the other hand, comparison of actual blood viscosity with 
the value calculated according to eq.(3.17) confirmed our suspicion that we had grossly 
underestimated blood viscosity (Chapter 3). "Vith blood, the Rr no longer seemed flow 
dependent, probably showing that the higher viscosity of blood diminishes turbulence. If the 
blood flow rate would be predicted by just combining this laboratory data on hemofilter 
resistance during blood perfusion with a more accurate estimation of blood viscosity 
(considering the correction factor of 1.43) and a fiber diameter 8~ 1 0% less than the specified, 
the flow rate would be overestimated by only 20%. It should be noted that according to 
Jenkins et al [7] the hemofilter hydraulic permeability may fall even after contact with water 
alone. To our knowledge, however, this finding was not reproduced by others. For the At"\f~69 
capillal)' hemofilter we did not observe a fall in hydraulic permeability between 1 and 150 
hours of saline perfusion (data not shown). The resistance to flow of the hemofilters studied 
was low enough to ensure an adequate blood flow rate commonly. By using laboratory data 
on hemofilter resistance and a more accurate estimate of blood viscosity, a reasonably 
accurate prediction of a blood flow rate under clinical conditions is feasible. 
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5.1 INTRODUCTION 
Continuous arteria-venous hemodiafiltration (CA VHD) is characterized by the use of a small 
surface highly permeable hemofilter, spontaneolls blood flow and spontaneous ultrafiltration. 
Solutes are removed by simultaneous convection, i.e., plasma water is removed together with 
all dissolved molecules that can pass through the membrane pores, and by diffusion [1,2]. 
CA VHD is a combination of continuous arteriovenous hemofiltration (CA VH) with slow 
hemodialysis, but it differs fi'om CA VB, conventional intermittent hemodialysis and 
intermittent hemodiafiltration in several respects: 
1) "Vith CA VH, solute transport occurs by convection and it is limited by the amount 
of ultra filtrate production. The patient's blood is pressed into hollow fibers with a 
highly permeable membrane. As a result of pressure difference across the membrane, 
fluid is lost from the plasma and it becomes a part of the ultra filtrate. In hemodialysis, 
diffusive transport is the major principle underlying blood purification, especially for 
the elimination of substances in the low molecular weight range, e.g., of urea and of 
creatinine. In CA YHD, however, the solute transport occurs both by convection and 
by diffusion simultaneously. Both processes have an influence on one another [3]. 
Ultrafiltration leads to an increased solute concentration in the dialysate side of the 
hemofilter and thereby decreases diffusion. Dialysis lowers the solute concentration 
in plasma water and thereby decreases the amount of solute that is removed by 
ultrafiltration. The ultrafiltration is due to the difference between spontaneous 
physiological blood pressure and the pressure on the dialysate side as a result of flows. 
2) Since the CA VHD treatment is a slow and continuous process, the rate of dialysate 
flow (up to 60 mllmin) is lower than it is in conventional hemodialysis (500 ml/min). 
Dialysate flow rates (l0-60 mllmin) are very low compared to the blood flow rates 
(50-35G mllmin) and, consequently, the change in dialysate solute concentration over 
the length of the hemofilter cannot be taken to be linear, as in conventional models 
of dialysis [4]. The dialysate flow rates that are used in CA VHD might be too low for 
optimal distribution of dialysate over the dialysate compartment. ',Vith low dialysate 
flow rates, the resistance to diffusion exerted by the dialysate compartment may be 
much higher than in conventional hemodialysis. 
3) The diflhsive performance of a CA VHD hemofilter is determined mostly by its overall 
diffusive mass transfer coefficient (K.J. In mathematical analysis of solute transport by 
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combined convection and diffusion, the overall (diffusive) permeability (K,J is defined 
as the ratio of the solute flux UJ to the solute concentration gradient (.6.C ;::;: Cw - Cd) 
when ultrafiltration volume flux U\,) vanishes [5]. This corresponds to the overall mass 
transfer coefficient (K.J used for conventional hemodialysis. The r<u of a dialyzer used 
for conventional hemodialysis OJ' hemodiafiltration for a specific solute is ca1culated 
not only at zero-ultrafiltration, but also with standard values of blood (200 mUmin) 
and dialysate flow rates (500 mllmin). This is due to a lower rate of ultrafiltrate 
production (::::5 mllmin for hemodialysis and ::::50-60 mllmin for intermittent 
hemodiafiltration) than the dialysate flow rates (500 ml/min). In CAVHD however, 
the blood flow is spontaneous and the ultrafiltration flow rates are no longer negligibly 
low as compared with the dialysate flow rates. It is then questionable whether the 
value ofKo ' usually obtained at negligible ultrafiltration and at high dialysate flow 
rates, is valid in the conventional range of ultra filtrate production (up to 20 mIl min) 
as it is in CAVHD. 
4) In contrast to intermittent hemodialysis (4-5 hours in a week), CA VHD is a 
continuous technique. 'Vith prolonged use of the hemofilter, deterioration of the 
membrane is likely not only to decrease the rate of ultrafiltration but also to impair 
diffusive performance [6]. 
CA VHD is a new renal replacement technique. Insight into the determinants of solute 
clearance is needed to determine the optimal flow rates. Also, data on drug clearance are 
needed. For some drugs dose adaptations may be necessary [7]. For this and the above 
reasons, existing models of hemodialysis and hemofiltration are not likely to be useful for the 
analysis of solute transport in CA VHD. Therefore, we need a mathematical model that could 
be used to analyze solute transport by CA VRD. 
Previous tnodels of solute transport by hem.odialysis and hem.odiafiltration 
In the mathematical model of conventional hemodialysis, as published by Sargent and Gotch 
[4], a linear change in the solute concentration over the length of the dialyzer is assumed. 
Convective transport is neglected. Thus the rate of solute transport depends on the difference 
between the concentration in blood and that in dialysate and on the overall ~ss transfer 
coefficient of diffusion (Ko). By using this model, one may calculate the length·averaged ~ 
fi·om the total solute transport and the log-mean concentration difference over the membrane. 
In CA VHD, the contribution of convective transport is relatively great. Also, because of the 
ratio of blood and dialysate flow rates, a curvilinear decrease of blood solute concentration 
over the length of the hemofilter is to be expected. 
Rose et al [8] published a one dimensional model of simultaneous hemodialysis and 
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ultrafiltration. In their model, which they developed for intermittent hemodialysis, the analysis 
of solute transport was based on the assumption that the ultrafiltration volume flux is constant 
along the membrane, which corresponds to a situation when the ultrafiltration is proportional 
to the transmembrane pressure difference. The overall mass transfer coefficient was 
determined by clearance measurements at zero~ultrafiltrationJ hence the effect of 
ultrafiltration on the overall diffusive mass transfcr coefficient was neglected. The overall mass 
transfer coefficient of diffusion is the inverse of the total resistance to diffusion, which consists 
of the resistance to diffusion of the blood compartment, that of the membrane and that of the 
dialysate compartment [9]. In conventional dialysis the bigger part of the resistance to 
diffusion is exerted by the blood compartment and the membrane. According to Grimsrud 
and Babb [10], the resistance to diffusion in the dialysate compartment approaches zero at 
a fast and turbulent dialysate flow. Accordingly, they developed a model of solute transport 
in which the resistance to diffusion of the dialysate compartment was neglected. Also in their 
model, ultrafiltration rate was taken to be zero. In CA VHD, this approach is not valid 
because of the low dialysate flow rate and the relatively high rate of ultrafiltration. 
In his mathematical analysis of combined convection and diffusion, Sigdell [11] gave 
expressions for the overall diffusive permeability (I<-d) with ultrafiltration and (Ko) without 
ultrafiltration, noting that the ultrafiltration reduces the effective difillsive permeability due 
to reduction of the concentration gradient (liC), but at the same time adds even more through 
convection. His expressions are valid for the operational limits of conventional hemodialysis 
(Qr" Qr,; « Q.;). 
Sigler et al [12] first described solute clearance by CA VHD in patients. They did not discern 
the local solute transport by convection fi'om that by diffusion and the study does not provide 
any insight into the determinants of diffusive transport. Pallone et al [13] studied solute 
transport by CA VHD in a laboratory setting. They presented a model in which they defined 
the local solute flux by convection and by diffusion. These fluxes were then integrated over 
the length of the hemofilter to calculated the solute clearance. 'Vith their model, they could 
calculate the curvilinear change in solute concentration along the hemofilter. Since their 
model did not provide an analytical expression of Ku, the Ku was determined by using curve-
fitting techniques. They did not recognize the influence of differences in the dialysate flow rate 
on Ko (See Chapter 7).Jaffrin et al [14] published a mathematical model of combined 
convection and diffusion, to be applied to intermittent hemodiafiltration, which is a pump-
driven hemodiafiltration technique. They expressed Ku as a function of the resistance of 
diffusion in blood, in membrane and in dialysate. These values are, however, not readily 
available. They determined the proper mass transfer coefHcient {KJ by making use ofKofi'om 
the clearance measurements at zero-ultrafiltration and curve fitting techniques. 
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In \~ew of the shortcomings of the above models, we developed a ncw model orCA VRD. In 
the present chapter, we first define a general model of CA VHD that can easily be 
implemented in any spreadsheet program or programmed in any higher programming 
language. Then, with some simplifications (Chapter 6), we analytically solve the model 
equations, so as to provide expressions of~ depending on the local behavior of ultrafiltration 
volume flux, as a function of blood, filtrate and dialysate flow rates and solute concentrations. 
By virtue of this expression ofKrl ) the model is well suited for the analysis of diffusive 
transport in CA VHD. 
5.2 MATHEMATICAL MODEL OF CAVHD 
Model description 
In Figure 5.1, a schematic representation of a CA VHD flow system is shown. Blood fr?m the 
arterial line flows inside the fibers (blood compartment) to the venous line. Blood enters the 
hemofilter at x=O (blood inlet) and leaves it at x= Lr (blood outlet). The dialysate fluid flows 
counter currently outside the fibers (dialysate compartment). Dialysate enters the hemofilter 
at x= 1,. dialysate inlet) and leaves at x=O (dialysate outlet). The dialysate and blood 
compartments are separated by the fiber wall (membrane) 
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Figure 5.1: Schematic representation of CA VI-ID flow system. 
The hemofiltel' is characterized by a small surface, highly permeable membrane and consists 
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orN number afhollaw fibers each with an effective length (4) and internal radius (If) and its 
surface area (S=2NrcrrW is equal to the sum of the filtering surfaces of all the fibers. In Table 
5.1, the boundary definitions and variables of the model equations arc shown. 
Table 5.1: The boundary conditions of model variables for counter-
current operation. 
variables x=o x x = 1,-
blood flow rate Q,; Q, Q"., 
plasma watcr flow rate Q,j Q, Q," 
dialysate flow rate Q," Q, Q,; 
solute concentration in plasma water C"i C". Cwo 
solute concentration in dialysate Cd" Cd Cdi =0 
plasma protein concentration C pj C, C"" 
blood pressure Pbi Ph Poo 
hematocrit Htj Ht Ht" 
blood viscosity l)bi 11, 1100 
dialysate pressure Pd" Pd Pdi 
oncotic pressure IIpi II, II"" 
notations for radial solute concentrations 
r<0, blood bulk C"(O)=C,, 
Os;rs;db, blood boundary layer C,,(l~ 
r:::rd, blood-membrane interface C\\m 
dbs;rs;dm, membrane Cm(r) 
r=dm, membrane-dialysate interface Cmd 
dm::::rs;dd, dialysate boundaty layer Cd(r) 
r>dd' dialysate bulk Cd(r,,)=Cd 
Input variables 
The mathematical model requires the following input variables, which can all be obtained 
from either clinical measurements or manufacturers' specifications: 
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arterial blood flow rate (Q.,J, 
dialysate inlet flow rate (~i)' 
ultrafiltration flow rate (Q), 
infusion rate of subs tit uti Oil (predilution) fluid (Q"re-d)' 
arterial hematocrit (HtJ, 
arterial plasma protein concentration (Cp,J, 
temperature (T), 
solute concentration in the arterial blood plasma (CpU, 
solute concentration in the dialysate/ultra filtrate outlet (Cdo), 
solute concentration in filtrate (C[), 
total membrane surf.:'1ce area (S), 
length of the hemofilter (membrane) (1,), 
difillsive mass transfer coefilcient (Kd) that follows fi'om the model calculations, 
non-protein-bound fi-action or the solute (Ff), 
sieving coeflicient (y) that is the fraction of the solute mass that passes through the 
membrane during ultrafiltration, 
pre- and postfilter hydrostatic blood pressures (Pbi and Poo), dialysate pressure (Prl) or 
the height ofhemofilter ultrafiltration line (h,} 
From these input values of the variables we calculated the local solute concentrations, the 
local flow rates in both blood and dialysate compartments over the length of the hemofilter 
and thereby, the convective (CIJ and diffusive (CI,J contributions to the total solute clearance 
(el). 
Assumptions 
The derivation of the mathematical model is based on the following major assumptions: 
1) All of the hollow fibers in the hemofilter behave as a single capillary tube. 
2) The permeability coefficients are constant along the hemofilter length. 
3) Solute sieving coefficient is constant along the hemofilter length. 
4) The flow rates and concentrations arc time-independent for a given set of 
measurements (steady-state) 
5.3 EQUATIONS NEEDED FOR MATHEMATICAL SIMULATION 
Our mathematical model is based on the standard equations for continuity and mass balance 
of transmembrane volume and solute transport. The expressions for transmembrane volume 
and solute flux are combined with overall balances to obtain results in terms of the solute 
clearance. The model describes the flux of a solute from plasma water to dialysate by 
simultaneous convection and diffusion during countercurrent hemodiafiltration. The solute 
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concentration at the dialysate inlet is taken to be zero, As can be seen from Figure 5.2, the 
fiber wall (membrane) and a very thin concentration boundary layer at each side of the fiber 
wall may be considered as a virtual membrane. No concentration jell-layer forming is 
considered. Here, we briefly describe the equations and techniques required to provide 
mathematical simulation of solute and volume transport in CA VI-ID: 
• Pressure-flow relations 
Ultrafiltration or transmembrane volume flux, 
Overall solute mass balance, 
Transmembrane solute mass flux, 
Solute clearance, 
Approximations and analytical solutions (Sec Chapter 6), 
Computational techniques (See Chapter 9). 
Pressure - flow l.·elationships 
At the beginning of the fibers (hemofilter blood inlet), where they arise from the arterial line, 
the blood pressure, which tends to force the plasma water and small solutes out of the fibers 
to the dialysate side, considerably exceeds the sum of the opposing pressures. As the blood 
flows toward the venous line there is a gradual decrease in the effective ultrafiltration pressure 
(f~'IP). As a result, the blood flow rate decreases down the hemofilter length. Because of the 
continuity the dialysate flow rate increases. The decrease in blood flow (Q,) or in plasma 
water flow rate (Q,. ) and the increase in dialysate flow rate (Qn ) over a diflerential length dx 
(an annular segment of the hollow fiber wall of length dx lying at a distance x from the 
beginning of the fiber) may be expressed in the differential form by the following continuity 
equations: 
dQ. dQw dQd 
-- = -- = - -- '" - wi dr d< d, ,. (5.1) 
whereJ,. is the ultrafiltration volume flux (density), w is the ratio or total membrane surface 
area (S) to the fiber length (1,), whieh corresponds to the width of the hemofilter: 
s 
W ::: - '" 21trf N Lf 
where rf is the internal radius of a fiber and N is the number of fibers. 
Ultrafiltration vohuue flux 
(5.2) 
The ultrafiltration volume flux (density) depends on the hydraulic permeability (4) and the 
local transmembrane pressure difierence (T~'IP): 
J, = Lp TMP (5.3) 
The local transmembrane pressure diflerence is given by Starling'S law: 
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TMP = P -P -II b d p (5.4) 
\\~th Pbl Pd and ~ each representing the local blood hydrostatic pressure, dialysate pressure 
and oncotic pressure respectively. To determine the blood hydrostatic pressure (Ph) over the 
length of the hemofiltcr in cq.(5.4), the Poiscuillc's law is used in differential form: 
dPb R[ 
dt - L ~b Qb (5.5) 
! 
where Rr is the hemofiltel' resistance to the blood flow (See eq.(3.3) and eq.(3.8)) and '1b is the 
local blood viscosity, calculated from an empirical formula (See eq.(3.12» as described by 
Pallone et al [13,16].To determine the local blood viscosity in the hemofilter, the blood 
viscosity in eq.(5.5) has to be evaluated at each point (x) along the hemofilter length by 
relating hematocrit (Ht) and plasma protein concentration (Cp) to the local blood flow rate 
(Q,) as: 
HtiQbI (5.6) Ht=--Qb 
Cp 
Cpt QbP - HI,) (5.7) Qb(l - Ht) 
where H~, Q,i and Gpi are the hematocrit, blood flow rate and plasma protein concentration 
at the hemofilter blood inlet. The dialysate fluid flows in the opposite direction to the blood 
flow. Because of flow resistance in the dialysate compartment the pressure rises with the axial 
position (x). However, since the dialysate flow rate is small compared to the blood flow rates, 
the dialysate pressure drop is small and can be neglected. Therefore, the pressure (Pd, 
[mmHg]) midway on the dialysate compartment can be calculated from the height of the fluid 
column in the ultra filtrate line according to eq.{3.24). Oncotic pressure is given by a third 
order polynomial from the protein concentration according to eq.{3.25) of Landis-
Pappenheimer's empirical formula [16]. The GAVHD hemofilter membrane is essentially 
impermeable to the plasma proteins and they only contribute a transmembrane oncotic 
pressure difierence. Since the filtration of plasma water increases the concentration of the 
plasma proteins, the net oncotic pressure increases down the fibre axis. Since ~~le plasma 
proteins cannot pass the membrane, the local values of protein concentration can be derived 
from the overall protein mass balance, namely eg.{5.7). 
Overall solute Inass balance 
The mass balance for a particular solute over a differential length (dx) of the hemofilter 
implies that the mass removal from blood compartment is equal to the mass gain into the 
dialysate compartment. A mass balance for a particular solute may be written as a differential 
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mass transfer rate from the blood side (Q,.C,J or from the dialysate side (~Cd),: 
d(Q",C,) 0 _ d(QdCdJ 0 _ wJ 
dx d:( S (5.8) 
where], represents the transmembrane local solute mass flux (density), C w and Cd are local 
solute bulk concentrations in plasma water and dialysate respectively. Integrating the sum of 
both mass transfer rates in eq.{5.8) over a distance from 0 to x, we obtain the overall mass 
balance: 
r; (Q",C", + QdCdJdy 0 (5.9) 
where y is a dummy variable. Consequently: 
Q\I'C\~,+QdCd=Q\\'iCl\"i-QdoCdO - AM (5.10) 
which means that the solute mass transport rate from the blood compartmerit into the 
dialysate compartment is the same evctywherc along the hemofilter length and equals to il.!vl. 
blood bulk concentration 
(=0 " ..................... , .. "' .. "' .. "' ..... "' ......... . 
blood concentration 
boundary layer 
membrane 
C.lr) 
dialysale concentration 
boundary layer 
r::dd ............................................................................................... ,. 
dialysate 
bulk concen \raion 
FO --------------------------------------------------~ •• x=LI 
Figure 5.2: Radial concentration profiles in blood, membrane and dialysate 
compartments. See Section "Transmembrane solute mass flux". 
Solute lllass flux 
T1'allSnZenlbrmte solute nlass flux 
The local radial behavior of the solute flux a,) at some point (1') in the membrane can be 
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described by the equation: 
J = , (5.11) 
whercJ)s the local ultrafiltration volume flux, em(r) is the radial solute concenh'ation in the 
membrane, Dm is an eflective diffusion coefi1cient in the membfallc and y is the convective 
transport (sieving) coeflicient which is assumed to be independent of T. The continuity relation: 
a Cm(r) = _ oj,. 
at or (5.12) 
combined with the steady-state condition (assuming that a steady-state solute transport is 
achieved): 
leads to the differential equation: 
a' Cm(r) 
a r' 
a Cm(r) 
at = 0 
which has the solution for the radial solute concentration (Cm{r)) for dt .. s:rs;dm : 
J, J y-r 
.--!.)e D", 
J,. 
(5.13) 
(5.14) 
(5.15) 
where C\Hll is the solute concentration at the blood-membrane interface (at r=db with db 
representing the thickness of the blood concentration boundal), layer). Integrating eq.{5.11) 
over dim we find the net local solute flux in terms ofinterf..1.ce concentrations: 
J- YJ,·(C ·"-C) 
, - -.-- lillie IIId 
e /'i - 1 
(5.16) 
in which Cmd is the solute concentration at the membrane-dialysate interface (at r=dd with 
dd representing the thickness of the dialysate concentration boundary layer) and 
(5.17) 
is the membrane Peclet number with lIP m=Rm=dn/Dm representing the resistance of 
membrane to diffusion. The reciprocal ofR.n represents the membrane diflusive permeability 
(PJ. Eq.(5.16) expresses the net solute flux as) across the membrane in terms of the solute 
concentration (CnID) at the blood-membrane and the solute concentration (Cmd) at the 
membrane-dialysate interface [17,18] (See Figure 5.1 and Hgure 5.2) by simultaneous 
convection and difiusion. 
To incorporate eq.(5.16} into an overall description of solute transport during CAVHD, the 
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solute flux has to be expressed in terms of bulk solute concentrations. In general, these bulk 
solute concentrations will not be equal to the interface concentrations due to an unstirred 
concentrati~n layer in the blood region and due to an unstilTed concentration layer in the 
dialysate region. The interface solute concentrations can be related to the bulk concentrations 
by using thin film theOlY used by Jaffrin et al [14]. 
Solute flux front blood bulk to bfood-1Ue1l1b,'alle intelface 
The local behavior of the solute flux at some point (r) in the blood concentration boundary 
layer can be described by the equation: 
= J C ( ) _ D a C,,(r) 
is v I\' r b ar (5.18) 
where Cw{r) is the radial solute concentration in the blood boundary layer, Db is the effective 
diffusion coeflicient in the blood boundary layer. The continuity relation combined with the 
steadywstate condition leads to the diflcrential equation 
a2 Cw(r) ~ a C,,(r) ~ 0 
a r2 Db Br 
The solution for the radial solute concentration (Cw (1'» for Os:rs:db is: 
J, 
Cw (r) = - + (C,/O) J,. 
(5.19) 
(5.20) 
where C",(O) is the solute concentration at r=O (the blood bulk). The solute concentration 
at the blood-membrane interface (e"rol at r=rb follows from eq.(5.20); 
in which 
J, 
+ (Cw(O) -
J, 
J,) '. 
- e 
J,. 
db e, =J- =J,.Rb 
, Db 
(5.21) 
(5.22) 
is the Peciet number of blood boundalY layer with Rb = db/Db representing the resistance of 
blood boundary layer to diffusion. 
Solute flux front metnbrane-dialysate intetface to dialysate bulk 
The local behavior of the solute flux at some point (1) in the dialysate boundalY concentration 
layer can be described by the equation 
aCir) 
J, = J,. Cd(r) - D d ---
ar 
(5.23) 
where Cd(r) is the radial solute concentration in the dialysate boundary layer, Dd is an 
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effective solute diffusion coefi1cient in the dialysate boundary layer. The continuity relation 
combined with the steady-state condition leads to the differential equation 
a' Cir) J" a Cir) 
---"0 (5,24) 
The solution for the radial solute concentration (Cd (r» for drn~r.s:dd is: 
J., 
J, J-' C ( ) (C - ----!.) e D, d r =J+ md ~. J\. 
(5,25) 
The solute concentration at the membrane-dialysate interface (CrnJ at r=dm follows from 
eq.(5.25): 
in which Cd(rd) is the solute concentration at r=rd (the dialysate bulk) and 
dd ed = J~,- == J).Rd Dd 
(5,26) 
(5,27) 
is the Peelet number of dialysate bound at)' layer \\~th Rd:::: dd/Dd representing the resistance 
of dialysate boundary layer to diffusion. 
Solute flux from blood bulk to dialysate bulk 
Substitution of eq,(5,26) and c'l,(5,21) in c'l,(5, 16) yields the net solute mass flux from blood 
bulk to dialysate bulk: 
(5,28) 
where C",::::C,,(O) and Cd=Cd(dd) represent the solute bulk concentrations in (blood) plasma 
water and in dialysate respectively and A. represents: 
with 8 1 defined as: 
A " __ -;;---;;--".1 __ -:-_ 
(I-y)eo'(eo·-l)+y(e"-I) 
at :co Jv(Rb + ; + Rd ) = 6b + 8m + 8d 
m 
(5,29) 
(5,30) 
For y:::: I as can be seen from eq.(5.30), the total resistance (RId) to diffusive solute transport 
becomes equal to the sum of resistances of the membrane, the blood and dialysate 
concentration boundaty layers: 
I I 
-K = RId = Rb + - + Rd 
d Pill 
(5,31) 
where (K,i) represents an overall diffusive mass transfer or permeability coefIicient. Given the 
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overall mass transfer coefilcient (I(d) for an arbitral), solute, an obsclved Peclet number can 
be defined: 
(5.32) 
For y:::l J the theoretical total Peciet number (8J equals the observed Peelet number (80 ), 
Transmembrane solute flux in cq.(5.28) can be separated into the convective and diffusive 
components explicitly: 
with 
/, _6,,_1 ~ e 1\ -b e , 
1 f=-A+-
d e , 
(5.33) 
(5.34) 
(5.35) 
where fb and ftJ are the factors describing the relative weighting of blood and dialysate 
concentrations in the evaluation of the concentration of solute which is dragged by plasma 
water into the dialysate region or by dialysate fluid into the blood region in case of a back 
filtration. 
The second term on the right hand side of eq.{5.33) is the ciifillsive component and the first 
term is the convective component. As stated by Zydney [19] however, the division of solute 
flux UJ in eq.{5.28) into separate convective and diffusive contributions as in eq.{5.33) is 
somewhat misleading. It must be remembered that the convective flow alters the 
concentration profiles due to interaction between the convective and diffusive components. 
Also the effect of the convective flow on the concentration gradient is a function of the volume 
flux Gv) which in turn varies with the axial position along the hemofilter length. 
Solute sieving coefficient 
The solute dragged along by the plasma water f1O\\~ng through the membrane can be reduced 
by a hindrance factor called as the sieving coefficient of the solute, i.e. the ratio of solute 
concentration in ultra filtrate to that in plasma water. In CA VHD, an apparent sieving 
coefficient is calculated as: 
y (5.36) 
with Cr is the concentration of non protein bound solute that passes through the membrane 
during ultrafiltration at zero dialysate flow rate. For practical clinical purposes, the unbound 
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free fraction of uraemic solutes and therapeutic drugs (administered to sick lCU patients), 
equals the ratio arsolute concentration in the ultra filtrate to the mean solute concentration 
in plasma water in the hemofiltcf, thus the solute sieving coefficient. During clinical usc, for 
uraemic solutes of up to at least 1000 Daltons, the apparent sieving coefficient is one. 
Therefore the apparent sieving coefficient is equal to the free fraction of solutes which arc 
bound to plasma proteins [7]. 
Solute cleat'ance 
In clinical conventional hemodialysis, the ratio of the rate of solute mass removal to its 
concentration at the blood inlet is called clearance (CI) or clearance rate. It is calculated from 
the macroscopic (overall) mass balance equations and measured either from dialysate side or 
blood side of the hemofilter [12]. 
Depending on the profile of ultrafiltration volume flux GJ, when solute sieving coefficient (y) 
and the overall difillsive mass transfer coefficient (KJ are known, the total clearance can be 
obtained, in moles per unit of time, by integrating eq.(5.28) over the membrane length and 
dividing by C"i: 
(5.37) 
To express the clearance as the contributions of convective and diffusive transport separately 
one can use the solute flux expression fi'om eq.(5.33) in eq.(5.37). Separating the first and the 
second terms on the right hand side of eq.(5.33) into convective (CIJ and diffusive (CI.,) 
components [13], we define: 
(5.38) 
(5.39) 
In order to determine the solute clearance £l'om eq.(5.37) or eqs.(5.38M 5.39), the local flow 
rates, the solute concentrations, the solute sieving coefficient, the overall diffusive mass 
transfer coefi1cient (or the individual resistances to diffusion) are required to be known. 
Equations governing the local flow and concentration profiles can be solvtd by using 
numerical integration methods or, instead} can be solved directly from the continuity 
equations by using numerical diflerentiation techniques [20]. 
5.4 DISCUSSION AND CONCLUSION 
This model takes into account the variation of concentration in the blood and dialysate 
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boundary layers as well as inside the membrane in the presence of simultaneous diffusive and 
convective solute transports. The drawback of this model is that it requires an estimation of 
blood, dialysate, and membrane resistance and not just their sum to determine the solute 
clearance in CAVHD. The boundal), layer thickness (db) of blood side and that (d,,) for the 
dialysate side are not known. Precise values ofRbJ Rd and lIP m can hardly be obtained from 
clinical data. To some extend, the db and dd may be calculated from inner and outer 
diameters of the hemofilter fibers as described by Sigdell [11]. However, Sigdetl's expressions 
arc related to the cil)' or wet state condition of membrane only, not to the operating hcmofilter 
membrane index (~dI) which decreases with time (See Chapter 3). Therefore, depending on 
the membrane condition (i\H) and the dialysate flow rate (Qn;) and the precise values ofRb, 
Rd and liP m have to be determined in ill vitro studies. Also, use of numerical models is time-
consuming. 'Ve therefore decided to make some simplifications in the modeling of solute 
transport in CA VHD, so as to obtain the overall diflhsive mass transfer coefficient (I(d) from 
clinical data (See Chapter 6) at first and then to analyze the resistances Rb, Rd and liP m under 
difierent operational and clinical conditions (See Chapter 9). 
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ANALYTICAL SOLUTIONS TO SOLUTE TRANSPORT IN 
CONTINUOUS ARTERIO-VENOUS HEMODIAFILTRATION 
6.1 INTRODUCTION 
Chapter 6 
In Chapter 5, a mathematical model of solute and volume transport in continuous arterio-
venous hemodiafiltration (CA VHD) was introduced. The model takes into account the 
variation of concentration in the blood and dialysate boundmy layers as well as inside the 
membrane in the presence of simultaneous diffusive and convective solute transports. The 
drawback of that model is that it requires an estimate of blood, dialysate, and membrane 
resistance and not just their sum to determine the solute clearance in CAVHD. However, the 
boundalY layer thickness (db) of blood side and that (d,) of the dialysate side are not known. 
Precise values ofRbl Ru and lIPn! can hardly be obtained from clinical data. Also, the use of 
numerical models is time-consuming. ''''e therefore decided to make some simplifications in 
the modeling of solute transport in CA VHD so as to obtain the overall diffusive mass transfer 
coefficient (KJ from clinical data under different operational and clinical conditions. The 
drawback of mathematical models of others [1-2] was that also in the presence of remarkably 
high ultrafiltration flow rates, overall mass transfer coefficient (KJ of a dialyzer is calculated 
first at zero-ultrafiltration with standard blood (200 mllmin) and dialysate flow rates (500 
mllmin) and then determined by means of the curve-fitting techniques. That of course 
resulted from the mass balance errors in their calculations when they calculated the overall 
mass transfer coefficient (Kd) of a dialyzer at zero ultrafiltration in a flowing system where the 
ultra- filtration was indeed not negligibly small. In CA VHD, the dialysate flow rates are low 
compared to the rates of ultrafiltration flows, making the dialysis treatment as slow as possible. 
Therefore, the overall mass transfer coefficient of a CA VHD hemofilter has to be calculated 
in the presence of ultrafiltration. 
In this chapter, analytical solutions to solute and volume transport in CA VHD are presented 
in order to calculate the diffusive mass transfer coefficient (K,J for a solute when blood, filtrate 
and dialysate flow rates and solute concentrations are known. ''''e therefore made 
simplifications in eq.(5.3) and eq.(5.33), each representing the ultrafiltration volume flux IT,.) 
and solute mass flux GJ respectiv~ly. In the following sections, we introduce analytical 
solutions to solute and volume transport in CA VHD, so as to obtain expressions of the overall 
diffusive mass transfer coefficient, depending on ultrafiltration volume flux under the 
foHowing conditions: 
Ko for zero ultrafiltration volume flux G\.=O), 
~ for a constant, mean volume flux Gv=Ja=QlS), 
• K.t for a linear decreasing volume flux G\.=u + px). 
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The overall mass transfer coefficients (~, I<.t and K d) are derived from the equations 
governing the overall mass balance. 
6.2 MATHEMATICAL MODEL 
Model descdption and assuulptions 
This mathematical analysis of CA VHD is valid primarily for a hollow fiber dialyzer or 
hcmofilter, but ,,~th some minor modifications also for parallel plate dialyzer. Sec Chapter 
5, Section 5.2 for the model description and Table 5.1 for the definition of boundary 
conditions. The derivation of the mathematical model is based on the following assumptions: 
1) All fibers behave equal. Hence the effective smfacc area of the hemofilter S::::2Nnrrl,-
with f,- the inner radius and l, the effective hemofilter length. 
2) The hydraulic and diffusive permeability CLr and Kd) are constant along the filter 
length. 
3) The solute concentration in the blood (C\,) and in the dialysate (Cd) arc "mixing-cup" 
concentrations [1]. This avoids the mathematical complexity of partial differential 
equations describing the concentration boundary layers and concentration 
polarization. This is also because we measure the average solute concentrations from 
arterial blood and from dialysate line connecting to the collection bag (see Figure 5.1), 
not directly from the blood bulk inside the fibers and from the dialysate bulk outside 
the fibers. 
4) The flow rates and concentrations arc time-independent during measurements 
(steady·state). 
5) The transmembrane pressure gradient decreases linearly with increasing longitudinal 
distance (x). 
6) The sieving coefiicient is one (for solutes such as urea, creatinine and phosphate). The 
sieving coefi1cient is a constant (O:;;y:;; 1), depending on the relative size of the 
membrane passing molecules and the membrane pores. It indicates the fraction of the 
solute that ultrafiltration drags through membrane. 
Solute nlass flux 
Generally, mathematical analysis of solute transport by combined convection and diffusion 
in clinical hemodialysis is based on the following solute flux equation: 
J, 0 Y J,JibC", + idCd) + Kd(C", - Cd) (6.1) 
whereJs is local solute mass flux, Cw and Cd are local "mixing-cup" solute concentrations in 
blood and dialysate compartments, y is sieving coefficient, Kd is the overall diflusive mass 
transfer coefficient representing the reciprocal of the overall resistance to diffusive solute 
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transport. Further, the fb and fd are factors describing the relative weighting of blood and 
dialysate concentrations in the contribution to the convective solutc removal. Eq.(6.1) provides 
a tigorous expression for the solute flux for arbitrary values of the transmembrane volume flux 
J" along the hemofilter length. In the limit of vcry highJ., the convective weighting factors 
become fb= 1 and f.J=O, and consequently, independent from the solute sieving coefficient, 
eq.(6.l) becomes equal 10: 
(6.2) 
In the limit of zero transmembrane volume flux UI'=O), eq.(6.1) reduces to: 
Js ::0: Ko (el\' ~ Cd) (6.3) 
where the solute flux is governed by the diffusion only and the overall diffusive permeability 
(K1.') is determined at zero ultrafiltration. For low and moderate ultrafiltration volume flux (for 
small Peciet numbers, yJJKd «I), the (length averaged) weighting factors are equal to 
fh=~~O.5 [2,3] (See Figure 6.1). Therefore, for y=l, eq.(6.l) becomes: 
eW + Cd J, = J,. 2 + Kd(Cw - Cd) 
The condition yJJKd «I is verified in hemodiafiltration for most solutes with sieving 
coefficient y=l [2]. 
2.5.,----------------------, 
i 2.0 
J! 
o 
il ~ 1.5 
~ 
c Y = 0.4 
8 1.0f,.~.~.~.~.~.~.~.~ . ~.~.~.~.~.~.~.~.~.~.~.7.~.~.~~------
~ '" . fd 
~ y= 1 
o 0.5 +-~:.:.:........~~-~. ~ ..~.~ .. '"'._:'. :C .. C:.-:-. :-:---
o '" . 
' .. 
'. 
0.0 +--~~_~~._-~~_~~._-__ ~~r_n_I 
0.01 0.10 1.00 10.00 
Figure 6.1: Theoretical convective concentration t'lctors fb and fd (dashed lines) 
calculated from eq.(5.34) and eq.(5.35) respectively as a function of total Peclet 
number 8 t:::::yJJK..J:::::yJ,Rtd for sieving coeflicient y:::::l and y:::::OA [19]. 
(6.4) 
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PreSSU.l'e -flow relationships 
At the beginning of the fibers (x=O, blood inlet), the blood pressure (PbU exceeds the sum of 
the opposing hydrostatic dialysate pressure (Pdo) and oncotic pressure of the plasma proteins 
(lIpV. Since the filtration of plasma water makes the concentration of the plasma proteins (Cp) 
to increase, the net oncotic pressure increases down the fiber axis. From the blood inlet to the 
end of the fibers (x::::: Lr, blood outlet) there is a gradual decrease in the effective ultrafiltration 
pressure. This decrease is due partly to the fall in hydrostatic blood pressure, which occurs 
because of the resistance to flow through the capillary fibers, and partly to the rise in cncotie 
pressure. Dialysis fluid flows in the opposite direction to the blood flow. Due to flow resistance 
in the dialysate compartment the pressure rises with the axial position (x).The most general 
formulation of ultrafiltration or transmembrane volume flux OJ for simultaneous convection 
and diffusion is given by Sigdell [4]. In fact, Sigdell's formulation was intended for 
intermittent hemodialysis or hemodiafiltration, not for CA VHD. After some minor 
modifications in the original expression, we rewrite Sigdell's formulation as for our 
conventional symbols (See reference [4] and the appendix for a detailed derivation ofeq.(6.5)): 
~(!!.P:-M) J,. = LpTMP;Cosh(xa1) - -1 d Sillh(xa1) (6.5) a2 Lf 
where 4 is the hydraulic permeability, TlvlPj is the transmembrane pressure difference at the 
hemofilter blood inlet, APb" is the total pressure drop along the hemofilter length on the 
blood side, APd is the pressure drop along the hemofilter length on the dialysate side of the 
membrane, a[ and az are constants, x is the axial position of the hemofilter. Transmembrane 
pressure difference at the hemofilter blood inlet (IMP,) is given by: 
(6.6) 
with Pbi, Pdo and TIp;, each representing the hydrostatic blood pressure, dialysate pressure 
and oncotic pressure respectively at the hemofilter blood inlet (x::::O). Pressure drop along 
the hemofilter length on the blood side of the membrane (APbC) is given by: 
(6.7) 
,,~th Pho and TIpo' each representing the hydrostatic blood pressure and oncotic pressure at the 
blood outlet (x=l.J. Oncotic pressure TIpiand TIpoare calculated from a third order polynomjal 
from the protein concentrations according to eqs.(3.16.-3.18), the Landis-Pappenheimer's 
empirical formula [5]. In eq.(6.5), the constants a l and a2 represent: 
(6.8) 
a, (6.9) 
- 76-
Chapter 6 
where Qm and Qh} represent the blood flow rate at the blood inlet and the dialysate flow rate 
at the dialysate outlet respectively. For a1<0, direction of ultrafiltration flow is backwards, 
indicating the process of back filtration. In CAVHD, the ultrafiltration VOlllillC flux ITv) is 
moderate. It is controlled by membrane hydraulic permeability (I"p) and local transmembrane 
(or ultrafiltration) pressure (r.MP). Colton et a1 [6] has proved that at low transmembrane 
pressure differences (up to 200 mmHg), the]., is proportional to the product of TlvlP and LpJ 
whilc, at high T!vIP's, the ultrafiltration volume flux reaches a limit, at which the 
concentration polmization takes place. Since in CA VI-ID, the observed T~'1P is up to 80 
mmHg, we can assume that the ultrafiltration volume flux varies linearly with the hemofilter 
length. For small values of a, 's (See Appendix), eq.(6.5) can be approximated by: 
with 
p 
J, ~ a + px (6.10) 
L ~(!!.p' -!!.P) L b d 
'f 
(6.11) 
(6.12) 
Pressure drop along the hemofilter length on the dialysate side of the membrane (6Pt.!) is 
given by: 
(6.13) 
with Pili representing the hydrostatic pressure at the dialysate inlet (x:::: 1,). The dialysate fluid 
flows in the opposite direction to the blood flow. Due to flow resistance in the dialysate 
compartment the pressure rises with the axial position (x). But, since the dialysate flow rate 
is small compared to the blood flow rates, the dialysate pressure drop (AP J is small and can 
be neglected. Therefore, the pressure (p,)) [mmHg]) midwayan the dialysate compartment 
can be calculated from the height of the fluid coluilln in the ultra filtrate line (ho [em]) 
according to Pd=-h,/ 1.36. 
Local flow rates 
On integrating eq.(5.1) fi'om 0 to x using eq.(6.1 0), we find the local plasma water flow rate: 
Q ~ Q . - w(ax + £x2) (6.14) 
IV lH 2 
where Q,i is the flow rate of plasma water at the blood inlet (x=O). Similarly, one can obtain 
the equation foJ' local dialysate flow rate (Q,): 
Q ~ w(ax + £X2) - Q (6.15) d 2 do 
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where ~o is the flow rates of dialysate at x=O. See Table 5.1 for the definition of the 
boundary conditions. 
Net ultrafiltration flow rate 
The total ulh'afiltration rate (Q) is the value of the cumulative flow rate at x=L f which follows 
from integrating the second term on the right-hand side of eq.(6.14): 
(6.16) 
where Q,.o and ~i are respectively the flow rates of plasma water and dialysate at x= l,- and 
T!vlP m the mean transmembrane pressure difference: 
I I TMPm " 2:(P" + P bo) - Pd - 2:(IIp, + IIp,) (G.17) 
The hydraulic permeability ~) expressing the ultrafiltration coefficient per unit of membrane 
surface area, can be calculated from eq.{6.l6) and eq.{6.17). 
Solute mass balance 
The mass balance for a particular solute over a differential length (dx) of the hemofilter 
implies that the mass removal from the blood compartment is equal to the mass gain into the 
dialysate compartment. Using eq.(5.1) and eq.(G.IO), we substitute eq.(6.4) in eq.(5.8) and get: 
dC" " II' (J, -K ) (C" - Cd) 
d (6.18) dx 2 QlI' 
( J,. K) (C" - Cd) = w-+ 2 d Qd 
(6.19) 
Eq.(6.18) and eq.(6.19) can be solved analytically for Cw and Cd' using eq.(6.1O) and eq.(G.4). 
Concentration profiles 
On integrating the difference {dC,.! dx - dCdl dx) from eqs.(6.18-6.19) over a differential 
length (dx) of the hcmofilter we obtain: 
(G.20) 
where C"i and Cdo are respectively the plasma water and dialysate solute concentrations at 
x=o and variables I, II and 12 represent: 
I ".1.ln( Q",Qd' ) 
2 Q,,(-Qd) (6.21) 
I rx dy 
I "Jo P Q. 
__ y2+ay_~ 
2 IV 
(G.22) 
-78 -
Chapter 6 
(6.23) 
Defining the discriminant qk: 
(6.24) 
where ifk=l, q,=ql, Qc=Q"i yielding II and ifk=2, q,=q" Qc=Q" yielding I,. The solutions 
to eqs.(6.22-6.23) are to be found in standard reference books [7]: 
for qk>O: 
Inl px+a-fh
l 
-Inl a-fh
l 
I = px+a+.;--c4 a+{tE 
k fh 
px+a a 
arctan(--) - arctan(--) 
I " .pq; .pq; 
k .pq; 
2 
2 a I "-(1---) 
k a a+px 
(6.25) 
(6.26) 
(6.27) 
Multiplication of eq.(6.20) by Q". and subtraction of the resulting expression fi'om eq.(5.13) 
yields: 
(6.28) 
where AM is given by eq.(5.1 0). In a similar way, multiplication of eq.(6.20) by Q, and 
addition of the resulting expression to cq.(5.1 0) yields: 
llM-Q (C -C ) 1.Kp,-1,) 
c- wlI'idiJ e 
d -
QII; - QdIJ 
(6.29) 
To solve the concentration equations (6.28-6.29), one needs to know the mass transfer 
coefficient (Kd). Detailed description and derivations of eqs.(6. 1 4-6. 18) can be found elsewhere 
[8]. 
Concentration profiles at zero ultrafiltration volunle flux 
In the limit ofJ.::::O, the solute transport occurs only by diffusion. The flow rate of the plasma 
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water (Q,,=Qw) and that of the dial),sate (Q,0=Q,;) do not Vat)' with the distance along the 
hemofiltcr length. Consequently, eqs.(6.28-6.29), representing the concentration profiles on 
both blood and dialysate side of the membrane become: 
_ wKo (1 _ Q"i) 
Mf - Q .(C . - C ) e Q"; Q" 
C dl III fbi w '" __ -'-''-'...-'''c_= ____ _ 
Qwi ~Qdi 
(6.30) 
(6.31 ) 
Flow rates and concentl'ation pt'ofiles for a constant volume flux pt.·ofile 
In most clinical applications however, the ultrafiltration volume flux is assumed to be constant 
along the hemofilter length and calculated from the net rate of ultrafiltration flow, using 
eq.(6.16): 
Q 
Ja ::: ;::: LpTMPm (6.32) 
With], as given b), eq.(6.32), the flow profiles fi·om eqs.(6. 14-6. 15) become: 
Q\\, ::: QUi - wxJa (6.33) 
(6.34) 
The boundary values of eqs.(6.33-6.34) at x=~. give the net total ultrafiltration flow. Using 
the mean, constantl.=Ja in eq.{6.20), the concentration gradient can be written: 
K" I K" 1 
C -C "(C .-C )[QW],"-'.[ Qd'],"-' 
II' d 1\1 do' Q. _Q 
II't d 
(6.35) 
?vlultiplication of eq.(6.35) by Q,. and subtraction of the resulting expression from eq.{5.1 0) 
yields: 
Mf - Qd,(C"j - C,J F(x/" 2 
ell' = ---=Q7"--oQ=----
lI'i - do 
(6.36) 
In a similar way, multiplication of eq.(6.35) by ~ and addition of the resulting expression 
to eq.(5. 10) yields 
with 
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K" 1 
Mf - Q"i(C"i - C,J Fe,),"' , (6.37) 
Qu'i - Qdo 
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F(t) (6.38) 
Detailed description and derivations of eqs.(6.32~6.38) can be found elsewhere [9, I 0]. 
Clearance and ovel.'all ntass transfer coefficient 
In clinical hemodialysis, solute clearance (el) is defined as the ratio of the amount of solute 
removed per unit of time to its concentration at the blood inlet, with the assumption that 
solute concentration at the dialysate inlet (Cdi ) is zero. It is calculated from the flow rates and 
measured solute concentrations fi'om either blood or dialysate compartment as: 
Cl = Qw;(i - ~"") + Qj ~wo = Qd; Cdo + Qj Cdo 
wi lI'i elfi ClI'i 
(6.39) 
where C\\O is the solute concentration at the blood outlet. In their evaluation of CA VHD, 
Sigler et al [11] and others [l2,I3] used eq.(6.39) to separate solute clearance into estimates 
of diffusive and convective components. "Ve designate these as CIl) and Clc respectively: 
a=~+~ ~~ 
with: 
C Cd" CID Q . (I - --"") Qd;c. (6.41) 111 C. 
11'1 1\'1 
Cl Cl Q[ Clc Q[(l_QD) D Q
di 
(6.42) 
Hi 
However, the Cln in eq.(6.41) is a hypothetical clearance that would produce the same 
concentration at the outlet of the hemofilter without ultrafiltration ((1=0). Thus, CID is not 
the clearance measured at zero~ultrafiltration for the same blood and dialysate flow rates. 
Therefore it may not be regarded as the contribution to dialysis to the overall clearance and 
eq.(6.41) may not be used to predict the diffusive performance in CAVHD, unless the 
outgoing dialysate solute concentration (Cuo) is measured at (1=0. In conventional 
hemodialysis, since the cOllvective component (Cld is practically zero, the solute clearance 
is mainly by diffusion (CI=Clo for (1=0). However, we are interested in CA VHD where the 
volume flux OJ decreases along the membrane length as given by eq.(6.5) or by eq.(6.1O). 
This means that the condition of zero net ultrafiltration (QrO) is not necessarily combined 
with the condition ofJ,.=O, but for example with the case of .1,.>0 in the first half andJ\"<O in 
the second halfOJack filtration} of the hemofilter. Therefore, in case of CA VHD, Clo and Clc 
in eq.(6.40) are not rigorously defined in terms of true diffusive and convective clearances. For 
J\"=O and consequently for QrO, Clo represents pure diffusive clearance. 
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For an ultrafiltration volume flux profile, as given by eq.(6.10), clearance calculations of 
solutes \\~th small molecular weight, provided by using eq.(6.40), do not (physically) describe 
the simultaneous diffusive and convective mass transport processes. Therefore, the solute 
clearance has to be calculated from the local solute flux (eq.{6.4» along the hemodialyzer 
length [I} 14, 15]. In order to determine the cOIlvective and difiusive clearance (designated here 
as CJ.: and Cld respectively), we define the convective and diflilsive components as in cq.(5.38) 
and eq.(5.39) respectively: 
(6.43) 
(6.44) 
In eq.(6.44), the product SKd is the permeation coefficient or diffusive performance capacity 
in ml/min. Given the solute clearance by eq.(6.40), the overall mass transfer coefficient (Ko) 
in eqs.(6.30-6.31) is determined from CI ~ Clo [12,13]. At theoretical zero ultrafilh'ation IT ,=0, 
consequently QrO), as applied in intermittent hemodialysis, the mass transfer coefficient can 
be obtained by solving SKo at the boundmy values of eq.(6.30) and eq.(6.31) at x=L,-: 
CID - Q. Qd-In ( "')(-') 
C/D - Qdi Qwi (6.45) 
As a measure of diffusive performance of the dialyzer, the product SKo [mi/min] is termed 
the permeation coefficient or diffusive pel{ormance capacity in mllmin at zero ultrafiltration 
[13]. In case ofQ"i=Qoi' eq.(6.45) may be approximated by using I'Hopital's rule: 
..!.. " S(_I- - _I ) 
Ko CID Qdi (6.46) 
Using eq.(6.45), clearance (CIo) of a dialyzer \\~th an overall diffusive mass transfer coefficient 
or permeability (Ko in pm/min), including boundary layer eficcts, in counter-current 
operation at zero ultrafiltration, may be predicted: 
SK(J(Q,,( _ I) 
l-eQ",Qdi 
(6.47) 
Eqs.(6.45·6.47) correspond to the formula's used for intermittent hemodialysis [4].To 
determine the mass transfer coefiicient I<U for an ultrafiltration flux profilejv=a+px, we solve 
eq.(6.20) for K, at the boundary condition (x=L,) and write it in terms ofK,,: 
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(6.48) 
in which IJ(L) and I,(L) arc calculated from eqs.(6.22·6.23) at x=~" Forj,.=O, Kd/Ko= I. As 
can be seen fi'om eq.{6.48), the term II(I..,-)MI2(l.ii) is not explicitly determined in terms of 
measurable flow rates and solute concentrations. 
Withj, as given by eq.(6.32), the flow profiles fi'om eqs.(6.14-·6.15) become equal to the flow 
profiles fi'om eqs.(6.33-6.3<1). Using eq.(6.33) and eq.(6.34-) for Q" and Q. respectively in 
eq.(6.22) and in eq.(6.23), the term IJ(L)-I,(L) in eq.(6.48) can be written as: 
f,(L) - f,(L) ~ ...I'.ln( Q"oQ",) 
Qj QlliQdi 
(6.49) 
On substitution of eq.(6.49) in eq.{6.48), one obtains the diffusive mass transfer coefIicicnt K" 
for a mean, constant volume fluxla: 
SK
Q
{ Q\\1 - Qdi ) + lln( QJroQdi ) 
QdiQ\\"i 2 QU'iQdo Ka ~ ----~~~~--~~ 
...I'.ln( Q"oQdO) 
Qf QlljQdi 
(6.50) 
which may also be obtained by solving K,l fmIll the boundaty value of eq.(6.35) at ),;::::4. 
"Vhen the overall diffusive mass transfer coefficient (KJ for a given ultrafiltration flow rate is 
known, one may predict the solute clearance, by writing cq.(6.50) in terms of clearance from 
eq.(6.39): 
CI (6.51) 
K" , 
1- Qll'i (QdQQlrQ)S~+2 
QdQ QdiQIJi 
Eq.(6.'15) is valid forJ,.=O. Eq.(6.48) is valid f01'j,.=«+px. Eq.(6.50) is valid f01'1,.=j,=(2,/8 
and not valid for Q,i:o;;Qn+Q.r. Using l'Hopital's rule it can be seen that, at zero ultrafiltration, 
eq.(6.48) and eq.(6.50) become equal to eq.(6.45). 
Boundary values 
The flow rate of plasma water (Q,i ) at the blood inlet is calculated from the arterial blood 
flow rate (Q,j, taking into account the hematocrit (Htj, the plasma protein concentration 
(Cpj and the rate of substitution fluid infusion (~rffi) according to: 
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(6.52) 
where 0=0.00107 1/ g [6] is a factor to calculate the protocrit fi'om plasma protein 
concentration,Jis the fractional volume distribution of solute in blood cells if=O.8 for urea and 
1=0 for other uraemic solutes and drugs [171). A patient treated by CA VHD, will loose a 
certain amount of ultra filtrate (plasma water) which must be replaced by an almost equal 
amount of sterile substitution fluid. In CAVHD, one injects this fluid into the blood line 
before the hemofilter (prcdilution) or after the hemofilter (postdilution). In this study, the 
predilution mode is used. The rate of substitution fluid (C4,rcd) depends on the overall fluid 
balance and desired weight loss of the patient [I8]: 
(6.53) 
where Q. is the rate of ultrafiltration flow (400-600 mUh), QJ1 is the rate of urine, insensible 
and GI losses (50 mil h), Q, is the hyperal (hyper alimentation fluid) rate (up to 100 mUh), 
~ra is the fluid of drug administration rate (40 mUh) and Q.rm is the necessary rate of 
excessive fluid removal fi'om the patient's body (l00-150 mUh). The solute concentration in 
plasma water at the blood inlet {C"J is calculated from the solute concentration in arterial 
plasma (Cpl) as: 
(6.54) 
The solute concentration in arterial plasma {CpU has to be corrected for unbound fi'ee tiaction 
(Fr) if the solute in question is bound to plasma proteins} because only unbound solutes in 
plasma water participate in the process of diffusion and convection. Solute concentration in 
plasma water (C"o) at the blood outlet can be calculated from eq.{5.1O) at x=Lr. Solute 
concentration at the dialysate inlet is C,H:::::O and that at the dialysate outlet (Cno) is measured 
from a collection bag. Plasma water flow rate (Qm) at the blood outlet equals Q,i -Qr with Qr 
the net rate of ultrafiltration flow. The flow rate of dialysate (~o) at the dialysate outlet equals 
QJj+Q-, with ~i the dialysate inlet flow rate. 
6.4 DISCUSSION AND COMMENTS 
Eqs.{6.39-6.42) are used for conventional intermittent hemodialysis, where the ultrafiltration 
flow rate Qr is almost zero and the clearance is mainly due to difillsive mass transport. \,Vith 
the help of eqs.{6.4 I -6.+2), eq.{6.40) mal' be interpreted as the sum of diflusive clearance (Clo) 
when the ultrafiltration is zero and the convective clearance (Clc) when the dialysate flow is 
zero. In conventional hemodialysis, since the convective component Clc is practically zero, 
the interpretation of eq.{6.40) as separate contributions to total measured solute clearance 
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may not be wrong. However, as we mentioned earlier in Chapter 5, we arc interested in 
CA VHD where the volume flux GJ decreases along the membrane length as given by eq.{6. 
10). This means that the condition of zero net ultrafiltration (1=0 is not necessarily combined 
with the condition ofjv=O, but with the case of1.>0 in the first half andl.<O in the second 
half(back filtration) of the hemofilter. In CAVHD, a theoretical zero local ultrafiltration is not 
realistic. To some extend, by equalizing the pressure on dialysate side to the total pressure on 
the blood side of the hemofilter, a net zero ultrafiltration can be achieved. "Vithant such a 
pressure equalizing system (as it is in the clinical applications of CA VHD), a local zero 
ultrafiltration is not likely because there is a decreasing pressure drop along the hemofilter 
length on the blood side of the membrane. 
When the effective surface area of dialyzing membrane is calculated (or known), flow rates 
and solute concentrations are measured, one can calculate the overall diffusive mass transfer 
coefficients (Ko for],.=O, K.. forJ,=Qr/S and Ku for],.=a+px). 
The numerical values of the overall mass transfer coeflicients, as defined in the equations 
(6.45), (6.48) and (6.50) may hardl), be interpreted in terms of the real mass transfer coefficient 
of the hemofilter, since they are all based on the assumptions we made. Separate in lIilTO 
studies, using membrane characterization (permeability measurements) techniques, such as 
differential scanning calorimetty and inverse size exclusion chromatography might be helpful 
in providing the real mass transfer coefficient [16]. So far, such techniques are not used to 
provide the real mass transfer coefficient of the hemofilters or dialyzers under clinical 
conditions. 
6.5 APPENDIX 
We assume that the transmembrane pressure difference is given by: 
TMP = P,' - Pd (6.55) 
in which Pb~ is an effective blood pressure on the blood side and Pd is that on the dialysate 
side of the membrane. The Pb e and Pd may he determined by Poiseuille's law in differential 
form as: 
dP,' Rr (6.57) 
dx -L Qb~b r 
dPd Rrd (6.56) dx -LQd~d r 
where '1b ('1,) is the apparent blood (dialysate) viscosity and R, (R,,) is the resistance to the 
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blood (dialysate) flow. Q, and ~ arc local blood and dialysate flow rates respectively. \Ve 
assume also that the viscosities arc constant along the x-direction. ''''e integrate cq.(6.55) from 
o to x: 
(6.58) 
where 
(6.59) 
is the Ti\,IP at the hemofilter blood inlet (x=O) with Pbi' Pdo and I4i' each representing the 
hydraulic blood pressure, dialysate pressure and oncotic pressure respectively at the hemofilter 
blood inlet (x=O). By making use of eq.(5.1) for the blood (Q,) and the dialysate 
flow rates (QV, eq.{6.58) can be written as: 
TMP-IMP, 0 (&Pd-&Pb')x + G!;'<J:'lVJ,.(Z)dz)dy (6.60) 
with 
&P; 
= APb
e 
= PM - P bo - IIpi + IIpo 
Lf Lf 
(6.61 ) 
(6.62) 
(6.63) 
in which .6Pb" is the pressure drop along the hemofiltcr length on the blood side or the 
membrane, ..6..Ptl is the pressure drop along the hemofilter length on the dialysate side of the 
membrane, ~i and ~o represent the blood flow rate at the blood inlet and the dialysate 
flow rate at the dialysate outlet respectively. Pho and TIp<! are hydrostatic blood pressure and 
oncotic pressure at the blood outlet (x= 4)' Derivation of eq.(6.60) with respect to x yields: 
dTMP 0 &Pd-&P; + lVGf'J(y)dY (6.64) dr 0 ~ 
and again derivation of eq.(6.64) with respect to x yields: 
d'TMP 
o wGJ,{r) 
dr' 
Eq.(6.65) rna)' be rewritten as: 
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where k is a constant. The second order derivation of eq.{6.66) yields the follO\\~ng differential 
equation: 
d'J,.(x) k' 
-- ~ -GJ,(x) 
d-.;2 w ~ 
where aJ is a constant. From eq.(6.67) follows that 
k' , 
-G::: a1 
IV 
Eq.(6.67) has the solution: 
in which a and b are constants. Derivation of eq.(6.69) with respect to x yields: 
dJJx) G[,t b -OIX 
-- =aa1e - ale 
dr 
At x=O (blood inlet), eq.(6.66), eq.(6.69) and eq.(6.70) become: 
,TMP; 
J,.(O) ~ a + b = a1 --G 
, 
dJ,N ai, 
--I _ = (a-b)a ~ -CoP -oPb ) dr: x-o I G d 
From egs.{6. 71) and eq.{6.72) follows that: 
Using eq.(6.66), a length average TMP can be defined as: 
TMP ~ ...!..fLITMP(X)dt ~ ~fLIJ,.(X)dr 
Lf 0 k
2Lf 0 
where 
is the net ultrafiltration flow rate. Eq.{6.75) may be rewritten as: 
From eq.{6.77) follows that: 
TMP = Qj 
k'L ! 
(6.67) 
(6.68) 
(6.69) 
(6.70) 
(6. 71) 
(6.72) 
(6.73) 
(6.74) 
(6.75) 
(6.76) 
(6.77) 
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Substitution ofeq.(6.78) in cq.(6.68) yields: 
2 Q, 
° ~ --0 ~L'O 
, S'TMP p 
in which 4 is the hydraulic permeability (See also eq.(3.22) in Chapter 3): 
~~L 
S'TMP p 
Substitution of eq.(6.73) and eq.(6.74) in eq.(6.69) gives: 
a1 e . J,. ~ LpTMP,CashGw,) + O(oPd-OP,)SlIlhGw,) 
Substitution of eq.(6.61), eq.(6.62), eq.(6.79) in eq.(6.81) gives: 
~(tJ.P -tJ.P) J, ~ L TMP. Cash(xo,) - p d 'Sillh(xo,) P I a L 2 f 
where at and a2 represent: 
For small ai's the first term on the right hand side of eq.(6.82) becomes 
Lp TMP, Cash(xa,) ~ LpTMP, 
and the second term becomes: 
~(tJ.P -tJ.P) ,x 2 d 'Sillh(xo,) ~ Lp (tJ.P, - tJ.Pd)-0, L, L, 
From eq.(6.85) and eq.(6.86) follows that 
J,.ex) - Lp[TMP,- (tJ.P; -tJ.Pd)Zl 
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Chapter 7 
7.1 INTRODUCTION 
Continuous arteria-venous hemodiafiltration (CA VHD) differs from conventional 
hemofiltration and dialysis by the interaction of convection and diffusion, the use of very low 
dialysate flow rates and by the deterioration of membrane conditions during the treatment. 
To study the impact of these phenomena on diffusive transport, an analytical mathematical 
model orCA VHD was presented, by which the overall diffusive mass transfer coeflicient (KJ 
for a solute may be cakulated from blood, filtrate and dialysate flow rates and solute 
concentrations that can be measured in the clinical setting. The model was set up as a onc-
dimensional analysis of solute transport from plasma water to dialysate by simultaneous 
diffusion and convection. "Vi thin both the blood and the dialysate compartment, the solute 
concentration was assumed to vary in the axial direction but not in the radial direction, i.e., 
calculations are based on local "mixing cup II concentrations. Thus, diffusive solute transport 
results fi'om a concentration gradient between plasma water and dialysate only. Furthermore, 
the membrane permeability for ultrafiltration and for diffusion was assumed to be constant 
over the entire membrane length. The sieving coefficient of the solute, i.e. the ratio of its 
concentration in ultrafiltrate to that in plasma water, was taken to be one. The dialysate solute 
concentration at the dialysate side inlet was taken to be zero. The model concerns the 
countercurrent mode of blood and dialysate flows. A detailed description of the mathematical 
derivation is given in Chapter 6. 
Our model is the first detailed mathematical description of solute transport in CA VRD. It was 
meant as a tool to study the impact of variables such as blood, dialysate, ultrafiltration flow 
rates and the deterioration of membrane conditions with continued use of the hemofilter on 
solute transport (l]. In clinical practice, as ultrafiltration rate has to be monitored, convective 
clearance is easily determined. There is, however, a need for methods to estimate diffusive 
(and therefore total) solute transport. Hence we focused on the parameter K d, which 
represents the mass transfer coefficient of the hemofilter membrane for diffusion. 
In this chapter, the model is applied to clinical data obtained with 0.6 m2 AN~69 capiHalY 
hemofilters. This was carried out to analyze the influence of dialysate flow rates and of the 
deterioration of membrane conditions \\~th prolonged use of the hemofilter on the hemofilter 
performance. Further, the model equations governing the overall mass transfer coefficients 
(Ko' ~ and KJ are evaluated by applying them to data of urea clearance measurements. 
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7.2 METHODS 
Clinical conditions 
To evaluate the mathematical model equations (6.45, 6.48 and 6.50), data were obtained from 
clearance measurements of the urea uncler various clinical circumstances. Patients were 
treated with CA VHD for acute renal failure and either sepsis, circulatOlY, respiratOlY or 
neurological instability or a combination of these, using the AL'J-69 0.6 m2 capillaty dialyser 
(wlultiflow GOR, HaspaJ, France). In all cases blood access was via SF CAVH catheters in the 
femoral artery and vein. Our clinical routine is to infuse the substitution fluid into the arterial 
line ("predilution"), to prevent excessive hemoconcentration in case of a sudden decrease in 
the blood flow rate. Hepatin was given at a dose of500 U/h unless clinically contraindicated. 
Dialysate, heated to 38°C, was run counter currently at a rate of 0.5 to 3.0 IIh using a roller 
pump (Bellco BL758, j\IIirandola, Italy). :~'I'Ieasurements were performed according to a special 
protocol on 15 occasions up to 5 days ofhemofilter use. 
Measurenlents and calculations 
\Ve measured pre- and postfilter hydrostatic blood pressures (Pbi and plxJ in the arterial and 
venous tubing. \Ve calculated dialysate pressure (Pd) from the ultrafiltrate column height 
(0.74x column height in centimeters). Following the displacement of an air bubble we 
measured arterial blood flow rate (Q.J over a length of tubing, containing a volume of 13 ml. 
Arterial hematocrit (HtJ and arterial plasma protein concenh'ation (CpJ were measured to 
calculate the inlet (Cpi) and outlet (Cpo) plasma protein concentrations from protein mass 
balance equations, eqs.{3.16, 3.18). The pre- (lIp;) and postfilter (II",,) oncotic pressures were 
calculated according to eq.(3.25) by a third order polynomial fi'om the inlet and outlet plasma 
protein concentrations respectively. Dialysate flow rate (Qn) and infusion rate of the 
substitution fluid (~Jr.J 'predilution' were determined by means of an electronic weighing 
device. The net ultrafiltration rate (Q-) was determined by timed collection. The infusion 
rate of the subtitution fluid (<4rffi) was determined according to the overall fluid balance. At 
the dialysate inlet, ~i was set at 1.0,0.5, 2.0, and 3.0 IIh, and after a suitable period for 
equilibration urea concentration was measured in the mixture of ultra filtrate plus spent 
dialysate (Cdo) as well as in arterial blood plasma (Cpl)' Plasma water flow rate (Q,i) and urea 
concentration (C",) at the hemofilter inlet were calculated according to eqs.(6.52) and (6.54) 
respectively. 
Statistics 
Data were examined by regression analyses. Regression equations are given only when 
statistically significant (p<O.O 1). The goodness of curve-fitting is given by the corresponding 
correlation coefficients (R?-values), or by the coefficient of variation (COV) of the values 
predicted by the regression equation. 
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7.3 RESULTS 
Model equations 
The model equations have been evaluated for clinical data of urea clearance. \'Vithin the 
limits of operating conditions by CAVHD (see Table 7.1), urea clearance was measured with 
the same type ofhemofilters (Multi flow AN-59 Hospal with S=0.5 m' and L,~0.13 m). For 
each measurement the hydraulic permeability and the mass transfer coeflicients (or the overall 
permeation cocflicients), the diffusive and convective urea clearance were calculated. 
Table 7.1: The ranges of measured values during clinical 
measuring of urea clearance. 
Variables Range of values Variables Range of values 
Q" [mllmin] 80 - 345 Pb; [mmHg] 37 - 88 
Q" [mllmin] 7 - 56 Pbo [mmHg] 12 - 42 
Q. [mllmin] 3 - 18 - Pd [mmHg] 1-65 
Or"d [mil min] 0- 17 Ht, 0.18 - 0.38 
c." [gil] 37 - 85 Cdo [mmolll] 6 - 39 
C" [mmolll] 9 - 40 Cd; [mmolll] 0 
Table 7.2: Urea clearance and overall diffusive mass transfer coefficients for two different 
sets of measurements (See Text). The flow rates, clearance and overall permeation 
cocflicients (SKu, S.K...t, SKo) are in units of mil min. 
Q,; Cd./C"i CI Cln Clc CI, CI, SKd SK, SI(" 
Data 7.3 0.93 23.6 6.8 16.8 7.8 15.8 29.1 31.0 20.0 
set 18.0 0.92 33.1 16.6 16.6 17.9 15.2 58.'1 60.6 47.8 
I 35.5 0.87 46.7 31.0 15.7 32.4 14.4 88.7 90.8 80.0 
51.0 0.80 55.4 40.9 14.4 41.9 13.4 97.7 99.5 92.5 
Data 8.8 0.81 11.9 6.9 5.1 7.0 4.9 15.2 15.5 14.1 
set 18.0 0.70 17.2 12.6 4.6 12.7 -1.5 24.5 24.8 24.0 
II 35.6 0.57 24.2 20.5 3.7 20.2 4.0 35.1 35.3 35.7 
53.0 0.51 30.5 27.1 3.3 26.7 3.7 46.1 46.3 47.2 
Data set I: Q,;=250A mllmin, Qr 18 mllmin, T~vIPm=78.4 mmHg, 1H= 13.8 mll(1rmmHg) 
Data set II: Q,;=81.5 mI/min, Q- =6.5, mIl min, Ti\·IP m::::52.6 mmHg, MI=7.4 ml/(h' mmHg) 
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In Table 7.2, the results of urea clearance measurements and calculations arc shown for two 
set of measurements with different filtration fractions (Q.JQ,J. Data of the first sct of 
measurements were obtained ,\~th a new hemofilter characterized by a relatively high rate of 
ultrafiltrate production. The second one was obtained with a hcmofilter used for three days. 
Deterioration of the hemofilter conditions is reflected in both a lower value of the hydraulic 
permeability index !vII and lower values of SKu. The diffusive and convective components of 
the urea clearance were calculated both from the boundary values using eq.{6.41) and 
eq.(6.42) and from the concentration and volume flux profiles using cq.(6.43) and eq.(6.44). 
The calculated diffusive (CID and Cld) and convective (Cle and Clo;) components of urea 
clearance are slightly different. The relative difference, (Cd-CD)/Cd [°/0], between the values 
ofCld and CID depends on the values of both dialysate and ultrafiltration flow rate. It varied 
from 2.4% at Q.,=3I1h to 13% at Q,;=0.5I1h for Q=18 mllmin and fi'om -1.45% at 0.,;=3 
IIh to 1.42°/0 at ~;:::O.5 lIh for Q=6.5 mllmin. The difillsive clearance increases with 
increasing rate of dialysate flow while the convective component decreases slightly. Despite 
those small differences, the sum ofCID and Cle equals the sum of Old and Cle. 
Concentration profiles 
The concentration profiles (Cw for the local urea concentration in plasma water and Cd for 
the local urea concentration in the dialysate compartment) were calculated using eq.(6.28) 
and eq.{6.29), assuming that the ultrafiltration volume flux decreases linearly with the distance 
along the hemofilter length. The concentration difference L\.C=Cw-Cd is responsible for the 
diffusive urea removal. The urea concentration that is dragged by plasma water by convection 
fi'om blood into the dialysate compartment is given by Cm=(C
"
.+CJ/2. In Figure 7.1, the urea 
concentration profiles are shown as a function of the distance along with the hemofilter length 
for an ultrafiltrate flow rate ofQ= 18 mllmin and the plasma water flow rate ofQ,i=250 
ml/min at diflerent dialysate flow rates of 00;=7 .3, 18,35.5 and 51 mllmin. 
In Figure 7.2, the urea concentration profiles are shown for a relative low rate of ultrafiltration 
and blood flow, namely Q=6.5 mllmin and Q.,-r=81.5 mil min at different dialysate flow rates 
of~;=8.8, 18,35.6 and 53 mllmin. As can be seen from Figures 7.1 and 7.2, the urea 
concentration at the dialysate inlet of the hemofilter (CdU is zero. The removed urea 
concentration (Cdo) at x:;:::O equals the sum of the urea concentration removed by ,Jiffusion and 
that by convection. Evidently, the high rates of dialysate flow favor the concentration 
gradient. At relative low rates of ultrafiltration and blood flow and at relative high rates of 
dialysate flow, the concentration profiles seem as those in the conventional hemodialysis 
where the concentration profiles develop almost linearly along the hemofilter length. 
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Figure 7.1: Urea concentration profiles in blood (C,,) and in dialysate (C.J 
compartment as a function ofhemofilter length (x/~-) for ~j=7 .3, 18,35.5 and 51 
mil min with Q,;=250 ml/min and Q-= 18 ml/min [8]. 
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The overall diffusive pernleation coefficients (SK.u SKa, and S~) 
Chapter 7 
Under the same conditions the overall permeation coefficients SKo) SI<-.1 and S~ were 
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calculated from eq.(6.45), e'l.(6.50) and e'l.(6.48) respectively. The expressions for the overall 
permeation coefi1cients SKo, SI<a and SKrl were derived from the overall mass balance 
equations, depending on the profile of ultrafiltration volume flux, namelyJv=O,J\'=Q-/S and 
Jv=a+px. To demonstrate the influence of the ultrafiltration (volume flux profile) on the 
overall permeation coefi1cient SKdJ the ratio Ko/Kd as well as the ratio K,/Ku are illustrated 
in Figure 7.3 in relation to the dialysate flow rates at 3 different ultrafiltration flow rates (or 
filh'ation fi·actions). The trend lines show that at high rates of dialysate flow and low rates of 
ultrafiltration, the ratio K,/Ko approaches to 1 where the value ofKd=Ko is independent 
from the ultrafiltration flow rate and it represents the permeation coe!l1cient of the dialyzer 
in a conventional hemodialysis. At flow rates for Q«Q,i«<1ti' the effect of ultrafiltration on 
the overall permeation coe!l1cient is negligible, as almost the case in conventional 
hemodialysis. "Vhen the dialysate flow rates are low as compared with the rates of 
ultrafiltration flow, the effect of ultrafiltration on the overall permeation coe!l1cient becomes 
significant. 
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Figure 7.3: Ratio of the mass transfer coefficient Ko to the mass transfer coefficient 
~ in relation to dialysate flow rate for the filtration fractions Q-/Q,;=6.2/182.5, 
9.7/196 and 18/250. The broken lines show the relation between K/Kd and the 
dialysate flow rate ~i [8]. 
In order to show the general trend, the ratio K,/Kd in relation to the ratio Q-/<1ti is shown 
in Figure 7.4 for 67 different sets of the urea clearance measurements. The trend line shows 
the best fit to the experimental data points with the following regression equation: 
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(7.1 ) 
with R2=O.85 and n=67. The Ku increases with the decreasing rate of ultrafiltration flow (Q). 
As can be seen from eq.{7 .1), at QrO, Kd becomes equal to~. The ultrafiltration flow 
reduces the overall mass transfer coefficient due to the reduction or the concentration gradient 
[3]. At flow rates for ~i«Q«Q'i , the total mass removal ,\~11 be dominated by ultrafiltration, 
especially at the first half of the hemofiltcr. For the diffusive transport, the second half part of 
the hemofilter will be important. Lowering the dialysate flow rate rather than the rate of 
ultrafiltration can cause dialysate saturation (CrljC"i --> 1) or diffusion equilibrium. As can be 
seen from Figure 7.4 , the big departures from Kd/Ka::: I come out at high values of Qr and 
low values of Qu where the convection dominates the clearance process. The clearance 
becomes equal to the ultrafiltration flow (Cl=Qr, only water transport) when conditions 
0",=0 and Cdo/C",= 1 arc fulfilled (See further Chapter 8). 
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Figure 7.4: The ratio K,/Kd in relation to the ratio of the ultrafiltration flow rate to 
the dialysate flow rate (Qr/~J for different filtration fractions [8]. 
In Figure 7.3, the ratio K,/Kd is illustrated in relation to the dialysate flow rates. The 
differences between the values of~ and Ku at different dialysate and ultrafiltration flow rates 
are relatively small. Howevcr, one important condition of using the constant volume flux 
model a,=QlS) is that within the hemofilter there is no back filtration from dialysate into the 
blood compartment. If the transmembrane pressure gradient becomes negative somewhcre 
in the hemofilter, the assumption of constant volume flux is not valid any longer. 
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SK.tnlax - Wilson's plot 
As can be seen from Table 7.2, the overall permeation coefficient (SKd) increases with the 
increasing rate orthe dialysate flow. In Figure 7.5 the SKd is shown as a function of the 
dialysate flow rate (Qli)' This curvilinear increase in the SKd is a result of the fact that with 
the increasing rate of dialysate flow the dialysate concentration will be bettcr distributed over 
the whole membrane surface area and the dialysate resistance to diffusive mass transfer will 
be smaller. 
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Figure 7.5: 'Vilson's plot represents the relation between l/SKd and l/~i for urea. TIle 
linear regression lines show the \Vilson's plot at two different values of membrane index, 
namely i\H=7.4 and MI= 13.8 milCh mmHg). 
The overall permeability coefficient (SKu) reaches its maximal value at an infinite dialysate 
flow rate. This maximal value, designated as "SKdmax", can be obtained by extrapolation. 
In Figure 7.5, the reciprocal ofSKd is shown as a function of the reciprocal of~i. The value 
of I/SKdmax is the intercept of the corresponding regression line with the I ISKd-axis. The 
value of I/Kdmax equals the sum of the resistance to difiusion of the blood boundary layer 
(Ru) and the resistance to diffusion of the membrane (RJ according to "Vilson's plot [2]. The 
maximal value ofSICo depends also on the membrane hydraulic permeability index (NIl). In 
Figure 7.5, the (dashed) trend lines represent the follo\\~ng regression equations (\\~th R2=O.99 
and n=+): 
+ for MI~7.4 
68 (7.1 ) 
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On perfUsing a new hemofilter (8:::0.6 m2) ,\~th a dialysate flow rate of 5 IIh, the maximum 
value of SKu was 120 mIl min, which was determined by extrapolation from urea clearance 
data[lJ. See Chapter 9 for a detailed explanation of Wilson's plot. 
Linear decl'easing versus a constant volume flux profile 
Using the data from Table 7.4, the urea flux profiles are shown in Figure 7.6 for a constant 
ultrafiltration volume flux model Gv=Ja=Q/S) and for a lincar decreasing ultrafiltration 
volume flux (j,.=a+flx) model. 
Table 7.'1: The urea clearance is separated into the convective and difitlsive 
components according to the ultrafiltration volume flux models:Jv=O,J.=Ja=Q/S 
andJ.=a+flx. 
clearance [mil min] and standard depending on volume fluxJ. 
overall permeation eq.(6.40) ],=0 J,. = J, = Q,/S ],.= a+px 
coefficients [ml/min] 
GI 15.7 15.7 15.7 15.7 
Clc 13.1 0 
GID 2.6 15.7 
GI, 4.4 6.4 
GI, 11.3 9.3 
SKo 18.4 
SK, 15.2 
SK, 10.4 
'Vith: Pd= -1 mmHg, Pb;=73 mmHg, Pbo::::25 mmHg, Cp.,=85 gil, Q)~=60 ml/min, Qr::8 
milmin, ~j=40 mllmin, Ctlo=12,3 rumoI/I, Hta:::O.39, Cp1:::::;32.2mmoIlI, Orrcd=O ml/min. 
The total urea flux, calculated from the data in Table 7.4 is separated into the convective 
(J,.Cml and the diffusive (KdLlC) components by calculating the local solute flux (JJ using 
eq.(6.4), the local volume flux (JJ using eq.(6. 10) and the overall mass transfer coefficient (KJ 
using eq.(6.48). The concentration Cm=O.5(C,,'+C,J represents the local solute concentration, 
which is dragged by plasma water into the dialysate region. The 6.C=Cw·Cd represents the 
local concentration difference (gradient). The same total urea flux is also separated into the 
convective (J,Cml and the diffilSive (K"LlC) components by calculating the local solute flux (JJ 
using eq.(6.4), thel, using eq.(6.32) and the K" using eq.(6.50). In Figure 7.6, the local 
convective solute flux OaCJ and the local diflusivc solute flux (I<-a6.C) are shown with dashed 
(broken) lines. The corresponding cumulative values of the same urea clearance are shown 
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Figure 7.7. The measured total urea clearance, calculated from the urea flux profiles in Figure 
7.6 is separated into the convective (CIJ and the diffusive (CI.,) components by using eqs.(6.43) 
and (6.44) respectively. 
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In Figure 7.7, the same components forJ,.=II.=QiS are shown by dashed lines. According 
to the lineal' decreasing volume flux model, the transmembrane pressure difference is zero at 
about x/1,'=O.58 where (J,.=O and K,,=Ko) the diffusive flux (KdAC) and the cumulative 
convective clearances reach their maximal values. From x/l'f>O.58 to x/~..:::l whereJ\,<O, 
the ciiflilSivc flux and cumulative convective clearance decrease with the length because of 
backwards convective flux. According to the urea flux profiles GaCm and KaAC, shown by 
broken lines) of the constant volume flux model, the effect of back filtration on the diffusive 
urea flux will not be observed. The backwards dialysate fluid (volume flux) reduces the 
concentration gradient from blood into the dialysate side, resulting in a reduced overall 
permeation coefficient. 
7.4 DISCUSSION 
Previous lllodeis 
Our model diflers from previous models of diffusive solute transport in several respects. The 
anticipated differences between CA VHD and conventional hemodialysis and 
hemodiafiltration are borne out, first, by the demonstration of the curvilinear solute 
concentration profiles in the blood and dialysate compartments (Figures 7.1 and 7.2). Second, 
the hemofilter performance had indeed decreased appreciably after three days of use (rable 
7.2). It must be remembered that the Ku cannot be measured directly, but is calculated from 
the resulting solute transport, assuming a constant membrane surf.1.ce area. A decrease in I~ 
may therefore result either fi'om a decrease in the (eflective) membrane permeabilityor fi:om 
a decrease in the (effective) membrane surface area. The latter may be due to clotting of 
fibers. It might also be due to unequal distribution of the dialysate over the dialysate 
compartment, which is likely to occur at very low dialysate flow rates. This influence of 
dialysate flow rates on Kd was not recognized by Pallone et al [4]. In a recent publication 
Pallone et al [4] give a detailed description of solute transport in CAVHD. In that article the 
curvilinear changes in blood and dialysate solute concentration along the length of the 
dialyser are demonstrated. However, the authors apparently lack a mathematical expression 
to calculate Kd• In their article they assume that I~ does not depend on the dialysate flow 
rate. Our experiments show that, for the range of dialysate flow rates used in CA VHD, we 
cannot safely make that assumption. Indeed, also for the particular plate hemodialyzer that' 
is described in ref. [4], we found that Kd increases with Qli [11,12]. Furthermore, a similar 
finding had already been reported by Babb et al [13], who also studied solute transport 
through the parallel plate dialyzer. 
In the classical model of dialysis, as described by Sargent and Gotch [7], the influence of 
ultrafiltration is not taken into account. Furthermore, their model is based on the assumption 
that there is a linear increase in blood and dialysate solute concentrations along the length of 
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the dialyzer. This assumption clearly is invalid in CA VHD [1,4,8,9]. The model developed 
by Jaffrin et al [5,6] is a description of pump-driven hcmodiafiltration. In that model, 
however, changes in blood and dialysate solute concentrations are not considered and, hence, 
that model does not provide a means to estimate the diffusive mass transfer coefIicient. The 
same applies to the model by Van Geelen [10]. 
Overall diffusive n1.ass transfer coefficient 
The mass transfer coefficient (KJ represents the overall (apparent) permeation coefficient or 
diffusive performance capacity of the hemofilter. Its value depends on the flow rates, 
ultrafiltration, concentration gradient, membrane permeability, the solute molecular weight, 
deteriorating conditions such as clotting and other physical conditions such as temperature. 
It represents the overall mass transfer coeflicient of a flowing system, from which the lifetime 
is limited by some unfortunate deteriorating conditions ~H). Therefore, it cannot be 
considered as a constant during the whole operation time of the hemofilter. In conventional 
intermittent hemodialysis, where the dialysate flow rate is 5 to 6 times larger than that of 
CA VBD and the ultrafiltration flow is practically zero, the mass transfer coemcient (I(o), 
calculated by using eq.(6.45), will not be afleeted by the dialysate and ulh'afiltration flows. 
'Vhen the dialysate flow rates are low as compared to the ultrafiltration flow rates, the mass 
transfer coefficient (Kd) of a CA VBD hemofilter has to be determined ill the presence of 
ultrafiltration. By using eq.{6.50), one can calculate the mass transfer coefi1cient (I(d) when the 
ultrafilh'ation volume flux Uv) is given by J.==o:+px. The calculated values ofKd and Ko show 
that the departure ofKo/Ku from one occurs at high values ofQ-/~i' For Q-/~i«l, the 
mass transfer coefficient Ku equals the mass transfer coefi1cient Ko calculated at zero-
ultrafiltration. Values of the overall permeation coefi1cient depend not only on the rate of 
ultrafiltration flow but also on its direction. 
The calculated mass transfer coefficient I<..t shows that at high values of dialysate flow and 
low value of ultrafiltration, the overall mass transfer coefficient (Ku) of a CA VBD hemofilter 
equals the mass transfer coefficient (Ko) of a dialyzer in conventional intermittent 
hemodialysis. Also, the calculated mass transfer coefficient Kd shows no significant diflerences 
when the ultrafiltration volume flux is assumed to be constant along the length of the 
hemofilter if no back filtration occurs in the hemofilter. Unfortunately, it is not possible to 
show the effect of different rates of ultrafiltration flow on the overall permeation coefficient 
at a constant rate of dialysate flow, since the way of ulh'afiItrate production in CA VBD differs 
from that of the pump-driven intermittent hemodiafiltration. In the intermittent 
hemodiafiltration, one can adjust the rate of ultrafiltration flow to a certain value while in 
CA VBD it is limited by the spontaneous transmembrane pressure. For the mathematical 
simplicity, the diffusive mass transfer coefi1cient can be calculated from eq.{6.50) which is valid 
for a constant volume flux model Uv==Ja==Q-/S). Considering a constant ultrafiltration along 
- 102-
Chapter 7 
the membrane length will have minor influence on the calculated convective transport, due 
to a relatively small decrease of solute concentration in the blood compartment. A similar 
conclusion '.vas reached by JailEn et al [5,6]. If there is no back filtration in the hemofilter, the 
use ofKa in place ofRu is preferable. Nevertheless, assuming a constant volume flux is risky 
concerning monitoring the pressure distributions along the hemofilter length, because, from 
a clinical point of view, back filtration needs to be avoided. \'Vhcn the dialysate fluid is filtered 
back into the blood of the patient, the back filtration can cause potentially unsterile dialysis 
fluid or pyrogen to enter the blood of the patient. 
Shortcomings 
This model is based on a linear decreasing volume flux model. A linear decreasing volume 
flux model is not always correct, especially at very high transmembrane pressure differences. 
The model equations apply to solutes \\~th a sieving coefficient of one. This condition is likely 
to be met for most solutes, which are considered to contribute to the uraemic state. I<U will 
depend on solute parameters, of which the molecular weight or diameter is likely to be most 
important. The difference in molecular weight may fully account for the finding (See Chapter 
8) that under equal circumstances the value ofKu for creatinine was 0.75 times that of urea. 
For phosphate, the value of~ is likely to be decreased also by its polatit)', which will increase 
apparent molecular weight by the binding of many of water molecules, while it will be 
increased by its negative charge, which increases the sieving coefficient. Such considerations 
are especially relevant when our model is used to analyze the clearance of other clinically 
relevant solutes, like drugs, by CAVED. So far, our analytical model does not apply to solutes 
with a sieving coefficient of less than one. According to the specifications of the manufacturer, 
with the ANR 69 membrane, solutes up to at least 1000 Daltons may be expected to have a 
sieving coefficient of one. "Vhen applying our model to the kinetics of still larger solutes, we 
should bear this limitation of our model in mind. Also, when considering drugs, protein 
binding and its influence on sieving would have to be taken into account. In those cases, the 
Kd derived from eqs.(6.4R and 6.50) can be used as an estimator. 
7.5 CONCLUSION 
Considering some simplifying conditions, the mathematical analysis shows that the diffusive 
mass transfer coefficient Kd can be calculated from the clinical data of CA VRD. The 
diffusive mass transfer coefficient proved to depend on the dialysate flow rate. The calculated 
mass transfer coefficient Kd shows that at high values of dialysate flow and low values of 
ultrafiltration, the overall mass transfer coefficient (Kd) of a CA VHD hemofilter equals the 
mas:> transfer coefficient (KJ of a dialyzer in conventional intelmittent hemodialysis. Also, the 
calculated mass transfer coefficient ~ shows no significant differences when the ultrafiltration 
volume flux is assumed to be constant along the length of the hemofilter if no back filtration 
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occurs in the hemofilter. "Ve conclude that our model is a useful addition to the existing 
models ofhcmodiafiltration, especially since it allows calculation of the diffusive mass transfer 
coefficient. It may be used both as a means to further our insight in the determinants of solute 
transport in CA VHD and to acljust clinical settings, e.g. dialysate flow rate, based on the 
predicted clearance of uraemic solutes. 
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Chapter 8 
8.1 INTRODUCTION 
In continuous arterioMvenous hemodiafiltration (CA VHD), the removal of excess water is 
administered by using continuous artcrio~venous hemofiltration (CA VH) while the removal 
of uraemic solutes is achieved by continuous slow dialysis, allowing manipulation of 
extracellular volume and solute concentration. Since the solute transport in CAVHD occurs 
by simultaneous convection and diffusion, it is necessalY to make a clinical protocol 
prescribing the amount and ,\~th which flow rate the solute will be withdrawn, coupled with 
the removal of excess water simultaneously. As we have mentioned earlier, the ultrafiltration 
flow rate (QJ and the solute clearance (el) arc used as measures of the removal rate of excess 
water and the removal rate of solute respectively. In CA VHD the solute clearance is 
determined by the dialysate flow rate (QJ, the overall diffusive permeability coefficient (SKJ 
of the hemofilter, the plasma water flow rate (Q,v at the blood inlet and the ultrafiltration 
flow rate (Q,): 
Its relative low rates of dialysate flow make the CA VHD a unique treatment method, 
especially for the acute dialysis patients [l,2]. In CA VlID, the patient is mostly 
hemodynamically unstable [2]. Therefore, controlling the patient's uraemic state with 
dialysis as slow as possible is important. In the previous chapters, we have 
demonstrated that the dialysate flow rate is the main determinant for controlling the 
rate of solute removal by diffusion. However, how slow or how fast the dialysate flow 
rate will be is usually not known, since the administration of dialysate flow depends 
on the patient's uraemic state. According to the clinical experience, a dialysate flow 
rate of 1 IIh is enough to control the patient's uraemic state [3]. 
The rate of solute removal by diffusion depends on the solute concentration driving 
force (concentration gradient) and on the overall diffusive permeability coefficient 
(K.:::SKJ. In Chapter 7, we have demonsh'ated that the overall diffusive permeability 
coefficient (~:::SKJ is an important parameter allowing us to manipulate the diffusive 
solute removal in the presence of ultrafiltration [4]. It includes the flow rates, the 
solute concentrations and the membrane surface area, which may be obtained from 
clinical measurements and manufacturers' specifications. 
In intermittent hemodialysis, the patient's blood is dialyzed \\~th pump-driven blood 
and dialysate flow rates by adjusting them to their standard values, namely 200 and 
500 ml/min respectively. The ultrafiltration flow rate is negligibly small. In CA VHD, 
however, the blood flows spontaneous (not routinely measured in the clinic) and 
depends on the patient's cardiac output and the resistance of the extracorporeal 
circuit. The ultrafiltration flow rate (Q) is also spontaneous. As we have studied in 
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Chapter 3 the ultrafiltration flow rate decreases over the treatment time because of the 
deterioration of the hemofilter membrane. \Vith prolonged use of the hemofiltel', 
deterioration of the hemofiltel' membrane is likely not only to decrease the rate of 
ultrafiltrate production but also to impair the diffusive solute transport [4]. 
In this chapter we studied the determinants of uraemic solute clearance in CAVHD. First, on 
considering the spontaneous blood and ultrafiltration flows, we analyzed the clearance of 
uraemic solutes such as urea, creatinine and phosphate in the region of relative low dialysate 
flow rates. Second, by analyzing the effect of the dialysate, blood and ultrafiltration flow rates 
on the uraemic solute clearance we investigated the degree of conditions in which blood-
dialysate solute equilibrium can be achieved. Third, we investigated the diffusive component 
of solute clearance in relation to the overall diffusive permeability coefficient (SKJ. Fourth, 
the diffusive permeability coefficients of urea and phosphate were related to diffusive 
pem1eability coefficient of creatinine. Further, by running a simple sensitivity analysis on the 
overall diffusive permeability coefficient (SKu=K,), we analyzed the dependence ofK, on the 
flow rates and on the strength of concentration driving force at the blood inlet of the 
hemofilter (Cdo/C"i)' The sensitivity analysis provides information about the reliability of 
predicting the K, from flow rates and solute concentrations. 
8.2 METHODS 
Solute clearance (el) and the ovet'aU diffusive permeation coefficient (~=SK.t) 
In CA VHD, solute clearance (CI) is a measure of the rate of solute removal by simultaneous 
convection (ClJ and diffusion (CldJ. Both mechanisms have effect on each other. Usually, the 
solute clearance (dialysance) is calculated fi'om the mass balance equations of either the blood 
side or the dialysate side of the hemofilter membrane. Since the inlet dialysate uraemic solute 
concentration (CdJ is zero, the uraemic solute clearance may be calculated from eq.{6.39). In 
Chapter 6, we derived an expression of solute clearance, which may be calculated from the 
flow rates and the overall diffusive permeability coefficient ~=SKdJ in the presence of 
ultrafiltration. The solute clearance pCI' unit rate of ultrafiltration is given (See eq.{6.51)) by: 
K, \ 
1 _ (Q,.,Q,v/Q,·-' 
C/ ~ Q" ____ Q=-ede..:,Q::c'''-,_-::_ 
Qf Qf K,\ 
1 _ Q'i (Q,., Q,")sQ,'" 
Q,., Q", Q" 
(8.1) 
where QIi is the inlet flow rate of plasma water, ~i is the inlet dialysate flow rate, Q,·o=Q.i+ 
Qris the flow rate of outlet plasma water, ~o=~i+Q. is the outlet dialysate flow rate, Q. is 
the net flow rate of ultrafiltration, S is the total surface area of the hemofilter membrane and 
finally Kd is the overall diffusive mass transfer coefficient. To calculate the solute clearance 
from eq.(8.1) one needs the overall diffusive permeability coefficient (K,=SK.J. Using eq.(8.1) 
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and eq.(6.39), the overall diflhsive permeability coefficient (I<,::::SK.J) per unit rate of the 
ultrafiltration flow (Q) can be reformulated as: 
In [ Qdo Coo - Q\\,jC\li] 
Qllj(Cdo - C,,) 1 
2 (8.2) 
where Cdo is the solute concentration at the dialysate/ultrafiltrate outlet, C"i is the solute 
concentration at the blood inlet. The overall diffusive permeability coefficient (K,::::SK,J per 
unit rate of the ultrafiltration flow (Q) represents the relative importance of solute removal 
to the removal rate of excess water. This expression is valid only for solutes with sieving 
coefficient y= I and for a constant profile of ultrafiltration volume flux along the hemofilter 
length. In pre\~ous chapters, \VC used I<a to represent the overall mass transfer coefficient for 
a constant profil~ of ultrafiltration. "Ve have proved in Chapter 7 that assuming a constant 
profile for the local ultrafiltration volume flux has negligible em~ct on the numerical values of 
~. In this text, therefore, the notation (\~ll is simply replaced by the notation "Ki'. 
Sensitivity analysis ofK,. 
In eq.(8.2), solute concentrations and flow rates are variables and measured clinically. The 
considered values of CUll CtlOJ Q'lJ ~j and Q- are within the range of clinically measured 
values during CA VHD treatment. The variation in each data point, namely AC,,] in Clll J 
ACdo in CdoJ AQ,i in Q,i) A~i in ~i and AQ- in Q-, will contribute a variation AK, in the 
calculated value ofK,. The variation 61(, can be estimated by using the following expression: 
aK aK aK aK aK (6K)' (6C ')' , (6C __ ')2, (6Q . __ ')' , (6Q ._')2 + (6Q _')2 (8.3) 
r '" \,i aCII1 ,u, ac,u, IH aQlri dl aQdi 'aQ, 
where the derivatives on the right are partial derivatives, each representing the diflerentiation 
ofK, with respect to one variable (Clli , Ctto, Q,iJ <2ti and Q-) while the other variables are 
supposed to be constant. All the variations in eq.(8.3) are estimated experimental variations 
in measuring the related variable and supposed to be independent of each others. From 
eq.(8.2) one can derive the partial derivatives needed in eq.(8.3). The variations of ~ with 
respect to solute concentrations C II, and Cdo are given by: 
where kJ and k2 arc defined as: 
aK, QJ Cd' (0"" - Q".,) 
acw' k, k, (C"., - C,,) 
QJ C"., (Qwl - Qd) 
k, k, (C"., - C,,) 
(8.4) 
(8.5) 
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(8.6) 
(8.7) 
The variations ofK, with respect to the flow rates Q,il ~o and Qr are given by: 
8K Q Q C k Q 
, ...1[~-(-'-)( __ f_)l 
aQlI'i kl Q\ljk2 k\ QlI'oQ'tIt (8.8) 
(8.9) 
(8.10) 
(8.ll) 
Experimental evaluation 
The sensitivity analysis of the model to the parameters at low dialysate flow rates was 
performed using clearance data of uraemic solutes such as urea (1v1'N:60 Daltons), creatinine 
(l13 Daltons) and phosphate (174 Daltons), obtained from different patients who were treated 
with CA VHD for acute renal failure, using the AN-69 capillary hemofilters (lvIultiflow 60, 
Bospal, France, S::::0.6 m2 and 1,..:::0.13 m) [5]. Blood and ultrafiltration flows were 
spontaneous. Arterial blood flow rates (C!t.J \"ere determined by the displacement of an air 
bubble over a length of tubing, with a relative variation of .6.C!t.JC!t.J.:::: 10%. The range of 
blood flow varied from 82 mllmin to 345 mllmin. An electronic weighing device determined 
dialysate flow rates (~J, with a relative variation of .6.Qm/Qm::::5°/o. For each blood flow rate, 
the dialysate flow rate was varied \\~th Qli::::0.5, 1, 2 and 3 IIh. The net ultrafiltration rate (Q) 
at each set of blood and dialysate flow rate was determined by timed collection \\~th a relative 
variation of .6.Qr/Qr=5%. The measured net ultrafiltration rate varied from 3 to 18 mllmin. 
Accordingly, solute concentration (C"i) in the inlet plasma water and the removed solute 
concentration (Crlo) were determined with a relative variation of .6.c.,JC"i::::.6.Crlo/Grlo::::3°/o. 
8.3 RESULTS 
In Table 8.1, the operational and clinical conditions and also the results of model calculations 
(~H, ~, GI, etc.) for the measurement of urea, creatinine and phosphate clearance are shown 
in average values within their ranges. 
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Figure 8.1: Blood, dialysate, ultrafiltration, substitution fluid flow rate, arterial plasma protein 
concentration and hematocrit of a patient during a CA VHD treatment of 3 days. 
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Figure 8.2: Overall, diffusive and convective urea clearance ofa patient and the hydraulic (fiH) and 
diffusive (SK.J performance of an AN·69 capillary hemofilter during a CA VHD treatment of 3 days 
Figures 8.1 and 8.2 show an example or blood (Q,J, dialysate (Q,J, ultrafiltration (Q), flow 
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rate of substitution fluid {(4rc.{), arterial plasma protein concentration (CpJ, hematocrit (FIt,.), 
the overall (CI), diffusive (CI.,) and convective (Clcl urea clearance and the hydraulic (WII) and 
diffusive (SKu) performance of an Ai\'~69 capillary hemofilter during a patient treatment of 
3 days with CA VHD. 
Table 8.1: Urea, creatinine and phosphate clearance under diflcrent clinical and 
operational conditions measured ,,~th ~\'lultiflow~60 AN-69 capillary hemofilters and 
special CAVH catheters UvI8CAVHD4, 11.410ng with an internal diameter of2. 7 mm) 
for both arterial and venous access. 
average [range) value (n=51) average [range) value (n=51) 
Cp, [g/I) 60.4 [37.6 - 85.3) K, -urea [ml/min) 51.1 [7.5 - 111.6) 
Q" [mllmin) 187.2 [82 - 3<l5) K, - creatinine [mil min) 42.3 [7.2 - 108.+) 
Ht, 0.27 [0.18 - 0.32) K, - phosphate [mil min) 31.2 [7.2-60.1) 
Q" [mil min) 27.9 [8-56) CI -urea [mil min) 28.1 [7.3 - 55) 
Q[mllmin) 9[3-18) CI ~creatinine [mllmin] 25.7 [7.1 - 49.6) 
Q"", [mil min) 8.3 [ 1.7 - 17) CI -phosphate [mil min] 22.9 [6.4 - 42.1) 
TMPm [mmHg] 67 [24 - 107) R, [mmHg/mlmin) 0.24 [0.04 - 0.53) 
T ('C) 37 MI [mllhmmHg) 8.3 [2.5-18.7] 
URAEMIC SOLUTE CLEARANCE 
Dialysate flow !"ate (Q.,,) 
For conventional intermittent hemodialysis, where the ultrafiltration flow rate (Q) is almost 
zero [6,7,8,9], the solute clearance is mainly due to diffusive mass transfer. In CA VHD 
however, solute removal occurs by simultaneous convection and difiltsion. Since the rate of 
ultrafiltrate production limits the solute convective clearance, higher rates of solute diffusive 
clearance are achieved by increasing the dialysate flow rate. Depending on the patient's 
uraemic state, it varies between 0.5 and 3 lIh. In Figure 8.3, the urea clearance measured 
under the conditions in Table 8.1 is shown in relation to the dialysate flow rate at two 
diflerent rates of blood flow, e.g. an averaged blood inlet flow rate of295 mllmin and 160 
mllmin. The corresponding average ultrafiltration flow rates were 12.6 and 9 mllmin 
respectively. The values obtained by extrapolating the clearance (dashed lines) at ~i::::O arc 
the convective contIibutions (ct) to the overall urea clearance. The average contribution of 
convective clearance was 11.5 for ~i::::295 and 7.8 mllmin for ~i:::: 160 mil min. 
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Figure 8.3: Urea clearance in relation to the dialysate flow rate (QuJ for two difterent rates 
of the blood inlet flow (Q,J and the ultrafiltration flow (Q,) [1OJ. 
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Figure 8.4: Urea clearance as a function of the blood inlet flow rate (Q,J for dialysate flow 
rates 0[0.5, 1,2 and 3 IIh and for an ultrafiltration flow rate of approximately QrO.5l/h. 
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Blood flow rate (Q.,) 
In CAVHD, the blood (Q,,=50-350 mUmin) and ultrafiltrate (Q=5-20 mUmin) flows are 
spontaneous. Since the blood flow depends on the patient's cardiac output and the resistance 
of extracorporeal circuit, high rates of blood flow may be difficult to achieve. The urea 
clearance measured at different blood flow rates is shown in Figure 8.4 for the dialysate flow 
rates of 0.5, 1,2 and 311h. The trend lines show a curvilinear increase in urea clearance with 
Q,i at relative high rates of the dialysate flow. High blood flow rates favor high rates of solute 
removal. The fluctuations in the clearance data in Figure 8.4 are due to the fluctuations in the 
ultrafiltration flow rate. The blood flow rate is strongly dependent on the resistance of the 
eXh"acorporeal circuit to the blood flow CRr). Data of uraemic solute clearance fot' Rc>O.4 
mmHg/(mllmin) were disregarded. For I~0.4 mmHg/(mllmin) the hemofilterwas assumed 
to be clotted. 
Ultrafiltration flow rate (Q,) 
Values of the same urea clearance data corresponding to the different ultrafiltration rates are 
illustrated in Figure 8.5 
60 O.(SD)(UhI 0" (SD) [mUminl 
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Figure 8.5: Urea clearance as a function of the ultrafiltration flow rate (Q) for 
dialysate flow rates of 0.5, 1,2 and 3Uh [10]. 
Evidently, increasing the rate of ultrafiltration (Q-) wiU result in an increased urea clearance 
since the convective contribution to total urea clearance is proportional to the rate of 
ultrafiltration. To some extend the ultrafiltration flow rate can easily be controlled by 
adjusting the hemofilter position with respect to the patient's bed. Furthermore, the hemofilter 
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characteristics may change with time due to the binding of plasma proteins to the membrane 
or due to clotting. ,,\lith CAVHD, effectiveness of therapy rests in large part on low solute 
clearance continuously maintained over a prolonged period of time. Hence the effect of 
deteriorating conditions over time on the hcmofilter performance is important. The 
ultrafiltration flow rate rapidly decreases with the treatment time. After a variable time span, 
ultrafiltration flow rate falls below the level necessary for fluid removal and the hemofilter 
must be changed. The fall in the ultrafiltration flow rate over time results in a decrease in 
solute clearance primarily due to a decline in the convective component. The trend lines in 
Figure 8.5 show that as ultrafiltration is increased the overall (total) urea clearance increases 
linearly. Since the sieving coefficient of urea (and of other uraemic solutes) for the AN-69 
membrane is I, the convective clearance is essentially the same as the ultrafiltration flow rate. 
According to eq.{6.39), the intercepts of the trend lines with the clearance (CI)- axis at Qr=O 
rnllmin correspond to the pure diffusive contributions to the overall urea clearance. In Figure 
8.5, the data of urea clearance corresponding to the ultrafiltration flow rates less than 3 
mllmin were not taken into account. 
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Figure 8.6: The normalized diffusive and convective contributions of urea clearance 
in\lation to the dial),sate flow rate, normalized with respect to (Q,/Q,}.[!O]. 
Diffusive and convective contl'ibutions to the uraemic solute cleal'al1ce 
As we have stated earlier in Chapter 5, the division of solute clearance (CI) into separate 
convective {CIt;} and diffusive (CIn) contributions as in eq.{6.'H) and eq.{6.42) is somewhat 
misleading since the convective flow alters the concentration profiles because of the inter-
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action between the convective and diffusive components. Therefore, model predictions of the 
diffusive (Cld) and convective (CIJ contributions to the total (overall) urea clearance were 
calculated according to eq.(6.44) and eq.(6A3) respectively. The overall urea clearance 
normalized to the ultrafiltration flow rate (CI/Q) calculated according to eq.{8.1), the diffusive 
component normalized to the ultrafiltration flow rate (Cld/Q) calculated according to 
eq.(6.44) and the convective component normalized with respect to the ultrafiltration flow rate 
(CIJQ) calculated according to eq.(6.43) are shown in Figure 8.6 in relation to the dialysate 
inlet flow rate normalized with respect to the ultrafiltration flow rate (~/Q). In the analysis 
of regression lines representing the relation between CIIQ- and Qp/Q, the blood flow rate 
varied from 82 to 345 mllmin, yielding an averaged value of213 mllmin. The lines in Figure 
8.6 represent thus the general trends for an average blood flow rate of~a=213 mllmin. 
In CAVHD, the dialysate flow is administered in the presence of ultrafiltration. Therefore, 
in the analysis of solute clearance fi'om the 'dialysate flow' point of view, the presence of 
ultrafiltration flow has to be taken into account. As can be seen from Table 7.2 and Figure 
8.6, the convective component of the overall urea clearance decreases (slightly) with the 
increasing rate of the dialysate flow. One of the differences between CA VHD and 
conventional intermittent hemodialysis is the effect of increasing dialysate flow rate (~j) on 
ultrafiltration flow rate (Q). In intermittent hemodialysis systems increases in Qpj results in 
decreases in Q because of the increased hydrostatic pressure in the dialysate compartment, 
which decreases the net transmembrane pressure difierence. However, in CA VHD, increases 
in dialysate flow rate do not decrease Q. because the dialysate flow rate is so small in size and 
compliance of the dialysate compartment. 1\5:, can be seen fi'om Figure 8.6, the urea clearance 
pel' ultrafiltration flow rate (CIIQ) increases with increasing rates of the normalized dialysate 
flow (Qm/Q.) in a quadratic form. Figure 8.6 shows a linear relation between the normalized 
urea clearance and the dialysate flow rate for ~/Q:;;3. Lowering the dialysate flow rate 
faster than the rate of ultrafiltration weakens the concentration driving force and eventually 
dialysate saturation (diffusion equilibration) takes place. At Qm=O, solute removal occurs only 
by convection (CI=Q), resulting in the solute concentration in the blood inlet (C"i) becoming 
equal to the solute concentration in the dialysate/ultrafiltrate outlet (CdJ if there is no clotting 
in the hemofilter. 
nlalysate-blood equlUbJ-iUJll (satllratloll) 
In contrast to the conventional intermittent hemodialysis, in CA VHD an excellent dialysate-
blood equilibration is achieved. To determine the degree to which blood and dialysate achieve 
equilibration of urea concentration during CA VHD, we analyzed the normalized dialysate 
flow rate in relation to the ratio (Cdo/C,J with Cdo the uraemic solute concentration at the 
dialysate/ultrafiltrate outlet and C
'Il the uraemic solute concentration at the blood inlet of the 
hemofilter. 
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Figure 8.7: The ratio of solute concentration at the blood inlet to that at the 
dialysate outlet (CdJC"J as a function of the dialysate flow administered per 
ultrafiltration flow rate (Q,/Q,) (dashed line) and as a function of the ratio of 
dialysate flow rate to the blood inlet flow rate (Q,/Q,J [10]. 
Chapter 8 
In Figure 8.7, the ratio (Cd.!C"J is related to the normalized dialysate flow rate (Q,/Q,) and 
to the ratio of dialysate-ta-plasma water inflow (~/Q,J. From Figure 8.7 it can be seen that 
for approximately ~/Q:<;;3 and ~/Q,-js;O.2, the ratio Cdo/C"j increases from 0.7 up to 1 
where complete blood-dialysate equilibration for urea is achieved. Sigler et al [2] assigned the 
reduction of the dialysatc-to-blood-urea concentration ratio (edo/e"J below 1 to an early sign 
ofhemofilter clotting. ""hen Crlo/C"j<O.6 complete clotting can be anticipated within next 
3 to 4 hours. They stated this for a dialysate flow rate of Il1h. In fact, the term Cdo/C\\j 
represents the strength of the concentration driving force at the hemofilter blood inlet. The 
smaller the ratio Cdo/C"j (thus CdJC',i«l), the stronger the concentration driving force. Also 
in the absence of clotting, by relative high dialysate flow rates, as can be seen From 8.7, values 
:5:0.6 for CdJC\\i may be achieved, leading to a solute clearance more by diffusion than that 
by convection. 
In the region oflow dialysate flow rates, where the dialysate-blood equilibrium occurs, the 
ultrafiltration may improve the dialysis. It is, in fact, a prediction of our mathematical model 
that at low dialysate flow rates and low overall diffusive permeability, the diflusive component 
of solute clearance may increase as ultrafiltration flow rate rises. During simultaneous 
convection and diffusion, the ultrafiltrate formed across the hemofilter membrane carries 
solute at a concentration (Cm , see eq.(5.15)) that is less than that in the plasma water. By that, 
true convective clearance must be less than the rate of ultrafiltration. If the ultl'afiltrate so 
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formed, particularly near the hemofilter blood outlet where the solute concentration in blood 
is least (See Figures 7.1 and 7.2), is to leave the hemofilter at the dialysate/ ultranItrate outlet 
in equilibrium with the blood side, pdor to exit of that ultrafiltrate fi'om the hemofilter, some 
additional solute from the blood side must be transported by diffusion. From Figure 7.1 can 
be seen that as the dialysate flow rate decreases, nearly complete equilibrium can exist in the 
first half of the hemofilter length, while diflhsion transports solute in the second half from the 
blood side. For conditions of perfect blood-dialysate equilibration at the blood inlet of the 
hemofilter, the entire solute carried by the dialysate flow must be transported by diffusion (in 
the second half of the hemofilter) so that the total rate of diffusive solute removal will excecd 
the rate of dialysate flow (Cl>Q,J. Nevertheless, Sigdell [9] and other authors [12] have 
suggested that, due to solvent drag, increasing rates of ultrafiltration may diminish the 
difi1.lsive component of solute clearance by reducing the blood-dialysate concentration 
gradient. 
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FiguJ.·e 8.8: The calculated diffilsive and convective urea clearance as a function of the 
ratio (Cdo/C"J. The Cln and Clc represent the diffusive and convective contributions to 
the solute clearance respectively in the manner used by Sigler et al [2]. 
In the analysis of solute transport the fact that CdjC\Ii~l allows the diffusive and convective 
components to be computed as separate components of solute clearance. Justification of this 
assertion rests on the fact that when there is dialysate saturation (or equilibrium) where 
Cdo=C\\i' the diffusive transport will always be the one value that is the upper limit for a given 
solute concentration and volume flow rate. The explicit upper limit is numerically equal to 
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the dialysate flow rate (Cl:::~;) where Q'i»~i' As Q,i falls or becomes equal to ~i there are 
progressive deviations fi'om complete dialysatc~blood urea saturation. In intelmittcnt 
hemodialysis, dialysate saturation does not occur and it is not possible to accurately compute 
the separate difrusive (CID) and convective (Clc) components from eq.(6.41) and eq.(6.42). 
:rvIodel predictions orthe diffilsive (CID) and convective (Clc') contributions to the total (overall) 
urea clearance were also calculated in the manner used by Sigler ct at [2] according to 
eq.(6.41) and eq.{6A2) respectively. In Figure 8.8, the ratio of diffusive clearance according 
to eq.(6.41) to the diffusive clearance according to eq.(6A4) (CID/CI~ and the ratio of 
convective clearance according to eq.(6.42) to the convective clearance according to eq.(6.43) 
(CIC/Cl e) are shown for various values of the ratio Cdo/C"i' 
At about Cdo /C,d=0.7, CID becomes equal to Cld and the Cle becomes equal to Cleo For 
Cdo/C"iLO.7, the fraction of urea clearance due to diffusion, as determined by eq.(6.44) was 
underestimated by eq.(6.41). As is shown in Table 7.2 this underestimation corresponds to the 
values of low dialysate flow rates at relative high rates of ultrafiltration flow. From 
Cdo/C"i=0.7 up to Cdo/C"i=l, the underestimation rises up to 20°/0. For Cdo/C\d~0.7, the 
diffusive clearance by eq.(6.41) with respect to the diffusive clearance by eq.(6.44) is 
overestimated by no more than 5%. In contrast to the diffusive clearance, from Cdo/C",=0.7 
up to Cdo/C"i=I, the fi'action of urea clearance due to convection as determined by eq.(6.43) 
is overestimated by eq.(6.42). According to eq.(6.41) and eq.(6.42), the dialysate flow rate 
nOlTI1alized with respect to the rate of ultrafiltration flow (~/Q) equals the ratio Gln/Cle. 
According to the trend lines in Figures 8.6 and 8.7, we may hardly prove the existence of the 
relation Gln/Clc=~/Qr in CA VHD, since the definition of difihsive contribution (GIn) 
(or clearance) according to Sigler et al [2] is a hypothetical clearance that would produce the 
same concentration at the dialysate outlet without ultrafiltration. 
Overall diffusive permeability coefficient 
According to eq.(6.44) the diffusive urea transport (clearance) is proportional to the overall 
diffusive permeability coefficient (K,=SKd) and to the existing concentration gradient. An 
increase in the overall difrusive permeability will lead consequently to an increase in the 
diffusive solute clearance. The size of this increase depends strongly on the dialysate flow rate, 
noting that the overall diffusive permeability coefficient itself depends also on the dialysate 
flow rate [5]. In Chapter 7, the effect of dialysate flow rates on the overall diffusive 
permeability was demonstrated in Figure 7.5. 
In Figure 8.9, the relation between the diffusive urea clearance and the overall diffusive 
permeability coefficient is illustrated for the dialysate flow rates of 0.5, 1,2, and 3 limin, 
shO\\~ng the curvilinear increase of the diffusive urea clearance with the increasing values of 
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the diffusive permeability. To calculate solute clearance from eg.(S.I), the overall diffusive 
permeability coefficient (SKd:::::K.) has to be determined in the presence of ultrafiltration, 
noting the fact that we detived the overall diffusive permeability coefficient as normalized with 
respect to the ultrafiltration flow rate (SKd/Q) from the expression of the normalized urea 
clearance (CI/Q) according to eq.(8.1). The overall diffusive permeability coefficient (SK iQ} 
is a measure of the relative importance of solute removal by diffusion with regard to that by 
ultrafiltration (convection). At SKd/QrO, the solute clearance becomes equal to the 
ultrafiltration flow rate (CI=Q,). 
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Figure 8.9: Difillsive urea clearance (Cld) as a function of the overall diflusive 
permeability coefficient (](,) at different rates of dialysate inlet flow (Q,J [I OJ. 
Clearance of different uraemic solutes 
As can be seen fi'om Table 8.1, uraemic solutes such as urea, creatinine and phosphate were 
cleansed fi'om blood with different rates of removal under the same operational conditions, 
with the flow rates ranging fi'om Q",=82 to 345 ml/min, Q,i=0.5 to 31/h and Qs=3 to 18 
ml/min. It is evident that the difference in the clearance of uraemic solutes is caused by the 
overall diflusive permeability of the hemofilter membrane. Under the same operational 
conditions and hcmofilter charactetistics we calculated the overall diffusive permeability 
coefficients ~::::SKJ for urea, creatinine and phosphate. In Figure S.IO, the Ks's of urea and 
that of the phosphate are shown in comparison to the K. of creatinine, all under the same 
operational conditions and hemofilter characteristics. The regression lines, representing the 
following regression equations, 
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K,(lIrea) 0 1.32K,(crealillille) R' 0 0.94 II 0 36 (8.12) 
K,(phosphale) 0 0.75K,(creatillille) R' 0 0.88 II 0 36 (8.13) 
show that the K, of urea is 32% greater and that of the phosphate is 25% smaller than the K, 
of creatinine. 'Vith increasing molecular size (weight) of solutes, the overall diffusive 
permeability coefi1cient was observed to decrease. The data regarding the overall permeability 
coefficients of these solutes were obtained under the conditions where the hemofilter 
resistance to blood flow varied between 0.04 en 0.4 mmHg/(mllmin) as we mentioned earlier. 
The overall diffusive permeability coefficient (I<S) for urea, creatinine, phosphate and other 
solutes (some antibiotic drugs) up to 1500 Daltons are shown in relation to the hemofilter 
hydraulic condition (MI) and the dialysate flow rate (QJ in Chapter 9. 
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Figure 8.10: The overall difrusive permeability coefficients of creatinine and 
phosphate in relation to the overall diffusive permeability coefIicicnt of urea. TIle 
permeability coefficients were obtained under the same operational conditions. 
SENSITIVITY OF I{,; AT LOW DIALYSATE FLOW RATES 
As mentioned before, the CAVHD is a unique treatment method with its very slow dialysis 
that is mostly provided by keeping the dialysate flow at relative low rates. In order to 
determine the effect of flow rates and concentration gradients on predicting the values of 
diffusive permeation coefficient fi'om clearance data, a simple sensitivity analysis is performed 
by calculating the relative variations of the overall diffusive pem1cability coefficient (AKJK~) 
due to the relative variations or now rates and solute concentrations, according to eq.(8.3). 
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The relative variation of the overall diffusive permeability coefi1cient (L.\.KJ~) due to the 
concentration gradient (Cdo/C,,;), is illustrated in Figure 8.11. As can be seen fi'om Figure 
8.11, the L.\.KJ~ remains constant (unchanged) up to Cdo/C,,;=O.7, probably due to the fact 
that the ~ reaches its maximal value (I(dmax) where the concentration driving force at that 
moment is the strongest. From Cdo/C"i=O.7 up to 1 (dialysate saturation), the 6.KJK,shows 
a sharp increase of up to more than 30%, resulting from a sharp decrease in ~ due to blood w 
dialysate equilibrium. In Chapter 7, see for example Figure 7.5, we have demonstrated that 
the ~ increased with increasing rates of the dialysate flow up to its limiting (maximal) value 
in a quadratic fom1. By comparing Figure 8.7 with Figure 8.11, it can be seen that the value 
Cdo/C"j=O.7 corresponds to the value ~/Qr~3 and QJQ,/::O.2. This value may be interw 
preted as the limiting value of the dialysate flow rate to get rid of the trouble of ultrafiltration 
in manipulating the diffusive solute removal safely. 
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Figure 8.11: Relative vmiation arK, in relation to the ratio of solute concentrations (Cdo/C"j) 
for varying values offIow rates, (Qo.I,=O.5w3 lib, Qba=82 w345 mUmin and Qr=6w 18 mllmin) 
[10]. 
A dialysate flow rate slower than the ultrafiltration flow has consequences for the solute 
clearance: As the dialysate flow decreases, the concentration gradient between the blood and 
dialysate compartments on each side of the hemofilter membrane, which takes care of the 
diffusive solute removal, will be less or not effective on the first half of the hemofilter length 
[4,11]. Gradually, the dialysate outlet solute concentration (CdJ becomes almost equal to the 
incoming blood solute concentration (CIIJ. At Cdo~ClIi' clearance reaches a critical cut~offand 
equals the sum of rates of dialysate and ultrafiltration flows only. As the dialysate flow rate 
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becomes lower than the ultrafiltration flow, diffusive solute removal in the first half of the 
hemofilter wiH eventually stop as a result of dialysate saturation or diffilsion equilibrium. The 
ultrafiltration alone reduces the concentration gradient [2]. Reducing the concentration 
gradient will reduce the overall permeability coefficient (KJ [9]. Consequently, the solute 
removal by diffusion stops while the removal of excess water continues. In Figure 8.12, the 
.6.K/1<.. resulting from the variation of dialysate flow rates (~i) is shown for comparison at 
different rates of the ultrafiltration flow (Q). The L'lK/K, reaches his limiting (minimal) value 
at the highest dialysate and at the lowest ultrafiltration flow rate. This can also be seen from 
Figure 8.13 where ilK/I<... due to the variation of ultrafiltration flow rates (Q-) is shown for 
comparison at different rates of dialysate flow (QnJ. 
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Figure 8.12: Relative variation of~ in relation to the dialysate flow rate (QJ for different 
values of the ultrafiltration flow rate (Q) [10]. 
Concern that concomitant ultrafiltration flow might markedly interfere with the dialysis 
process was unfounded by other investigators so far [3). Figures 8.12 and 8.13 show that the 
ultrafiltration flow rate may interfere with the dialysis process by affecting the diffusive 
permeability, depending on the dialysate flow rate. The relative variations ofT\:.. decrease with 
the increasing values of (1/Q-. The higher the dialysate flow rates, the smaller the relative 
variations ofK,. At relative high rates of dialysate flow, one can predict a maximal value of 
K, (SKdmax) with relative small variations. This may be attributed to the fact that on high 
dialysate flow rates, the thickness of the dialysate boundmy layer will be smaller and the 
dhilysate fluid will be better distributed over the whole bundle of fibers in the hemofilter, 
resulting consequently in a better diffusive performance. At low dialysate flow rates on the 
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contrary, the ultrafiltration affects the I~ resulting in a poor diffusive performance. 
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Figure 8.13: Relative variation of ~ in relation to the rate of the ultrafiltration 
flow (Q,) [10]. 
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Figure 8.14: Relative variation of Ks in relation to the inlet plasma water flow 
rate (Q"i) [10]. 
In Figure 8.14, the ilK/Ks as a function of the blood flow rate is shown for comparison at 
different dialysate flow rates. Blood flow rate apparently docs not affect the 6.K/K,. In a 
laboratory setting we have studied the effect of blood flow rates on the overall diffusive 
permeation coefficient [1]. Also from the results of that study, we could not obselvc any 
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relation between the blood flow rate and the overall diffusive permeability coefficient (K). 
8.4 DISCUSSION AND CONCLUSION 
In the previous chapters, we introduced mathematical models to analyze the clinical clearance 
data in terms of the overall diflltsive permeability cocmcient (I~=SKd) as a measure of the 
solute removal by diffusion in the presence of ultrafiltration. In this chapter, we analyzed the 
determinants of uraemic solute clearance in CA VHD, especially at low dialysate flow rates. 
Further, by applying a simple sensitivity analysis to the clinical data of uraemic solutes such 
as urea and creatinine, we analyzed the dependence arKs on the flow rates and 
concentration gradient. 
In CAVHD, the ultrafiltratc (Qr5-20 mllmin) flow is spontaneous. Evidently, increasing 
the rate of ultrafiltration (Q) will result in an increased uraemic solute clearance since the 
convective contribution to total urea clearance is proportional to the rate of ultrafiltration. 
Our results show a curvilinear increase in urea clearance with OJ at relative high rates of 
the dialysate flow. Since the rate of ultrafiltrate production limits the solute convective 
clearance, higher rates of solute diflhsive clearance are achieved by increasing the dialysate 
flow ratc. Depending on the patienes uraemic state, it varies between 0.5 and 3 IIh. In 
CA VHD, the slow dialysis occurs in the presence of ultrafiltration and may be manipulated 
by adjusting the dialysate flow rate to a certain level to control the patient's uraemic state. 
Low rates of dialysate flow provide slow dialysis of small uraemic solutes such as urea and 
creatinine. In CAVHD, the blood (Qm=50·350 mllmin) flows are spontaneous. High blood 
flow rates favor high rates of solute removal. Our results show a curvilinear increase in urea 
clearance with Q,i at relative high rates of the dialysate flow. Since the blood flow depends 
on the patienCs cardiac output, the type of vascular access and the hemofilter characteristics, 
an adequate blood flow rate may be difl1cult to achieve. If the resistance of an AN·69 capillary 
hcmofliter to blood flow (R,) is higher than 0.4 mmHg/(mllmin), the hemofilter mal' be 
assumed to start clotting. 
rvIodei predictions of the diffusive and convective contributions to the total (overall) urea 
clearance were calculated in the manner used by Sigler et al [2] (See eq.(6.41) and eq.(6.42)) 
and also calculated according to cq.(6.43) and eq.(6.44). In cases with the relative high 
ultrafiltration flow rates, the fraction of urea clearance due to diffusion, as detcrmined by 
eq.(6.44) was underestimated by eq.(6.41). The convective contribution to urea clearance 
decreases (slightly) with the increasing rate of the dialysate flow. The diffusive clearance on 
the other hand increases with increasing rates of the normalized dialysate flow (~/Q) in a 
quadratic form. A linear relation between the normalized urea clearance and the dialysate 
flow rate was observed for ~/Q:;;3. 
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In contrast to the conventional intermittent hemodialysis, in CA VHD an excellent dialysate-
blood equilibration is achieved. Lowering the dialysate flow rate faster than the rate of 
ultrafiltration weakens the concentration driving force and eventually dialysate saturation 
(diffusion equilibration) takes place in the first half of the hemofilter length. At ~i=O, solute 
removal occurs only by convection (Cl=Q), resulting in the solute concentration in the blood 
inlet (CI,i) becoming equal to the solute concentration in the dialysate outlet (OdD)' 
Results of our measurements show a cun~linear increase of the diffusive urea clearance with 
the increasing values of the overall diffusive permeability. The size of this increase depends 
strongly on the dialysate flow rate, noting that the overall diffusive permeability coefficient 
itself depends also on the dialysate flow rate [5,11]. The overall diffusive permeability 
coefficient may be calculated fi'om clinical data. In contrast to the intermittent hemodialysis, 
this must be calculated in the presence of ultrafiltration, since the diffusive clearance in 
CA VHD is a combined clearance process with ultrafiltration rather than a pure diffusion 
process. "Vith increasing molecular size (weight) of solutes, the overall diffusive permeability 
coefficient was obselved to decrease. Under the same operational conditions and hemofilter 
characteristics, we found that the K, of creatinine is 25% and the K, of phosphate is 45% 
smaller than the K, of urea. 
In contrast to the conventional intermittent hemodialysis, in CAVHD excellent dialysate-
blood equilibration may be achieved. The concentration profiles depicted in Figure 7.1 and 
Figure 7.2 (See Chapter 7), show apparently that acljusting the dialysate flow can manipulate 
the concentration gradient to a certain degree in the presence of ultrafiltration, to control the 
diffusive removal rate of (uraemic) solutes. By setting the dialysate flow to a certain rate and 
by considering the blood and ultrafiltration flow rates, one can predict the rate of solute 
removal by simultaneous convection and diffusion on the hand of the nomograms from 
Figures 8.3, 8.4, 8.5, 8.6, and 8.9. From the relation between Cdo/C", and Q,/Q, and the 
relation between CJo/C"iand ~/QIi from Figure 8.7 one can estimate the necessalY rate of 
dialysate flow to achieve a certain rate of solute removal coupled with the simultaneous 
removal of excess water. 
Sensitivity analysis 
On one side, this sensitivity analysis ofK, shows that calculating the !<s at relative low rates 
of the dialysate flow in presence of ultrafiltration is not reliable, especially near 01' at complete 
blood-dialysate equilibrium. The higher the dialysate flow rates and the lower the 
ultrafiltration flow rates, the smaller the variations in ~. Calculating the overall permeability 
coefficient at relative high rates of dialysate flow is therefore important, for example by 
extrapolation (Kumax, see further Chapter 9). On the other side, the relative low rates of 
dialysate flow make the CA VHD unique for the treatment of hemodynamically unstable 
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acute dialysis patients. 'Vithin the operational limits ofCAVHD, with the upper values of 
Qr20 mllmin and Qm::::60 ml/mill, the effect of ultrafiltration on the predicted value of the 
permeation coefiicient is negligible if the condition ~/Q.~ 3 is fulfilled. In intermittent 
hemodialysis this problem does not exist (~i::::200 ml/min and Q<5 rut/min). "Vith slow and 
continuous dialysis, dialysate saturation can occur, especially at dialysate flow rates less than 
ultrafiltration flow rates, In that region of flows, the relative variations in the predicted values 
of the permeation coefiicient arc considerably high (up to 35%), especially for ~j..,:;3Q.. 
Keeping this controversial fact and the results of this sensitivity analysis in mind, a dialysate 
flow rate at least 3 times the ultrafiltration flow rate is enough to manipulate the solute 
removal by diffusion without considering the ultrafiltration. Both mechanisms of solute 
removal by simultaneous convection and diffusion are subject to the same blood flow. 
Two iml)Ol.'tant paranletel's indicating the hemofilter pel'fOl'nlanCe 
In therapies SUC~l as CA VHD, the membrane hydraulic permeability index (1rII) and the 
overall diffusive permeation coefficient (SKd) strongly determine the hydraulic and diffusive 
performance of the hemofilter. These two parameters are the decisive parameters in 
estimating the rate of ultrafiltration flow and diffusive solute removal in the presence of 
ultrafiltration. Both parameters decline over time, independently from the hemofilter 
resistance (VVe investigated data of declining ofKoJ in time in a different study.). 
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TRANSPORT IN CAVHD: A prediction model for antibiotic drug 
clearance 
Chapter 9 
9.1 INTRODUCTION 
In Chapter 5, on allowing for bulk mass transport limitations under the combined effects of 
solute convection and diffusion, we developed a one-dimensional mathematical model to 
analyze the removal rate of solutes in continuous arteria-venous hemodiafiltration (CA VHD). 
The analysis of the combined effects of mass transport by simultaneous convection and 
diffusion owing to bulk mass transport is limited to the knowledge of the relative weighting 
factors (fJ and (fd) for the convective part and to some extend to the knowledge of the overall 
diffusive mass transfer coefficient (KJ for the diffusive part of solute transport. The factors (fo) 
and (fd) describe the relative weighting of the bulk solute concentration in blood (C,,.) and in 
the dialysate (CJ compartments to the concentration C m=f bC w+f"c dthat is dragged by plasma 
water during the solute removal by convection. The Kd is regarded as the reciprocal of the 
sum of the resistance to diffusion exerted by the blood concentration boundary layer (Rb) and 
the resistance exerted by the dialysate concentration boundary layer ~) and the resistance 
exerted by the membrane (RJ. 
In Chapter 6 we were able to develop an analytical mathematical model for the solute and 
volume transport in CA VHD by assuming that the solute concentrations within both the 
blood and the dialysate compartments are 'mixing cup' concentrations. By virtue of this 
assumption (and some other assumptions of course) we could analytically solve the transport 
equations so as to yield an expression of the overall diffusive permeabilit), coefficient ~=SK.J 
as a function of the membrane surface area, the blood, filtrate and dialysate flow rates and 
solute concentrations [1,2,3]. "Vhen we applied our model to data obtained during CAVHD 
[4], the data showed that we cannot take the value ofKu as a constant because of the 
following reasons: 1) The Kd of a solute decreases in time. In our interpretation this reflects 
an increase of the resistance (Rb + RJ to diffusion because of ongoing protein adsorption and 
gradual clotting. 2) The Kd of a solute increases with the increasing rates of dialysate flow. 
This may be explained by a fall in the resistance to diffusion (RJ due to thinning of the 
dialysate concentration boundary layer. In simple terms, the improved mixing ,\~thin the 
dialysate compartment lowers the concentration of the solute neal' the membrane and by that 
promotes diffilsion [5]. These observations show that the assumption regarding the "mixingR 
cup" concentrations may not be valid in the low rates of dialysate flow as far as the dialysate 
compartment is concerned. Consequently, when our model is used for the prediction of solute 
transport rates, the influence of the membrane condition and that of the dialysate flow rate 
have to be taken into account. 
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In this chapter we described a numerical computational method for solving the equations 
governing the mass balance. The method was applied to the clearance data of uraemic solutes 
and some antibiotic drugs up to 1500 Daltons and to the data of hemofilter hydraulic 
condition measured during CA VHD, so as to determine the convective concentration factors 
(fb and fd) and the resistances (Rb + Rm and Ru) to diffusion from the overall diffusive mass 
transfer coefficient (Kd) within the operational limits of CA VHD. Depending on the 
hemofilter hydraulic condition (1vl!) and the dialysate flow rates (~J) the resistance (Rb + R,J 
of blood and membrane and the resistance (Ru) of dialysate to diffusion were determined by 
'-\filson's plots. Further) by making use of the capillary pore theory) the diffusive permeation 
coeflicients (Kj of some antibiotic drugs were related to that of the creatinine so as to predict 
the clearance of antibiotic drugs fi'om the clearance of creatinine under the same operational 
conditions and hemofilter characteristics (a prediction model). By this) it was demonstrated 
how, by using the results of this analysis) our one~dimensional analytical model may be 
applied to predict transport rates of dificrent solutes under different operational conditions 
and membrane characteristics. 
9.2 METHODS 
The model description and equations describing the overall mass balance are given in 
Chapter 5. In Table 5.1) the boundary definitions and variables are shown. 
COJnputational luethods for local flow and mass balance 
Calling Ax a length element on which aU variables are considered to be constant, all the first 
order differential equations governing the local flow rates, pressure and solute mass balance 
along the length of hemofilter membrane are solved by the Euler method [16]. The local 
blood pressure is computed from the following dificrence equation: 
R 
P,(n/H) 0 Pb(t) - Jl' ~b(X) Qb(X) I1x 
L[ 
with its starting value at x=O: 
P,(toO) 0 PhI 0 PI, - RooQ", 
(9.1) 
(9.2) 
Solution of eq.(9.1} at x=Lf results in the postfilter blood pressure Ph(L,]=Ph,. Local blood 
viscosity (llb) is related to the local protein concentration (Cp) and to the local hematocrit 
(Ht), according to eq.(3.12}. The local blood flow rate (Q,) is computed from: 
Q,(t + 11x) 0 Qb(t) - Qf,t. x + I1x) (9.3) 
with its value Q,j=Q,.1 +Orrw at x=O, with Orr(d the flow rate of substitution fluid [8]. In 
eq.(9.3), the term Q{x,x+Ax) represents the cumulative rate of ultrafiltration flow: 
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(9.4) 
Eq.(9.4) at x=4 results in the net rate of ultrafiltration flow. In the previous equations 
governing the local blood flow and pressure, the rate of blood flow entering the exh'acorporeal 
circuit (QJ is assumed to be measured. As we mentioned earlier in Chapter 3, the resistance 
of blood access components could reasonably be predicted fi:om their geomeh)', but the 
measured resistance of hemofiltcr to the blood flow was 3 times higher than its predicted 
value. "Ve, therefore, determine the blood flow rate (~J with the condition that the blood 
pressure at the venous access, Ph" calculated by means of eq.{3.1), becomes equal to the 
measured value of mean venous pressure (lvIVP). The equations are then solved with 
successive adjustments of ~a until the following condition is satisfied: 
128Lra MVP - [P,(9 - --4-~b(9Qb(91 < 10- 4 
1t dra 
(9.5) 
where Pb(L,), '1b(L,) and Qu(L,) are values of hydrostatic blood pressure, blood viscosity and 
blood flow rate at x=4, which result from eq.(9.1), eq.(3.12) and eq.(9.3) respectively. In order 
to compute the local flow rates and solute concentration profiles on both side of the 
membrane, which are needed for the conservation of local mass balance, the solute mass 
transfer rates (Q,.C".) and (~C.J are solved numerically by using the measured or calculated 
boundal), values as initials. In the blood compartment the solute mass transfer rate is 
calculated as: 
s C",(t+~x)QJx+~x) = QJt)C.,.(x) -L~xl/') 
~ 
(9.6) 
with the initial value Q,(O)C".(O)=Q'iC"i at x=O andJ$l the transmembrane solute flux, is 
given by eq.(5.33): 
(9.7) 
with the convective concentration factors fb and G and the overall diffusive mass transfer 
coefficient (KJ. The local flow rate of plasma water (Q,) is computed from: 
Qw(x + ~x) = Qw(x) - Q/x, x + ~x) (9.8) 
with its value Q,(O)=Q,i at x=O. The rate of sainte mass transfer in terms of dialysate 
variables is calculated as: 
C,/pM)QJt+~x) = ~ ~x l,(x) - CJt)Qix) 
L (9.9) 
with the initial value Q.(O)CiO)=Q.,Cdo at x=O. The local dialysate flow rate (Q) is computed 
from: 
QJx + ~x) = Q/x, x + 11x) - QJx) (9.10) 
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with its initial value -~(O)=~o at x=O. In all points along the hemofilter length, eq.(9.6) 
and eq.(9.9) obe), eq.(5.10) conserving the overall mass balance. 
In calculating the local mass balance, the overall diffusive mass transfer coefficient (Kd) is 
determined from the solution of analytical model [3,4,17] (See Chapter 6). For solutes with 
sieving coefficient y=l and for a constant profile of ultrafiltration volume flux, the overall 
mass transfer coefilcient can be predicted from eq.(6.50). In other cases, the overall diffusive 
permeability coefficient is calculated by iterative adjustment techniques using eq.(6.4B) as its 
initial value. All the equations governing the mass transfer rate are solved by adjusting the ~ 
successively with the condition that mass transfer rate, ~~)Cd(l.,.) at the dialysate inlet, 
which results from eq.(9.9) at x=L'iJ must equal the measured or known value of~jCdi=O. 
'Vith the condition met all governing equations are then solved with successive adjustments 
ofKJ until the following condition is obtained: 
Qj..9 Cj..9 - Q"C", < 10 - 4 (9.11) 
As the condition defined b), eq.(9.11) is provided at x=Lr, eq.(9.6) and eq.(9.9) obe)' eq.(5.10) 
conserving the overall mass balance in all points along the hemofilter length. 
The convective concentration factol's fb and fd 
In Chapter 5, the net solute flux across the membrane was expressed in terms of the solute 
concentration (C"TIl) at the blood~membrane interface and the solute concentration (Cmd) at 
the dialysate~membrane interface [6]. See Figure 5.2. Then, by using thin~film theory [7] the 
solute interface concentrations were corrected for the bulk mass limitations, namely for the 
bulk solute concentrations (Cw and Cd)' Eventually, the net solute flux was expressed by 
eq.(9.7) including the relative weighting (convective concentration) factors (fb and fd). The 
convective concentration factors, describing the relative weighting of blood (C,J and dialysate 
concentrations (Cd) in the evaluation of the concentration of solute (Cm=fbCw+fdCd) that is 
dragged by plasma water into the dialysate region or by dialysate fluid into the blood region 
in case of back filtration, were given b), eq.(5.34) and eq.(5.35) [8]: 
fb ~ 
eO, Kd (9.12) 
° 0 ° yJ, (l-y)e '(e ·-I)+y(e '-I) 
fd ~ - + Kd (9.13) (I - y)eo'(eo. -I) + y (eo'-I) yJ, 
wherej,. is the local ultrafiltration volume flux (density) as given b), eq.(5.3) or b), eq.(6.5) used 
also b), Sigdell [9]. 8, represents the sum of the Peclet numbers for the blood (8b), the 
membrane (8"J and the dial),sate region (8.J: 
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(9.14) 
where db) elm and dd are the thicknesses of the blood concentration boundaty layer, the 
physical membrane and the dialysate concentration boundary layer (See Figure 5.2) 
respectively. The Db) Dm and Du represent the effective difllision coefficients in blood, 
membrane and dialysate respectively. In Figure 5.2, the convective concentration factors were 
theoretically demonstrated for two diflercnt solutes with sieving coefficient y=1 and y=0.4 
as a function of the total observed Peclct number (yJJK.J. 
Analysis of the ovel.'all diffusive ntass transfel.' coefficient 
The overall mass transfer coefficient (KJ is to be regarded as the reciprocal of the slim of the 
resistances to diffusion exerted by the blood side (Rb), the membrane (Rm= I IP m) and the 
dialysate side (Rd) of the hemofilter: 
I 1 
-=R ='R +-+R K Id b P d 
d m 
(9.15) 
According to Colton [5], there is a linear relationship behveen Ru and ~i-m, with the value 
of JJl ranging between 0.5 and 1.0, depending on hemofilter geometry. For the overall 
resistance to diffusion, we used eq.(9.15) as: 
lIb 
---+-
Kd K;nax Q~I (9.16) 
where bQ'j-n corresponds to Ro. At infinite dialysate flow rate, the resistance to diffusion of the 
dialysate compartment will be zero and the maximum value ofKd, Kdmax, is obtained. 
Therefore, the term Rb+ liP min eq.(9.15) corresponds to the reciprocal ofKJnax. See further 
Chapter 8 for the sensitivity analysis of~ =8Ku on the blood, ultrafiltration and dialysate flow 
rates [10]. In CAVHD, the maximum value of Kd has to be related to the hemofilter 
condition (membrane index Ivl1) because Ku of a solute decreases in time. In accordance with 
eq.(9.16), a linear regression analysis of IIKd as a function of l/~i (,,'\lilson's plots,) yields the 
value ofK"max that is the reciprocal of the y-intercept of the corresponding regression line 
and the value of h, which is the slope of the regression line. The value of III is obtained by 
using the curve fitting procedure. 
Mass h'ansfer coefficient of solutes of diffel'ent nlolecular weights 
The rate of diffusion through the membrane is influenced by the size, the shape and the 
electrical charge of the molecule. The influence of the size, i.e. the molecular radius (r,) of the 
solute, may be theoretically predicted fi'om "capillal1' pore model". For a tigid non-adsorbing 
spherical solute difillsing through a cylindrical pore (radius r,,), the effective diffusion 
coefl1cient (Dill) is related to the free difillsion coefficient (D) in water according to [11]: 
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where solute radius (I'" [AJ) may be approximated from published data [12]: 
r
J 
"" 0.51MWo.315 
(9.17) 
(9.18) 
with i\H·V [Daltons] the molecular weight of solute. Eq.(9.17) is known as the Haberman and 
Sayre equation. For practical clinical purposes, if the overall mass transfer coefficient (KuJ for 
creatinine is known, the corresponding values for other solutes may be estimated: 
Kdc rs r D D r 
=: d - + d ~ [~] - + d ~ 
Kd b rc m rc D c Dm d rc (9.19) 
where the subscript c represents creatinine. However, the boundalY layer thickness (db) of 
blood side and that (d,J for the dialysate side are not known. The db and dd may be calculated 
from inner and outer diameters of the hemofilter fibers as described by Sigdell [9]. However, 
SigdeU's expressions are related to the dly or wet state condition of membrane only, not to the 
operating hemofilter membrane index ~H), which declines over time. Therefore, depending 
on the membrane condition 0,,11) and the dialysate flow rate (~J, the membrane resistance 
(Rm=l/Pm) has to be estimated in relation to the total resistance to diffusion using eq.{9.16) 
for a known pore radius. 
Clinical conditions 
Patients were treated with CA VHD for acute renal failure and sepsis and/or circulatory or 
neurological instability [13]. For vascular access we used special 11 cm CAVH-catheters 
(lVledcomp, 8 F) in the femoral vessels. Hemofilters were prepared by rinsing the dialysate and 
blood compartment respectively with 21 of saline containing heparin 5000 VII. Filters were 
placed in the upright position with the ultrafiltrate outlet up. Standard anticoagulation 
consisted of heparin 500 V/h into the arterial line of the hemofilter. No loading dose of 
heparin was given. No protamine was used. For fluid substitution Ringer's lactate or saline 
was infused into the arterial line (predilution). The amount of substitution fluid was adjusted 
hourly to the net ultrafiltration rate. Reasons for hemofilter replacement were clotting of the 
filter or an ultrafiltration flow rate <200 mllh. For dialysate a commercially available 
hemofihration substitution fluid was used (HF-21, Fresenius). Dialysate was heated to 38°C. 
It was run counter currently at a rate orO.5 to 3.0 I1h using a roller pump (Bellco BL758, 
i\IHrandola, Italy). The flow rate was adjusted to blood chemistry if necessmy. Antibiotic drugs 
were given as clinically indicated. 
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Measurements and study protocol 
The hemofilter we used is the 0.6 m2 AN~69 capillaly hemofilter (Multiflow-60R, Hospal, 
France). AN.-69 is a symmetrical high-flux membrane. The hemofilter contains 6000 fibers, 
15 em long including 1 em length of potting at both ends. The inner diameter of the fibers is 
220-240 I'm [14]). The pre-and postfilter blood pressure (Pm and Poo) were measured from the 
arterial and venous tubing using an electronic pressure monitor. The pressure in the dialysate 
compartment (Pd) was calculated from the ultrafiltrate column height (hJ. Oncotic pressure 
OIv) was calculated from the average plasma protein concentration (CpJ according to Landis-
Pappenheimer equation [15]. The arterial blood flow rate (Q,J was measured by air bubble 
displacement over a length of arterial tubing, containing a volume of 13 ml or by using an 
electronic flowmeter with a clamp-on probe around the blood line. The net ultrafiltration flow 
rate (Q,) was measured by timed collection. Dialysate (QJ and substitution fluid (Q.,,"') flow 
rates were determined by an electronic 'Neighing device. First, the infilsion pumps of dialysate 
and substitution fluid were turned off. "Ve measured the hemofilter resistance ~) to blood 
flow and the hydraulic permeability index eM1) to determine the hemofilter condition. 
Samples of arterial blood plasma (Cp!) and ultrafiltrate (Cd were taken to determine the 
apparent sieving coefficient. Then, the infusion pump of substitution fluid was turned on and 
the sieving coefficient was again determined. After that, the dialysate flow rate was set to 
~:::: I IIh. Dialysate samples (CdJ were taken fi'om the collection bag to determine the solute 
and drug clearance and the overall mass transfer coefficient (I~ fi-om eq.(9.2) and numerical 
iterations [16] provided that the condition defined in eq.(9.II) is fulfilled. Finally, the dialysate 
pump was turned ofT and NIl and Rr were determined again to control the hcmofilter 
condition according to eq.(3.2I) and eq.(3.3) respectively. Hemofilters had been used for up 
to 3-5 days. If the value ofR, was higher than 0.4 mmHg'min/ml, clotting of fibers was 
assumed and the data were discarded. The same procedure was repeated at dialysate flow 
rates of 0.5, 2 and 3 lIh. 
9.3 RESULTS 
Relative weighting factors fb and fd 
In order to determine the effect of relative weighting (convective concentration) factors (fb and 
f,J on the convective solute removal, the local creatinine concentrations (Cw and Cd! along the 
hemofilter length were calculated from the data of creatinine clearance, which was obtained 
with Q.=199 mllmin, Q.=6.2 mllmin, Q."",=5 mllmin, Q,,;=8.5 mllmin, Ht,=O.3, CI"'=80 
gil, PN=60, Poo=20 and Pd=-3 mmHg, Cpl=229 and Cdo=193 mmolll. The overall diffusive 
mass transport coefficient was calculatcd as Kdc=21.2 !-tm/min (21.6 rtm/min according to 
eq.(6.50)). The creatinine clearance by combined convection and diffusion was CI:::: 11.8 
mllmin (eq.(5.26)) and the convective clearance CI,=5.9 mllmin (eq.(5.27)). The relative 
importance of removal of plasma watcr to that of creatinine was eo ""QlSKd::::49% • The 
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contribution of convention to the creatinine clearance was CIJCI= 50%. 
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Figure 9.1: Creatinine concentration profiles and the concentration factors fb and fd 
in relation to distance along the length ofhemofilter and in relation to the local Peclet 
number (JJK,) [18]. 
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Figure 9.2: Length averaged convective concentration factors fb and fd in relation to 
the overall Peelet number (Q,ISK,,) and to the ratio (Q./Q,) (dashed lines) [18]. 
In Figure 9.1, solute concentrations contributing to diffusive (Cw-Cd) and convective 
(fbCw+fdCJ creatinine clearance are shown as a function of the distance along the length of 
the hemofilter and as a function of the local Peclet number UJKJ. The average contribution 
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of blood side to the convective creatinine removal was fb=54% and that of the dialysate side 
was G=46%. In calculating the factors fb and ~, we lIsed Rb:Rm:~ ::: 1 0:50:40. In fact, as can 
be seen from eq.(9.l2) and eq.(9.l3), the factors fb and fd depend on the local Peelet number 
GJKu), not on the ratio R" : ~ : Ru. In Figure 9,1, the fb and G are shown as a function of 
J/~ and as a function of the distance along the hemofilter length. The factors fb and fd equal 
0.5 atJ,=O. AtJ\,<O, where the filtration takes place from dialysate into blood (back filtration), 
the concentration factors become fb <0.5 and fd>O.5. "Vithin the conventional ranges of 
operational conditions (Q,a=50-345 ml/min, Qr5-20 ml/min, Qprcd=O -15 mt/min and 
~j=5 -60 rnl/min), we calculated the length averaged values offu and fd in relation to the 
overall Peclet numbers (Q/SKu) and in relation to the ratio of dialysate flow rate to the rate 
of ultrafiltration flow (Qu/Q:). As can be seen from Figure 9.2) the length averaged values of 
fb and fd depart fi"Om 0.5 up to I 0% \\~th increasing values of (Q/S~) and with decreasing 
values of(Q./Q). 
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Figure 9.3: Relationship between extrapolated value of Rb+R..n and membrane 
hydraulic permeability, as expressed by the value of MI. The drawn curve represents 
prediction of R., +R", according to the equation: Rb +R",=O.075IMI for MI < 12 and 
Rb+R",=1/160 for MI> 12 [18]. 
Predicting the overall mass trallsfer coefficient and solute clearance 
Under different operational conditions, we calculated the overall mass transfer coefficient (K.uJ 
for creatinine. For the calculation afRu + 1 IPm from eq.(9.16), 16 times regression analyses 
were performed. 'Vith our data, a linear relationship was best approached when we 
substituted 1.0 for the value of HI, where dialysate flow rate was varied between ~i=0.5 and 
3 lIh. The average slope of the regression equations, which indicates the influence of ~i on 
KdJ was b=0.15 (s.e.m. 0.05). For each data set, K d111ax was determined by taking the 
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reciprocal of the y-intercept of the corresponding regression equation. Further, l/Kdmax of 
creatinine was calculated at different values of the membrane permeability index (NII).The 
relation between Rb + R.i and ~H is shown in Figure 9.3. The relationship was then described 
by the following simple empirical equation for MI < 12 mll(ll'mmHg): 
1 0.075 0.15 (9.20) --- + Kd, MI Qdi 
and for !vII> 12 mll(h'mmHg): 
1 0.15 
+ 
K" 160 Qdj 
(9.21) 
By combining eqs.(9.20) and (9.21), we estimated the SKd for creatinine. We then compared 
them with the observed SKd values, which were calculated by using eq.{9.11) at different 
values ofQ"i and 1\'11. The value of Q"i varied from 0.5 to 3 IIh. 
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Figure 9.4: TIlC observed difiusive permeability coefticient (SK.J and the observed 
clearance of creatinine in relation to the values calculated by prediction. The broken 
lines show the 95% reliability intervals [18]. 
In Figure 9.4, the obselved SKu is shown versus the predicted SKdfor creatinine. The average 
difference between obselved and predicted values was 5°/0 according to the regression 
equation: SK", (obselved)=1.05·SK", (predicted) -3.02 with R'=O.77 ~nd n=112. Using both 
the observed and predicted values ofKd{l we calculated the observed and predicted creatinine 
clearance by eq.{6.51) and compared to each other in Figure 9.4. The average difference 
between observed and predicted values was 3% according to the regression equation: CI 
(obselved)=I.03CI (predicted)-1.25 with R'=94 and n=112. 
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Table 9.1: Observed values of the ratio Ku/Kdc for different uraemic solutes 
and antibiotic drugs with their free fractions in plasma water measured with 
an Al'l-69 membrane [2]. 
solute MW [Daltons] K./I(." n fi:ce fi'action n 
urea 60 1.32 109 
lactate 90 0.93 2 
creatinine 113 109 
uric acid 168 0.93 123 
phosphate 174 0.75 125 
vitamin Bl1 1355 0.24 5 
imipenem 317 0.68 20 1.00 22 
ciprofloxacin 331 0.85 2 1.02 6 
cilastatin 384 0.56 21 0.68 20 
cefuroxime 424 0.72 21 0.80 21 
cefotaxime 455 0.37 II 0.76 14 
tobramycin 468 0.72 26 0.82 19 
ceftazidine 547 0.66 22 0.92 12 
vancomycin 1449 0.37 5 0.67 5 
Mass transfer coefficient of solutes of different molecular weights 
Further, by calculating the overall mass transfer coefficients of other uraemic solutes and 
antibiotic drugs (See Table 9.1) up to 1500 Daltons, a fixed relationship was found from the 
foHowing regression equation: 
(9.22) 
In Figure 9.5, the ratio K,/Kuc is shown in relation to the solute molecular weight (nH'V, 
[DaltonsJ). Using "Vilson's plots, we estimated the contribution of membrane resistance 
(Rm/R-td) to the total resistance from our data. 
Table 9.2: !vlembrane resistance as a percentage of the total 
resistance to diffusion for different dialysate flow rates and 
mcmbrane hydraulic permeability index (l\.'II, [mllh·mmHgJ). 
0.5 
I 
2 
3 
membranc resistance to diftusion, R.n [% ofR{J 
for~1I~4 forMI~8 forMI-12 
34-51 29-34 26 
45 -68 
54-81 
57 -96 
43 -51 
56-68 
63 -76 
41 
58 
68 
As shown in Table 9.2, the ~ may vary between 26% and 86% of the total resistance, 
depending on MI and Q.i' At MI=8 mll(ll'mmHg) and Q.i= 1.0 IIh, a realistic estimation of 
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R",/R,d would seem to be 50%. Using eq.(9.20), the contributions ofRb and Ru to the total 
resistance (~.v were estimated by adjusting the parameters dm , db and dd in eq.(9.19) so that 
the values ofK.i/K" according to eq.(9.19) become equal to the values ofK,/K.i, from 
eq.(9.22). 
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Figw'e 9.5: Relationship between observed values ofK./I~c of different uraemic 
solutes and antibiotic drugs and their molecular weight. See text. Data were obtained 
with the 0.6 m2 AN-69 capillary hemofilter (rvlultiflow-60R, Hospal, France) [18]. 
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In Figure 9.5, the calculated values ofKd/Kdc from eq.(9.19) arc shown for pore radii rp::::30 
A and fp=60 A. vVith the AN-59 membrane, the pore radius is approximately 60 A. From 
Figure 9.5, we estimated that for creatinine, with an average membrane index (l\rfJ::::8 
ml/(h'mmHg)) and at a dialysate flow rate of 1 I1h, the resistances RbJ Rn and ~ are related 
to each other as Rb:~I:Ru= 10:50:40. In Figure 9.5, the curve 1 represents the regression 
curve: K"IK",={MW I 113)"°·42 with R'=O.76 and n= 15, the Clllve 2 represents the K"/K" 
CUlve according to Haberman and Sayre equation for pore radius rp::::60 A with 
Rb:Rm:Ru=lO:50:40 and the curve 3 represents the curve 2 fo~ l' ::::30 A. In Figure 9.6 a 
nomogram is shown for estimating the relative values of the blood (Rb), the membrane (Rm) 
and the dialysate (RJ in relation to molecular weight up to 1500 Daltons. 
Predicting the antibiotic d1"ug clearance 
Clearances of some antibiotic drugs were measured during CA VHD at the dialysate flow rates 
of I and 3 IIh (See Table 9.3). The clearance data were obtained ",th the Al'\f-69 capillary 
hemofilters at different operational conditions. 
Table 9.3: Range of antibiotic drug clearance during CAVHD at two different 
rates of dialysate flow. Data obtained with the AN-69 capillaly hemofilter [2). 
Drugs Q,. [mllh) CI [mllmin) CI [mil min) n 
Q,,=I IIh Q" =311h 
imipenem 180-720 8-34 17-49 23 
ciprofloxacin 410·490 18·23 24·39 4 
cilastatin 200-720 6·20 7·24 24 
cefuroxime 270·990 7·26 10-42 22 
cefotaxime 380·990 9-20 17·25 13 
tobramycin 240-880 13·24 17-32 30 
ccftazidine 240·890 13·30 17-38 24 
vancomycin 330·740 8-20 11·20 6 
The overall diffusive permeation coefficients of drugs were calculated using the iterative 
adjustment techniques with the condition described in eq.(9.11). The overall permeation 
coefficients calculated on this way we call «SKd obsetved». From the relation between the 
SK" of creatinine and the SKd of other solutes, as described by eq.{9.22), we predicted the 
overall diffusive permeation coefficient of drugs) which we call ((SKd predicted". Using the 
predicted values of the overall diffusive permeation coefficients, we predicted the clearance 
of antibiotic drugs from eq.{6.51). In Figure 9.7, the obselved values ofSK, and drug 
clearance are shown in relation to their predicted values. The average difference between the 
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observed and predicted values of SKd was 4% according to the regression equation: S~ 
(obselved)= 1.04·SK", (predicted) -1.72 with R'=0.65 and n= 106. The average difference 
between the observed and predicted values of clearance was 7% according to the regression 
equation: CI (obselved)=0.93CI (predicted)+ 1.89 with R '=86 and n= 112. 
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Figure 9.7: TIlC observed diffusive permeability coefficient (SKJ and the observed 
clearance of antibiotic drugs (See Tables 9.1 and 9.3) in relation to the values 
calculated by prediction. The broken lines show the 95% reliability intervals [18] 
9.4 DISCUSSION AND CONCLUSION 
'Vithin the conventional ranges of operational conditions, the factors fo and fd contributing to 
the convective clearance for uraemic solutes can be best taken to be equal to 0.5 with a 
variation of maximal 10%, so that the condition "fb=fd=O.5" for the validation of eq.{6.4) is 
fulfilled. The empirical equations, eq.{9.20) and eq.{9.21), in which the resistances Rb+Rn and 
R" are related to the ultrafiltration coefficient (MI) and to the dialysate flow rate (Q,;) 
respectively, are aimed not to gain a true physical picture of resistance to the diffusive solute 
transport in each region of the hemofiiter, but rather to show the impact of the dialysate and 
the ultrafiltration flow rate on estimating the creatinine clearance by combined effect of 
diffusion and convection. The "'Vilson's plots' allowed us both to determine R" + Rm and Rd 
separately and to quantify the influence of dialysate flow rate on Ru. This analysis serves three 
purposes: First, the estimation ofJ<.u allows our model to be applied in the prediction of solute 
transport under diHerent operating conditions. Second, quantitative information about the 
effect of the dialysate flow rate on the overall diffusive permeation coefficient (SKd), i.e. the 
slope of the regression line. Third, if the contribution ofRm is detelmined within certain limits, 
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the Haberman and Sayre equation may be applied so as to predict the transport rate of solutes 
of different molecular weight. The actual results showed that, in CAVHD, the precise 
determination ofl~, R.n and ~ is aflittle importance. The method allows a crude estimation 
of the relative contribution of~) R.n and Rd to the overall hemofilter resistance to diflusion. 
The latter may be ofimportance when one attempts to extrapolate to transport rates of solutes 
of different molecular weights. ''''e previously reported on our oncMdimensional analytical 
model of continuous arteriovenous hemodiafiltration (CAVHD) [3, 4, 10, 17]. In that model, 
the possible effect of bulk-mass limitations (the 'unstirred layer effect') was not taken into 
account. Unfortunately, as in CA VHD the dialysate flow rates are low and variable, the 
influence of dialysate flow rate on the resistance to diffusion cannot be disregarded. Therefore, 
this mathematical model can be used to take the efiect of bulk-mass limitations into account. 
This is, however, a numerical model that requires time consuming iterative calculations. 
:Moreover, it takes for input a number of variables (~, Ru and R,J, the value of which can be 
estimated by using Haberman and Sayre equation, as it is demonstrated in Figure 9.5 and in 
Figure 9.6. But, in our view, a more practical solution is to separately analyze the 
determinants of the resistance to diffusion, and incorporate the relevant regression equations 
(9.20,9.21 and 9.22) into the analytical model. 
So far, the overall diffusive permeability coefficient (I<-S::::SK.J were calculated by using 
eq.(6.50) as an initial value of numerical iterations so as to provide the condition given by 
eq.(9.11) is fulfilled. Eq.(6.50) was derived from the analytical solutions of the overall mass 
balance equations as we earlier described in Chapter 6. The overall difllisive pel1l1eability 
coefficients calculated by both computation techniques were compared to each other. For 
urea, creatinine and phosphate, we found that the K~ on the hand of analytical model was 
calculated with an average (n=65) difference of maximal 5% in respect to the Ks calculated 
according to the numerical adjustment techniques. The use of the predicting the overall 
diffusive permeability coefficients on the hand of the relation between the overall diffusive 
permeability coefficient of creatinine and other solutes, depending on the solute molecular 
weight as given by eq.(9.22) resulted in a fairly accurate estimation of the clearance of drugs. 
Furthermore, this prediction model can be used to estimate the clearance of other drugs of 
solutes used in case of self-poisoning. 
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EFFECT OFULTRAflLTRATION, DIALYSATE SODIUM 
CONCENTRATION, TREATMENT TIME AND UREA CLEARANCE ON THE 
TRANS CELLULAR FLUID SHIFT: A sirn.ulation study of sodiUlll therapy 
Chapter 10 
10.1 INTRODUCTION 
As we have mentioned in Chapter 2, the most frequent complication of conventional 
intermittent hemodialysis and hemodiafiltration therapy is the dialysis-induced hypotension 
[1]. An important factor in the development of hypotension during hemodialysis is a decrease 
in blood (plasma) volume, due to ultrafiltration and an insu01cicnt refilling the intravascular 
volume. The (rate aQ plasma volume refilling, a measure of the fluid transport from 
interstitium to the intravascular space during uitrafilh"ation, is onc of the ffi<tior determinants 
of vascular stability during conventional hemodialysis [2]. Previous reports pointed out a 
transccllular fluid shift from the extracellular volume (V~) compartment to the intracellular 
volume (V0 compartment during conventional (low dialysate sodium) hemodialysis, leading 
to a decrease in Vr that might intelfere with the process of repleting the intravascular volume. 
This insufficient refilling might be caused by a transcellular fluid shift from the Ve 
compartment to the Vi compartment [3]. It has been stated that the rapid fall in plasma 
osmolality during dialysis causes a fluid shift from the Ve into the Vi' so called disequilibrium 
syndrome [2,4,5]. This internal fluid shift together with external fluid removal by 
ultrafiltration results in a decreased intravascular volume and hypotension [3,6]. Plasma 
refilling is one of the major determinants of vascular stability during hemodialysis. It has been 
shown that the magnitude of hypovolemia and resultant intra dialytic hypotension is 
dependent upon the rate of fluid removal and vascular stability [7,8,9]. It has also been 
demonstrated that dialysate fluid \\~th a high sodium concentration can induce a transceilular 
fluid shift from Vi compartment to the Vr compartment [3,8,10,11,12]. The reduction in the 
incidence of hypotension [2,13], disequilibrium syndrome [10], and muscle cramps [14] by 
highMsodium hemodialysis may therefore be related to changes in fluid balance between the 
Vi and Vt compartments. 
In this chapter, we introduced a mathematical simulation model of sodium kinetic which may 
be useful for the clinical practice. The simulation is based on a 2-pool sodium kinetic model. 
By means of such a simulation model, the changes in the concentration, the volume, and the 
osmolality in both the intracellular and the extracellular compartments can be predicted 
during modeled dialysis sessions. "Vc analyzed the influence of dialysate sodium concentration 
and the rate of ultrafiltration and dialysis duration on the transcellular fluid shift during 
treatment \\~th modeled dialysis sessions of I to 8 hours. The simulation results show that the 
magnitude of fluid shift from Ve to Vi decreases \\~th slow dialysis, high sodium concentration 
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in the dialysate fluid and low rate and amount of ultrafiltration. Refilling of the intravascular 
volume is faster at high than at low rates of the ultrafiltration flow. To some extend, this 
reduces the fluid shift fi'om the Ve into the Vi compartment. Increasing the dialysate sodium 
concentration has therefore the greatest eflect on the transcellular fluid shift at low rates of 
ultrafiltration flow. 
10.2 MATHEMATICAL MODEL 
Previous models 
Previous investigators have developed mathematical models to calculate sodium mass balance 
[15, 16, 17] and to predict the volume changes in extracellular and intracellular space that 
occur during hemodialysis [18,19,20,21,22}23]. These models have made important 
contdbutions to the understanding of sodium therapy. However, these models do no~ include 
the effect of transcellular urea gradients on fluid shift; these models also assume that this fluid 
shift occurs instantaneously, so that osmotic equilibrium exists between Ve and Vi at all times 
during a dialysis session. These assumptions may be invalid for short-time, high-efficiency 
dialysis, where the difference between transcellular urea and non urea osmolar gradients may 
be large and time insufficient for equilibrium to occur. In their mathematical model, 
Heineken et al [24] have included the effects of urea osmolar gradient, and osmotic 
disequilibrium and were able to successfully simulate the high- and low-sodium dialysis 
experiments and calculate a whole body ultrafiltration coefHcient. However, in this model the 
correction factor for plasma water (F".), Donnan ratio (a""J of dialyzer plasma water sodium, 
transcellular reflection coefficient (uu) for urea, and hematocrit (HtJ dependence of sodium 
dialysance (DNJ were not included. Furthermore, the convective transport of urea from Vi 
to Ve was incorrectly calculated. By accounting these factors in their model, Pastan et al [25] 
were able to calculate the changes in osmolality, fluid shift and sodium and urea mass balance 
during dialysis. In their model, however, the changes in hematocrit and plasma protein 
concentration during a dialysis session were not included and the Donnan ratio was taken to 
be constant. In fact, the Donnan ratio is dependent on the plasma protein concentration 
which may also change due to ultrafiltration. Since sodium removal occurs from plasma water 
only, the changes in plasma water as a result of changes in hematocrit and plasma proteins 
have to be taken into account. These factors were accounted for in our model. Our model 
incorporates diflerential equations describing the mass balance of intra- and extracellular 
urea, nOllurea and plasma water as a function of treatment time (ttl). Our model formulation 
is similar to that of Past an et al [25], but not identical. 
Model description 
'Ve assumed a 2-compartment model consisting ofVe and Vi' Urea is constantly generated 
in the liver and assumed to directly enter to extracellular volume (V .. ) [26]. During dialysis, 
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urea transport between Vi and Ve and its removal across the dialyzer membrane occur by 
diffusion and convection. For the purpose of the mathematical model, all impermeant 
nonurea sol~tes (Nael, KCl, mannitol, etc.) are lumped together as a single Ilonurea solute. 
The only other additional extracellular osmotically active solute is assumed to be sodium 
(Na+) at a total (free plus bound) concentration Ce,Na' Between the Vi and Ve compartments 
ion exchange occurs by diffusion and plasma water is transported with an ultrafiltration 
coefficient (KF). The Donnan~ratio is taken to be dependent on the plasma protein 
concentration. We assumed that the changes in the plasma protein concentration and 
hematocrit depend on the changes in the extracellular volume. 
Intracellular water, urea and Na+ lllass balance 
The rate of volume flow behveen Ve and Vi equals the change in the Vi during dialysis and 
is taken to be proportional to the difference between the osmotic pressure in these spaces: 
dV. 
-' " -KFRTI10sm. (10.1) 
dt 
where KF:::: 149.41·Atm/mmol OK is the whole body ultrafiltration coefficient [24], that is, how 
quickly water enters or leaves the plasma volume from the interstitial space, R is the gas 
constant, T is the temperature. The magnitude of the net osmolar driving force is defined as: 
(10.2) 
where Ki\'a:::: 1.846 is a factor that converts the molar concentration ofNa+ and its 
accompanying anions into its osmotically equivalent osmolar concentration [27], Ce,i\'a is the 
extracellular Na + concentration, C i is the intracellular concentration of osmotically active 
nonurea, ou::::O.95 is the transcellular urea reflection coefficient [28], Ce,u is the extracelluar 
urea concentration and Ci,u is the intracellular urea concentration. The rate of non urea solute 
mass transport is assumed to be constant: 
d(V,C,) " 0 
dt 
(\0.3) 
The rate of intracellular urea mass transport is due to the sum of diffusive and convective 
transport from Vi into the Ve: 
d(\'iC,) _ 
dt - - K,( C,., - C",) 
dV 
+ sc. -' 
I,U df (10.4) 
where Ku::::800 mllmin is the diffusion coefficient of urea [24,29,30], s::::1 is the urea trans-
cellular sieving coefficient [25]. 
Extracellular water, urea and Na+ lllass balance 
The change in the extracelluar volume (V J during dialysis equals the sum of the rate of 
volume flows from or into Vi and that from dialyzer: 
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dV, 
dt 
(10.5) 
in which Q. is the net rate of ultrafiltration flow through the dialyzer. The mass balance of 
extracellular Na + is given by: 
d(V, C'.N') _ Qf 
dt - DNa(l - -Q .) (Cdi,Na - aNa eel'ia) - QlaNa Ce,Na 
'" 
(10.6) 
in which Cdi,i\'a is inlet dialysate Na + concentration, Q,j is the inlet plasma water flow rate, aNa 
is Donnan ratio [15, 31] and DNa is the dialyzer sodium dialysance [15].The terms on the 
right~hand side ofeq.(10.6) includes the rate ofNa+ mass transport by diffusion as well as by 
ultrafiltration through the dialyzer membrane. The Na+ concentration in plasma water 
(C"j~\'J at the dialysate blood inlet equals the Na + concentration in the extracellular volume 
(C,,,,). Plasma water flow rate (Q.J is calculated from the inlet blood flow rate (Q,J as: 
(l-0. 96Hta) 
~=~ F (IO·n 
". 
in which Fw::::O.927 is a correction factor for plasma water [31,32] and Hta is the arterial 
hematocrit. The rate of extracellular urea mass transport is given by: 
~~~J d~ ~ 
--,-",-,,,-. =K(C -C )-sC -+G -[D(l--)+QJC dt Ii 1,1i e.1I i.lf dt /I Ii Q
ba 
f e,1I (10.8) 
where the first term on the right~hand side is the rate of diffusive and the second term is the 
rate of convective urea transport, the third term (Gu::::O.083 mmollmin) is the urea generation 
rate [15,33] and the last term is the rate of urea removal by diffusion and convection through 
the dialyzer membrane with Du representing the dialyzer urea dialysance (clearance). Since 
the dialysate inlet urea concentration (Cdi,J is zero, the urea dialysance is the same as the urea 
clearance [IS]. The urea clearance can be calculated from eqs.(6A-5-6,47) using the flow rate 
of blood in place of plasma water. According to Pastan et aI [25], the Na+ dialysance may be 
derived fi·om the urea dialysance as: 
DN, = D,,( I -O.96Ht") (10.9) 
because Na + is removed only from plasma water. 
Donnan factol' aNa 
The impermeability of the dialyzer membrane for charged proteins causes a Donnan-effect. 
The so-called Donnan~factor is defined as the concentration (measured by flame photometry) 
ratio of electrolyte ions between plasma and dialysate after reaching an equilibrium. The 
Donnan~factor (ratio) is calculated according to the NCE "net cation equivalency" of proteins. 
Part of the sodium in plasma water is covalently bound or "complexed ll to proteins. This 
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amounts to no more than 1 % according to Van Leeuwen [34], and 1.37 mmol per 100 gram 
of hydrated proteins according to Bosch et al [35]. Depending on the plasma protein 
concentration, the Donnan-factor for Na+ vades up to 1.0. According to Bosch ct al [35], the 
Donnan factor has to be calculated as the ratio ofNa+ concentration in ultrafiltrate to that 
in plasma water both measured by ion selective electrode (ISE). In this way, for sodium 
plasma concentrations within the range of 136-146 mmolll, ~!Ian et al [36] has calculated the 
Donnan ratio from the ratio plasma-ta-dialysate concentration at equilibrium and found to 
be a~,=0.954. According to Stiller et al [31) and Sargent et al [15), the Donnan ratio 
amounts to 0,94. Shaldon ct al [37] derivated an empirical formula to calculate the Donnan 
ratio fi'om the plasma protein concentration: 
C + C 
aNa = 1.007 - 9'10- 4 pi 2 PQ (10.10) 
with C pi and CPOI each representing the plasma protein concentration at the dialyzer blood 
inlet and at the blood outlet respectively. Cpi and Cpo are calculated according to eq.(3.16) and 
eq.(3.18) respectively, with ~ITd::::O, noting that C pi becomes equal to Cpa' 
Hematocrit and plasma protein ,nass balance 
The arterial plasma protein concentration and arterial blood hematocrit are conselved with 
the following protein and hematocrit balance: 
HI, 
Cp , (0) V, (0) 
V, 
HI,(O) V,(O) 
V, 
(10.11) 
(10.12) 
in which C,jO), Ht,,(O) and V",(O) represent the predialysis (at t=O) values of arterial plasma 
protein concentration, arterial hematocrit and extracellular volume respectively. 
Dialysis efficiency index 
The delivery of a dialysis treatment is highly dependent on adequate solute removal, adequate 
fluid removal and the stability of the patienes treatment. The quantity of urea removed during 
dialysis is the product of dialyzer clearance (D1l' p/minJ) and the treatment time (tdJ[minJ). An 
adequate dialysis treatment is achieved if the total amount of urea clearance per treatment 
approximates the predialysis volume oCurea distribution (\'o=V,(t=O)+V,(t=O), D)) in patients 
who have negligible residual renal function. This statement is characterized by an efficiency 
index (DP) as: 
DP = In-;---:o= 
1 - FRU, (10.13) 
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where C"o(O) and C"o(td) are the pre- (t=O) and postdialysis (t=t.,j extracellular urea 
concentrations respectively and FRUe represents the removed fraction of urea (urea reduction 
ratio) from extracellular volume: 
FRU,[%] C, ,(0) - C, ,(Id) ,I , x 100 
C,,J0) (10,14) 
DP index is used as a measure of the effective dialyzer performance and also as a measure of 
the amount of dialysis (dose of dialysis), a fractional volume which is cleared per dialysis 
session. 'Vhen the efficiency index (DP) is grater than I, the treatment is considered adequate. 
An efficiency index ofDP= 1 corresponds to an urea reduction ratio of60 to 65°/0. To remove 
60 to 65°/0 of the predialysis urea in a given patient, a dialyzer with a low urea clearance will 
require a longer treatment time than a dialyzer with a high urea clearance. 
10.3 SIMULATION RESULTS 
AU equations governing the urea and sodium mass balance are numerically integrated by 
using the Runge-Kutta-Merson method [38] in the simulation programme Psile [39], See 
Appendix for the Psile listing of simulation. The computation times were short enough to 
perform the simulations. In Table 10.1 the constants and variables used for this simulation 
work are shown. 
Table 10.1: Values of parameters used for the mathematical simulation ofNa+ 
and urea transport. 
Parameter Value Units Parameter Value Units 
Cdi,l'a variable mmolll Q" 0,3 or 0,2 I/min 
Cd;,u 
° 
mmolll Q, Vur/t,! IImin 
C,(O) 140 mmolll plasma VUF I - 3 
C",,(O) 140 mmolll plasma V,(O) 16,4 
C",(O) 40 mmol/I plasma V;(O) 28,0 
C;,JO) 40 mmol/I plasma Vo 44,4 
Ht, (t=O) 0.3 
°
0 0,95 
C,,(t=O) 70 gil R 0,08206 IAtm/(OKmmol) 
T 310 oK KF 149,4 ml/(miqAtm) 
K" 800 mllmin Go 0,083 mmollmin 
KI'3 1.846 
Fw 0,927 DP 0,5 - 1.5 
The simulations were performed for an ideal 72 Kg patient, with an initial value of 
V,(t=O)= 16,4 I and V;(t=0)=28 I prior to dialysis, Initial values of C"N, and C; were 140 
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mmolll in plasma. In calculations, the urea and nonurea plasma concentrations were used 
in units of l1uTIoll1 in plasma water on dividing plasma concentrations by Fw=O.927. Initial 
urea concentrations Cj,u and C",u were 40 mmaI/I. Throughout each dialysis session we used 
Q,,=O.2-0.3 Ilmin, H,,(O)=O.3 and C p,(O)=70 gil. The modeled urea dialysance (clearance) 
was calculated from different values of dialysis performance index, eq.(lO.13), namely 
DP=O.5, 0.75, 1, 1.25 and 1.5 for varying treatment durations (ttl=1 to 8 hours). The 
predialysis volume of urea distribution was Vo=44.4/. For each dialysis session, the ultra-
filtration flow ratc (Or =VUF/tdl VUF represents the amount of ultrafiltration in liters) was 
adjusted so that VUf=2.41 plasma water was ultra filtered fi:om the Ve compartment. 
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Figure 10.1; 'llleoretical urea dialysance (clearance) for modeled dialysis sessions from I to 8 hours 
at different values of dialysis performance index (DP). An achievable urea clearance even with 
short, high efliciency treatments is maximal 0.33 IImin. The dashed line represents the urea 
reduction ratio (FRU~) versus the dialysis index. 
In Figure 10.1, the urea clearance for values of different dialysis index is shown as a function 
ofmodcled dialysis sessions from 1 to 8 hours. Figure 10.1 shows how a "shortwtime, high-
efficiency dialysis" may be modeled from the parameters of dialysis performance index (DP), 
the patient volume of urea distribution (V 0) and treatment time (to) under the condition that 
the same amount of urea and the same amollnt of water are removed at the end of each 
dialysis session. The dialysis indexes DP=0.5, 0.75,1,1.25 and 1.5 correspond to an urea 
reduction of 40%, 530/0, 63%, 71 % and 83% of the predialysis volume of urea distribution 
(V 0) at the end of dialysis session respectively. In short, high efficiency treatments (td<240 
minutes), an urea clearance ofO.26l1min can be achieved with a blood flow rate of 0.3 
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IImin, dialysate flow rate of 0.5 IImin and a dialyzer with an overall diffusive permeation 
coefficient ofSK.,::: 1.0 lImin t:Ku : overall diflilsive mass transfer coefficient and S : membrane 
stuface area, see eq.(6.45)). 'Vith a blood flow rate of 0.'1· I1min and dialysate flow rate of 1.0 
I1min and a dialyzer with SKo::: 1.0 l/min, an urea clearance of 0.33 lImin can be achieved. 
For urea clearance ofDu>0.33 IImin, higher blo'od flow rate than 0.4l1min and higher 
dialysate flow rate than 1.0 I1min are needed. In conventional intermittent hemodialysis, an 
urea clearance ofO.12~0.18 I1min is achieved with a dialysis session of3A hours. 
Effect of urea clearance on the fluid shift 
In the simulations, the ultrafiltration rate (Or) was adjusted so that at the end of each 
treatment session 2.4 liters of plasma water was ultrafiltered. The dialysate sodium 
concentration was Cdi,.\'a::: 140 moIlI. The urea clearance was adjusted so that for each dialysis 
session ofa period oftd:::4 hours, the dialysis index DP=0.5, 0.75, 1, 1.25 and 1.5 is obt~ined. 
Further, we calculated the time courses of trans cellular urea osmolar gradient, (C('",u~Cj,u), the 
nonurea osmolar gradient, KXa(C('",.\'a~Ci)' and resultant (net) osmolar driving force, .6.0sm.= 
ou(C",u-Cj,J+KXa(C('",i\'a-CJ, the changes in the intracellular volume, fj, Vi::: V j - V;(O), the changes 
in the extracellular volume, .6. Ve=Ve-Vc(O), for different values ofDP index. In Figure 10.2 
and Figure 10.3, these time courses are shown. 
240 180 120 '0 0 
, 0.2 
nelasmo/ar 
gradienl 
~ I .• 
-0.4 .... ~ 
~ 3.5 ~ e 
" m 0 
'3 0 .• nonurea gradient .§. 
·1 ~ ~W • ,; ~ 3 0 e 
• E 
m 
.- DP = 0.5 -1.6~ 0 
< E 
~ 
" < 0 
• 
-3.5 ~ 
• 
• -2.2 c; 0 
1.5 urea gradient 
., 
-2.8 
0 60 120 180 24' 
treatment time (mInutes] 
Figure 10.2: Time courses of urea, nonurea and net osmolar gradients for modeled 
dialysis sessions of 4 hours with Cdi.NA= 140 mmol/l and Q=O.O I J/min. 
Figure 10.2 shows that almost always in the first hour of each dialysis session, the nonurea 
(positive) and the urea (negative) osmolar gradients result in a (negative) net osmolar gradient. 
Urea osmolar gradient causes the water to move fi'om Ve to Vi while the nonurea osmolar 
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gradient works in the opposite direction. As water flows from Ve to Vi , the plasma sodium 
concentration rises slightly. This results in a nonurca osmolar gradient that is of the same 
magnitude as the urea gradient, but of opposing direction. A small water shift results in a 
relatively hlrge increase in' extracellular sodium concentration because the extracellular 
sodium mass is so large. This small degree of water shift is also a result of the dialysate sodium 
concentration Cdi,Na= 140 mmolll (See the following section "Effect of sodium concentration 
on the fluid shift".). As the magnihtde of the nct (negative) osmolar gradient (driving force) 
increases with the increasing rate of urea removal as a result of the fact that the nonurea 
gradient develops slower than its counter part, towards the end of dialysis time the net osmolar 
gradient reaches a zero value resulting in equilibrium or a positive value resulting in water 
movement from Vi to Vc' The faster the urea is removed, the faster the (negative) osmolar 
urea gradient develops. The time delay in developing both osmolal' gradients results from 
barIiers to solute diffilsion (noting the fact that the equilibration rate is less than infinite) and 
£i'om a decrease of extracellular osmolality more quickly than the intracellular osmolality with 
increasing rates of urea removal. Since the amount of ultrafiltration (and ultrafiltration flow 
rate) is the same for each dialysis session, the changes in Vi with urea clearance may be 
attributed to the urea clearance by diffusion through the hemodialyzer membrane. 
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Figure 10.31 9hanges in 6. Vi and 6. V~ in time for modeled dialysis sessions of4 hours 
with DP=0.5, 0.75, I, 1.25 and 1.5. 
The time courses of the changes in Ve and Vi due to the net osmolar gradient and ultra-
filtration are shown in Figure 10.3. The magnitude offluid shift from V, to V,,!J. V,=V"V,(O), 
is determined from the increase in Vi' The sum of postdialysis values of A Vi and /). Ve reaches 
the predefined amount of ultrafiltration volume, V,(td)+!J. V,(t,,)=, V Uf =2.4 I of water, which 
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means that at the end of each modeled dialysis session, 2.4 liters of plasma water is filtered. 
The size of fluid shift increases with increasing rates of urea removal. An increase in the rate 
of urea removal steepens the osmolar gradient between Vi and Ve compartments, resulting 
in a fluid shift into celis, thus contributing hypotension. 
Table 10.2: The relative changes in Vi and Ve compartments as a result of 
diflerent rate of urea removal at the end of a dialysis session of td=4 hours 
with a fixed Q=O.Ollimin. 
DP D" U/minJ 11 V;(tjJ/V;(O) 
[%J 
0.5 0.093 0.32 
0.75 0.139 0.58 
0.185 0.79 
1.25 0.231 0.96 
1.5 0.278 1.1 
11 V,(tjJIV,(O) 
[%J 
-15.18 
-15.62 
-15.98 
-16.28 
-16.51 
tcq• 
[min] after start 
113 
145 
148.5 
143.6 
136 
In Table 10.2, the relative changes in Vi and Ve as a result of different rates of urea removal 
at the end of a dialysis session oft,=4 hours with 11 V; (t,)=V; (td)-V; (0) and 11 V, (t.,)=V, (t.,)-
Ve (0). As the urea clearance increases, the Vi volume increases and the Ve volume decreases. 
However, the relative changes in size of both compartments because of diflerent rates of urea 
removal are small. The time at which an osmolar equilibrium occurs does change with the 
increasing urea clearance. In Table I 0.2, ~. represents the time of reaching equilibrium (zero 
net osmolar gradient) after starting the dialysis session. lvIodel predictions show for example 
with an urea clearance ofDu=O.139 !lmin, water movement fioom Ve to Vi stops at t(=teq)= 
145th minute and from that time to the end (t=td=240 min.) of the dialysis treatment time 
water removes fi:om Vi to Ve' 
Effect oftreatrn.ent tin1.e on the fluid shift 
\'Ve modeled dialysis sessions in which the same amount of urea and the same amount of 
water are withdrawn in different treatment durations. The urea clearance and ultrafiltration 
flow rate were adjusted so that the dialysis performance index DP= I is obtained and 2.4 liters 
of ultrafilhoation volume is filtered during and at the end of each dialysis session respectively. 
In Figure 10.4, the time courses of the osmolar gradients are shown for DP=l, Cdi,1\'a=140 
rnmolll and Q.=2.4/td during dialysis session from td= 1 to 4 hours. During a dialysis session 
with the longest treatment time, the net (negative) osmolar driving force is the lowest, e.g., the 
rate of fluid shift from Ve to Vi is the slowest with the longest treatment time. The time 
courses of the changes in Ve and Vi due to the net osmolar gradient and ultrafiltration are 
shown in Figure 10.5. It is e\~dent that as the duration of dialysis treatment increases, the size 
of trans cellular fluid shift decreases, noting that a zero 01' relatively more positive net osmolar 
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gradient is achieved earlier in short than in long duration of dialysis treatment. In Table 10.3, 
the relative changes in Vi and in Ve at the end of each dialysis session are listed for Cdi,.,\,a= 140 
mmolll, VUF=2.41, DP=I, V,(O)=28/ and V,(O)=16.41. From both Table 10.3 and Figure 
10.5 it can be seen that the magnitude of water shift from Ve to Vi is relatively small. This 
magnitude becomes smaller with longer duration of dialysis treatment and smaller dialysis 
performance index, namely with slower dialysis. The shorter the dialysis duration, the longer 
time is needed to achieve osmolar equilibrium. 
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Figure 10.4: Changes in nonurea, urea and net transcellular osmolar driving 
force 80sm. in time for modeled dialysis sessions from I to 4 hours. 
Table 10.3: The relative changes in V" dV,(t.,)=V,(I.,)-V,(O) and in V" 
d V,(t.,)=V,(t.,)-V,(O) as a result of varying treatment times with a fixed DP= 1. 
td Do Os a V,(ld)/V,(O) a V,(t.)/V,(O) teq. [min] after 
[minutes] [ml/min] [mllminJ [%J [%J start 
60 740 40 1.4 -17.03 49.9 
90 493.3 26.7 1.27 -16.80 64.8 
120 370 20 1.12 -16.54 80 
150 296 16 1.0 -16.34 97.5 
180 246.7 13.3 0.91 -16.19 116.8 
210 211.4 11.4 0.84 -16.07 137.3 
240 185 10 0.79 -15.98 158.5 
In Figure 10.6, the magnihlde of fluid shift from Veto Vi is shown in relation to varying 
dialysis duration and dialysis performance index. Dialyzing the patient in the shortest duration 
of treatment \\~th obtainable highest urea clearance results in the greatest magnitude of fluid 
shift. 
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Figure 10.5: Time courses of changes in 1:1 Vi and 1:1 V t • The dashed lines represent the 
postdialysis values of 1:1 Vi and 1:1 V€. 
Figure 10.6: Fluid shift at the end of dialysis sessions modeled for I to 8 hours at different values 
ofDP= Dot,lVo with Vo = 44.41. 
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Effect of dialysate sodiuJU concentration on fluid shift 
The main effect of sodium in dialysis therapy is the regulation of the water distribution 
between the intra- and extracellular space. To demonstrate the effect of dialysate sodium 
concentration on the transcellular fluid shift, we simulated dialysis schedules for a 4 hours 
treatment, keeping the rate (Q-=:O.OI IImin) and amount (\'UF = 2.41) of ultrafiltration and 
urea clearance (D1l::: O.185l!min) constant and varying the dialysate Na+ concentration 
(Cdi,l\·J fi'om 120 to 150 mmolll. In Figures ID.7a and IO.7b time courses of the osmolar 
gradients areshown. 
From the time courses of the transccllular urea, nonurea and net osmolar gradients in Figures 
10.7a and lO.7b, it is evident that an increased Na+ concentration leads to an increased 
non urea (positive) osmolar gradient while the urea (negative) osmolar gradicnt was almost 
unchanged. An increascd sodium concentration in the dialysate fluid leads to an incrcased nct 
osmolar gradicn~, but in the early hours or minutes of dialysis treatment this net osmolar 
gradient is more negative at low than at high dialysate sodium concentration. Not only the 
size of non urea osmolar gradient is increased \\~th increasing values ofNa + concentration, but 
also the time necessary for equilibrium (teq) is shortened. A zero or relatively more positive 
net osmolar gradient is achieved earlier with a high than with a low dialysate Na + 
concentration. 
The time courses of the changes due to val)'ing dialysate Na + concentration in the fluid shift 
are shown in Figure 10.B. Lower dialysate sodium concentration results in much larger 
transcellular volume shift from VI.' to Vi while higher dialysate sodium concentration show 
reversal with shift occurring from Vi to VeIn Table lOA, the relative changes in Vi and in V .. 
due to varying dialysate sodium concentration are listed. Up to almost Cdi,i\'a=140 mmolll, 
the fluid shift occurs from V .. to Vi' The equilibrium time is sensitive to the dialysate Na+ 
concentration. The higher the dialysate sodium concentration, the shorter the equilibrium 
time is. It is evident that in the veIl' early minutes of treatment, lesser amount of fluid is shifted 
from Ve and to Vi at higher than at lower concentration of dialysate sodium, therefore 
relatively lesser time is nceded to diminish the fluid shift. ',Vith highest Cdi ,L\'3' where the size 
of water shift from Ve to Vi reaches its minimal value, the shortest time is needed to refill the 
Ve compartment. This may indicatc that with high dialysatc sodium concentration water is 
shiftcd carlier fi'om interstitium to Vi than from plasma volume to Vi' The lower the dialysate 
sodium concentration, thc lower the rate of refilling the Ve compartment. For example with 
this particular setting of modeled dialysis session, if Cdi,Xa= 120 mmoll1, one deals with an 
insufficient refill. As thc amount of water shifted from Ve to Vi together with the amount of 
watcr withdrawn from Ve to the dialyzer outlet reaches its maximal value at the end of 
treatment, the maximal size of dccrease in plasma volume is reached. 
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A fluid shift from the interstitium toward the intravascular space fanns the only compensator)' 
mechanism to overcome or diminish hypovolemia. It is evident that dialysate sodium with 
high concentration prevents the fluid shift from Ve to Vi and further improves it fi'om Vi to V ~ 
Table 10.4: The relative changes in Vi and in V", at the end of dialysis session due 
to the changes in the dialysate sodium concentration. td=4 h, QrO.Olllmin. 
Cdj"...-" 11 V;(tdJ/V;(0) II V,(t.,j/V,(O) t~. [min] 
[mmol/l) [%] [%] after start 
120 6.90 ·26.42 insuflicient 
125 5.35 ·23.76 insufficient 
130 3.81 -21.13 insufficient 
135 2.29 ·18.54 insufficient 
140 0.79 ·15.98 149 
142 0.19 ·14.97 62 
144 ·0.39 ·13.96 44 
145 ·0.69 -13.46 39 
146 ·0.98 ·12.96 36 
148 ·1.56 ·11.97 30 
150 -2.14 -10.98 26 
Hypotension is morc likely to occur with lower dialysate sodium concentration. lfthe dialysate 
sodium concentration is lower than the plasma sodium concentration, the effects of osmotic 
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transcellular fluid shift consequent on the removal of urea will be exaggerated because the 
plasma will become even hypoosmolar relative to the cells as the result of movement of 
sodium from plasma to dialysate compartment. A high dialysate sodium concentration is, 
therefore, particularly important at the beginning of dialysis treahnent when osmolar gradient 
between Vi and V .. compartments is greatest as is shown in Figures IO.7a and 10.7b. 
Consequently, a high plasma sodium concentration will counterbalance the effects of 
transcellular fluid shift. As can be seen from Figure 10. 7b, the sodium concentration may 
better be decreased slowly towards the end of dialysis, by taking care of time which is 
necessary for the refill. After being reached a critical rate of sufficient refilling, the sodium 
concentration may later be increased again. But administration of too high sodium 
concentration may lead to an excessive water intake as a result of thirst, which may cause 
further problems for the next dialysis sessions. 
Effect of ultrafiltration on the fluid shift 
During the course of a single dialysis session of 3-4 hours, an ultrafiltration volume in 
magnitude equal to the entire plasma volume (several liters of fluid) are removed by 
ultrafiltration. The eflects of the amount of ultrafiltration or flow rate on the fluid shift were 
investigated by simulating dialysis sessions of 4 hours. Hereby the urea dialysance was fixed 
to 0.185 lim in and the ultrafiltration flow rates were varied from a to 0.04- J/min. The 
postdialysis volume of ultrafiltration was modeled 2.'} liters ultrafiltrate per 0.01 mlimin (9.6 
liters ultrafiltrate with QrO.O'} IImin). Further, the Cdi,O\'a was fixed to 120 mmolll for low, 
140 mmolll for normal and 150 mmolll for high dialysate sodium concentration. In Figures 
IO.ga, 1O.9b and 10.gc, the effect of varying ultrafiltration flow rate on the changes of 
nonurea, urea and net transcellular osmolar gradient is shown for high, normal and low 
dialysate sodium concentration respectively. The time courses of the changes in both Vi and 
Ve, due to vatying ultrafiltration flow rates are shown in Figures 10.lOa, 1O.10b and 10.lOe 
for high, normal and low dialysate sodium concentration respectively. ,,\lith high and normal 
dialysate sodium concentration, ultrafiltration has effect on the urea gradient in the early 
hours and on the nonurea gradient in the late hours of treatment. In the first hour of 
treatment, the nonurea gradients were almost unchanged. ,,\lith the low dialysate 
concentration, the nonurea osmolar gradient decreases in the early minutes and increases 
again within the first half hour. As the magnitude of osmolar urea gradient decreases with the 
increasing rate of ultrafiltration flow, the osmolar nonurea gradient increases in the opposite 
direction. The relative change in the magnitude of osmolar urea gradient with increasing 
ultrafiltration flow rate did not alter with the dialysate sodium concentration. The equilibrium 
time is also sensitive to the ultrafiltration flow rate. The higher the rate of ultrafiltration flow, 
the shorter the equilibrium time is. It is evident that the equilibrium time is shorter with 
higher dialysate sodium concentration. 
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Figure IO.9c: Effect of ultrafiltration flow rate on the transcellular osmolar gradients at low 
dialysate sodium concentration Cdi,N,,;::; 120 mmol/I. 
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sodium concentration C di•N, = 140 mmol!1. 
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Figure lO.10e: Em~ct of ultrafiltration on the fluid shift at normal dialysate sodium 
concentration Cdi,l\'a:::: 120 mmolli. 
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Table 10.5: The relative changes in ViI Vt'l arterial hematocrit Bta. or plasma 
protein concentration Cpa.1 and oncotic pressure IIp. Dialysis duration td=4h. 
tl.Htjt,J=Ht.(O)-I-It,(td), tl.ITp(t,J=f4(O)- f4(t,J with 1-lt.(0)=0.3 and C p.(0)=70 gil, 
ITp(0)=25.63 mmI-Ig 
Q, II V,(I,l/V,(O) II V,(I,)/V,(O) IIHI.(I,)/HI,(O) 1III,(I,)/II,(o) to,!. [min] after 
[l/min] [%J [%J [%J [%J staft 
Dialysate sodium concentration CdI,I\l= 140 01010111 
0 1.48 -2.52 2.59 4.04 insuHicient 
0.01 0.79 -15.98 19.02 31.91 149 
0.02 -0.09 -29.12 41.08 75.65 62 
0.03 -1.25 -41. 77 71.74 149.77 44 
0.04 -2.96 -53.49 115.01 284.51 36 
Dialysate sodium concentration Cdi.I\l= 120 mmolll 
0 8.11 -13.85 16.08 26.65 insuflicient 
0.01 6.9 -26.42 35.91 64.71 insuHicient 
0.02 5.4 -38.48 62.56 125.83 insuHicient 
0.03 3.4 -49.77 99.07 230.46 202 
0.04 0.47 -59.33 145.89 405.08 139 
Dialysate sodium concentration Cd;,I\l= 150 mmol/l 
0 -1.65 2.82 -2.74 -4.19 28 
0.01 -2.14 -10.98 12.34 20.13 25 
0.02 -2.77 -24.55 32.53 57.79 23 
0.03 -3.61 -37.73 60.59 120.89 21 
0.04 -4.88 -50.21 100.83 236.15 18 
In Table 10.5, the relative changes in ViI Vt'l arterial hematocrit Hta. or plasrna protein 
concentration Cpal and the colloid osmotic pressure IIp due to vmying rates of ultrafiltration 
are listed for high, normal and low dialysate sodium concentration. "Vith high dialysate 
sodium concentration, the fluid shift occurs fi'om Vi to Vt" The size of this fluid shift from Vi 
to Vt' increases as the ultrafiltration flow rates increase. At the same time the intracellular 
volume decreases more with the higher ultrafiltration flow rates. At zero ultrafiltration, 
however, fluid shift occurs fi'om Vi to Ve due to high sodium concentration in the plasma. At 
low dialysate sodium concentration, fluid shift occurs from Ve to Vi . Higher ultrafiltration 
flow rates result in more decrease in the size oflluid shift from Ve to Vi on one side and more 
decrease in the plasma volume on the other side. 'Vith a normal dialysate sodium 
concentration, the fluid shift occurs fi'om Ve to Vi at zero ultrafiltration and at a rate of 0.0 I 
IImin. At even larger ultrafiltration flow rates, the fluid shift occurs in the reverse direction. 
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Arterial hematocrit, plasma protein concentration and oncotic (calculated according to 
eq.(3.20), Landis-Pappenheimer fomlUla) pressure increase as the ultrafiltration flow rate rises. 
Our simul~tions showed that the removal of 2.4 I of ultrafiltrate over a 4 hours of period 
causes about 16% decrease 'in the extracellular volume with normal, II % with high and 26% 
with low dialysate sodium concentration. In spite of a relative decrease up to above 50% in 
Vel sessions with the ultrafiltration flow rates higher than 0.01 IImin may not be tolerated 
because of high levels in the changes of hematocrit and oncotic pressure. Removal of such 
ultrafiltration volumes greater than 2.41 should be better realized with sessions in longer time 
(slow dialysis). 
The hydraulic pressure of the interstitial fluid and the oncotic pressure in the plasma volume 
are important determinants of the rate of change of plasma volume. The interstitial fluid 
hydraulic pressure may decrease and even may become more negative if the interstitial 
volume falls below nonnal. This may further result in a decreased water shift from interstitial 
volume to the vascular volume. On the other hand, as the plasma volume decreases, the 
colloid osmotic pressure increases due to the increased plasma protein concentration retained 
in the plasma volume. According to Starling's law, the transvascular ( and transcellular) 
pressure difference decreases as the colloid osmotic pressure increases [53], which \\~ll result 
in an increased refilling rate of plasma volume by extravascular fluid because of reverse 
osmosis. "When refiHing of the inhoavascular (plasma) compartment by extravascular fluid does 
not keep pace with the rate of ultrafiltration flow, a variety of compensatory mechanisms (as 
acute stimulation of the sympathetic nervous system) come into play to maintain blood 
pressure. 
Our simulations showed that the fluid shift depends on both ultrafiltration flow rate and 
dialysate sodium concentration. For a specific setting of dialysis session of 4 hours with an urea 
clearance ofDu=0.185I1min, we calculated the "critical" dialysate sodium concentrations 
which are necessary for diminishing the fluid shift (zero fluid shift) at different rates of 
ultrafiltration flow. From Figure 10.11, which suggests a control mechanism that could 
account for the limitation of dialysis-induced fluid shift, we derived a correlation between the 
rate of ultrafiltration and the dialysate sodium concentration. In Figure 10.12, these "critical" 
dialysate sodium concentrations are depicted in relation to the ultrafiltration flow rates. It is 
very evident that the higher the dialysate sodium concentration, and the lower the rate of 
ultrafiltration, the smaller the magnitude of fluid shift from Ve to Vi' 
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Figure 10.11: Effect of ultrafiltration flow rate Qr on the changes in 6. Vi at the end (postdialysis) 
of a modeled dialysis session of 4 hours as a function of dillerent dial),sate Na + concentration with 
a fixed urea clearance of 0.185 I/min. 
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Figw'e 10.12: Relation between the rate of ultrafiltration Oow(Qr) and the"cdtical" dial),sate 
Na+concentration (Cdi"".) for minimizing the transcellular fluid shift (See Figure 10.11), for a 
modeled dialysis session of4 hours with a fixed dialyzer urea dialysance ofO.185l!min. 
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110.4 DISCUSSION AND COMMENTS 
Strategies 
In particular the dialysis doctor is interested in the question "How can we prevent the 
conditions which cause a serious fall in the blood pressure during the dialysis ?". This question 
may be fOlU1Ulated as "How and with which means the dialysisMinduced hypotension can be 
prevented?" Further, the follO\\~ng questions may form the basic of understanding the sodium 
and ultrafiltration characteristics towards the improvement of hypotension: 
• How (with which model and measurements) can the transport of urea and sodium be 
accurately predicted during a dialysis treatment? 
How can the sodium concentration be varied in the dialysate fluid during a dialysis 
session? 
• How can the efiect of val)'ing the sodium concenh'ation in the dialysate on the course 
of the body volume and the blood pressure be evaluated? 
rvIany clinical studies have demonstrated the benefits of high sodium concentration in the 
dialysate fluid [3,10,11,12], But, it is still not clear, in which measure and to which pattern the 
sodium concentration has to be administered. In the recent literature, there are lot of 
examples of different patterns of varying high and low rate of ultrafiltration and sodium 
concentrations which might be optimal for the individual patients [21,40-48]. 
Examples of difierent strategies of sodium administrations are according to De Vries et al 
(49): 
1. normal sodium concentration of 140 mmoI/l, 
2. sodium concentration profile between 140 and 150 mmaI/l, 
3. sodium concentration profile (140-150) and ultrafiltration flow profile from high to 
low rates. 
according to Raja et al [50): 
1. constant ultrafiltration flow rate and constant dialysate sodium concentration (140 
01010111), 
2. sequentially decreasing ultrafiltration flow rates (500/oJ 30% and 20% in the first, 
second and third hour of treatment) and constant dialysate sodium concentration, 
3. sequentially decreasing ultrafiltration flow rates (500/0, 30% and 20% in the first, 
second and third hour of treatment) and sequentially decreasing dialysate sodium 
concentration (from 150 to 140 mmoI/I), 
and according to Acchiardo et al [51] for high-flux dial),sis: 
1. constant sodium concentration (140 mmol/l), 
2. linear decreasing sodium concentration 9% (149 mmoI/I), 
3. step drop sodium concentration, 
4. exponential drop sodium concentration, 
with volumetric ultrafiltration control and bicarbonate dialysis fluid. 
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Refining the sodiun1. modeling 
So far, the mathematical description of the mass balance of urea, plasma water and non-urea 
between body fluid volume and dialyzer was based on a 2-pool volume model where the 
plasma volume (PV) and interstitial space were lumped together as a single volume, the so 
called extracellular space. In such models, the transport barriers between interstitium and 
plasma volume such as vascular wall are not taken into account. From a 2-pool model 
considering the plasma volume as one (separate) pool and the rest of body fluid volume as the 
second one, and including transcapillar filtration, Ahrenholz et al [52] was able to calculate 
the time courses for plasma sodium, total protein concentration and hematocrit during 
hemodialysis. However, in this model, the osmotic gradient through the cell-membrane which 
is caused by the decrease of urea concentration was not taken into account. By assuming a 3-
pool model of intracellular volume, interstitial space and plasma volume, we have simulated 
also the sodium and urea kinetic. According to 3-pool model, the plasma volume is taken as 
a single compartment and the trancapillar pressure difference is taken into account so that the 
effect of colloid osmotic pressure and hematocrit on the fluid shift is better modeled. (fhe 
simulation results are not shown). 
Evaluation and atomized controlling the blood volume during a dialysis session 
The predictions may be tested by measuring the osmolality and by determining the exact mass 
balance of both urea and sodium from the hemodialysis patients. The predicted values with 
regard to the mass balance of urea en sodium may be evaluated by an apparatus which can 
measure the exact volumes and by continuous sampling the dialysate fluid. An electronic 
counter may be connected to a balance unit of dialyzing machine and mixing unit of dialysate 
fluid which 6 mllmin in a 2 liters bag is recycled. The diffusive gradient of sodium may be 
determined by measuring the concentrations of sodium ions in plasma water and in the 
dialysate fluid. To measure those concentrations, an ion-selective electrode may be used. 
Further, the technical requirements for sodium modeling are in principle available [54-64]. 
Nowadays, all dialyzing machines offer the possibility of adjusting the mixing~pump to achieve 
different levels of sodium concentration in the dialysate fluid. In the modern machines it is 
also possible to choose a sodium concentration which changes further during the dialysis time 
according to a certain pattern. So, by means of measuring the conductivity of blood or 
dialysate, indirectly the sodium concentration can be measured. The signals representing the 
sodium concentration can then be feed-backed to the mixing-pump of the dialyzing machine. 
Conclusion 
\'Ve analyzed the influence of dialysate sodium concentration, the rate or amount of 
ultrafiltration, dialysis duration and urea clearance on the transcellular fluid shift during 
treatment with modeled dialysis sessions of 1 to 8 hours. The simulation results showed that 
the magnitude of fluid shift fi'om Ve to Vi decreases ,\~th slow dialysis, high sodium 
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concentration in the dialysate fluid, low rate and amount of ultrafiltration and low rates of 
urea removal. Refilling of the intravascular volume is faster at high than at low rates of the 
ultrafiltration flow. To some extend, this reduces the fluid shift from the extracellular into the 
intracellular fluid compartment. Increasing the dialysate sodium concentration has therefore 
the greatest effect on the transcellular fluid shift at low rates of ultrafiltration flow. Use of the 
conventional hemodialysis even with a better sodium modeling is contraindicated for the 
treatment of patients of serious hemodynamic instability. "Vith slow dialysis, the size of fluid 
shift decreases. fi1lanipulating the sodium and ultrafiltration profiles during a long duration 
of treatment (such us CA VHD) is easier than the shorter one. This means that the continuous 
arterio~venous hemodialysis is a good alternative for patients with serious hemodynamic 
instability. 
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10.6 APPENDIX: LISTING OF THE PSIIE MODEL SIMULATION 
Cc,Na TNT Ce,Na' 151.1 {Ve sodium concentration} 
Ce,u TNT C",u' 43.15 {Ve urea concentration} 
C, TNT C' , 151.1 {Vi non urea concentration} 
Cj,u TNT C"w' 43.15 {Vi urea concentration} 
Vo TNT V' , 16.40 {extracellular volume} 
V , TNT V·' , 28.00 {intracellular volume} 
Cd],!':" PAR 140 {dialysate sodium concentration} 
Cpao PAR 70 {plasma protein concentration at t=O} 
Fw PAR 0.927 
DP PAR {dialysis performance index} 
G. PAR 0.083 
Htao PAR 0.3 {arterial hematocrit at t=O} 
Kr PAR 0.1494 
K;-':a PAR 1.846 
Ku PAR 0.800 
Q" PAR 0.2 or 0.3 {arterial blooe! flow rate} 
R PAR 0.00008206 
s PAR 1.0 
G. PAR 0.95 
T PAR 310 {temperature} 
t, PAR 240 {duration of dialysis treatment} 
Vuf PAR 2.4 {ultrafiltration volume} 
V ro PAR 16.4 {extracellular volume at t=O} 
Vio PAR 28 {intracellular volume at t=O} 
aNa VAR 1.007-0.0009·(C"+C,,,,)/2 
CC,l'\a' VAR (D,;(I-Q/Q.}(C".,,-F2)-Q·F2)/V,-V:·C,.,/V, 
c",u 
, VAR (-Ce,u'V (' '+ F3-Vi I,S·Cj,u· F4+Gu)/V" 
G' , VAR (-V;'/V,)-C, 
Ci,u' VAR (-K.IV ,)-(C, .• -Co .• )+(s-I )·C, .• · V;' IV, 
Cr' VAR Cpao'Ve,jV" 
Cpi VAR C,;Q,,'( 1-HtJI (Q,,'( 1-HtJ) 
Cpi VAR Cp;Q,,'( 1-Ht.,)1 (Q,;( 1-HtJ-Q) 
.!IOsm VAR K"·(C""-C,)+G.·(C,,.-C,,J {net osmolar gradient} 
.!IV, VAR V("-Veo {changes in V,} 
.!IV, VAR VrVio {changes in V, = fluid shift} 
DNa VAR D;(1-0.96·Ht,) 
D. VAR DP'Vjtd {urea dialysance} 
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F2 VAR a"'a'Ce-,Na 
F3 VAR K"'(C;,,,-C,,J 
F4 VAR C",,'(D,,'(I-Q/Q,J+Q) 
Hta VAR Hr.,'V ro/V, 
NUgradient VAR KNa'(C",Na-Cj) {nonurea osmolar gradient} 
Q, VAR Q,;(I-O,96'HtJ/F" 
Q VAR Vu/trl {ultrafiltration flow rate} 
Ugradient VAR Ce-,u-Cj,u {urea gradient} 
V' , VAR -W-Q 
v.' , VAR -Kr'R'T'(K"(C"N,-C;)+o,,'(C,,,,-C;,J) 
V , VAR Vio + Veo {patient's volume of urea distribution at::::O} 
INT: integral, PAR: parameter, VAR: variable 
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Chapter 11 
Chapter 1: 
In this chapter, a short historical background and physical principles of continuous arterio~venous 
hcmofiltration (CA VH), intermittent hemodialysis (IHD) and continuous arterio~vcnous hemodia-
filtration (CA VHD) arc viewed. CA VHD was first introduced in the Dijkzigt University Hospital in 
1984 by Van Geelen and Vincent. TIle aims of this thesis are to describe the physical transport 
processes in CA VHD, to investigate the determinants of blood, ultrafiltration and dialysate flow rates 
and their influences on the uraemic solute and drugs clearance during CA VHD, to formulate the 
physical relationships between the hemofilter characteristics and operational quantities, and to access 
the efficac), ofCAVHD compared to intermittent hemodialysis or hemodiafiltration for the treatment 
of patients \\~th hemodynamic instability. 
Chapter 2: 
In this chapter, a short overview is given of the clinical problems encountered \\~th conventional 
intermittent hemodialysis or hemodiafiltration. The indications and contra-indications ofCAVHD are 
outlined. Futther in this chapter, the clinical equipment and the guidelines for priming the hemofilter 
and initiating the CAVHD are reviewed. The most frequent complication is the dialysis-induced 
hypotension. The most important indication of treatment by CA VHD is the combination of renal 
failure and circulatory instability. If the extracorporeal circuit interferes \\~th the mobilization of the 
patient, the CA VHD is contraindicated. 
Chapter 3: 
In this chapter, the results of feasibility of predicting the hemofilter performance arc given. TIle 
feasibility of predicting the hemofilter performance was studied by examining the determinants of 
blood and ultrafiltration flow rates under clinical conditions. In patients who were treated with 
CAVHD, serial measurements of blood flow rate, blood pressure and ultrafiltration rate were 
pel{ormed, so as to determine the hemofilter resistance (Rr) to blood flow and its hydraulic 
permeability index (fiH). Further, we predicted the blood flow rate circulating the extracorporeal 
circuit ofCAVHD from the manufacturer specifications of the circuit components and fi·om the blood 
viscosity in each circuit component depending on patient's arterial hematocrit, plasma protein 
concentration and temperature. During continuous treatments the net ultrafiltrate production was 
measured at least once evel), hour and the substitution infusion rate was adjusted accordingly. 
Observed hemofilter resistance to blood flow was two to three times higher than the predicted value. 
To explain this discrepancy we considered clotting of fibers, underestimation of blood \~scosity, 
htrbulent flow, additional pressure losses due to the sudden changes in the blood path diameter and 
deviations of the internal diameter of the fibers. Comparison of the actual blood viscosity with the 
predicted value showed that blood \~scosity was grossly underestimated. Herewith, part (43%) of the 
discrepancy between measured and predicted values of blood flow rates could be explained. Further 
the discrepancy between the observed and predicted hemofilter resistance could be explained if the 
fiber diameter would be 8-10% less than the value given by the manufacturer (See Chapter 4). \Ve 
observed a logarithmic fall of the ultrafiltration flow rate (Q-) in time. The fall in Q- over time may be 
explained both by changes in the membrane permeability, presumably resulting from protein 
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adsorption to the membrane, and by a fall in the available membrane surface area, e.g. due to 
unsuspected clotting of fibers. Under clinical conditions unsuspected clotting of fibers is unlikely to 
occur during the treatment. Indeed, the hcmofiltcr was clotted just toward the end of the treatment. 
TIlCrcfore, the decrease in membrane permeability with time is more likely to be due to ongoing 
protein adsorption. Estimating the blood flow rate from patients output such as artclio-venous pressure 
difference, protein concentration, hematocrit and hemofilter manufacturer specification, is not reliable 
as far as the hemofilter is concerned. 
Chapter 4: 
This chapter gives the results of resistance to blood flow and membrane permeability index (MI) 
measured in a laboratory setting. In laboratOl)' setting, for some of the CAVH(D) capillmy hemofilters 
the resistance to flow was measured with fluid solutions of diflerent viscosity. The hemofilters were 
perfused with saline, sucrose solution, pig blood and human blood as perfusion fluid. The effect of 
hemofilter resistance on the hydraulic pelfOlmance (ultrafiltration) was investigated by measuring the 
membrane permeability index (1\'II) and the resistance to (human) blood flow simultaneously over a 
survival time of about 220 hours. 
The resistance of the hemofilter, perfuscd with saline or a sucrose solution, was 40% higher than 
expected. Furthermorc, it was to some extent flow dependent, suggesting that turbulence does occur, 
most likel}' at the hcmofiltcr inlet. ''''hen ·we applied Bernouilli's law to estimate the pressure drop that 
results from the sudden changes in diameter at the filter inlet and outlet, we calculated a pressure drop 
offar lcss than 1 mmHg. On the other hand, a 40% increase in resistance would be explained if the 
fiber diameter would be a mere 8·10% lowcr than thc givcn value. "Vith pig blood, the hemofilter 
resistance to blood flow was 156% higher than expected and it seemed no longer flow dependent, 
probabl}' indicating that turbulence is diminished by the higher viscosity of blood. Comparison of the 
actual (pig) blood flow \\~th the value calculated, confirmed our suspicion that we had grossly mcasured 
the pig blood \~scosity \\~th a (Viscomat) viscometer. TIle measured average resistance (Rr) to blood 
flow was 0.16 mmHg/(mllmin) when the hemofilter was pcrfused with human blood. On considering 
a fiber diameter 8·10% less than the manU£'lcturer specification (for the AN·69 capillary hemofilter) 
and using the actual blood viscosity (1.'13 timcs the calculated blood viscosity, see Chapter 3) we 
overestimated the effective blood flow rate by no more than 20%. 'Vith human blood as have observed 
in the clinic, we observcd also a logarithmic fall of the membrane permeability index (MI) in time. 
According to some investigators the hemofilter hydraulic pcrmeability ma}, fall even after contact \\~th 
watcr alone. To our knowledge, however, this finding has not been reproduccd by others. For the AN· 
69 capillary hemofilter we did not observe a fall in hydraulic permeability between 1 and 150 hours 
of saline perfusion. TIle resistance to flow of the hemofilters studied was low enough to ensure an 
adequate blood flow rate in most cases. B)' using laboratory data on thc hemofiltcr resistance and a 
more accurate estimation of blood \~scosit}', a rcasonably accurate prediction of blood flow ratc under 
clinical conditions is feasible. 
Chapter 5: 
In this chapter, a mathematical model of solute and volume transport during CA VHD is introduced. 
Existing models of conventional hemodialysis are not likely to be useful for the analysis of solute 
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transport in CAVHD, since solute transport in CA VHD differs from that in intermittent hemodialysis 
or hemodiafiltration in several respects. The most important differences arc 1) "Vith CAVHD, solute 
transport occurs in the presence of simultaneous diffusion and convection. 2) Dialysate (Qn:::: 10·60 
mllmin) and blood (Q,a=50-3?O mllmin) flow rates are relative low compared to those in conventional 
hemodialysis (Qru=500 mllmin and ~a~200 mllmin). 3} Ultrafiltration flow rate is not negligible 
small (~5-15 ml/min) compared to that in conventional hemodialysis (Q-s5 mllmin) and small 
compared to that in intennittent hemodiafiltration (Qr up to 60 mllmin). 4) CAVIll) is a continuous 
technique. With prolonged use of the hcmofilter, deterioration of the hemofilter membrane is likely 
not only to decrease the rate of ultrafiltration flow, but also to impair diffusive permeability. 
In view of the shortcomings of previous models, we developed a new mathematical model ofCA VHD. 
VYe made the following assumptions: I) All of the hollow fibers in the hemofilter behave as a single 
capillary tube. 2) The permeability coefficients are constant along the hemofilter length. 3) 11le flow 
rates and concentrations are time-independent for a given set of measurements (steady-state). The 
overall solute mass balance is based on the solute flux GJ equation:l=Y J,(fbC".+fdC d}+KJCw-Cd}. This 
model takes into account the local variation of concentration (C) in the blood plasma water and 
dialysate fluid (C,J as well as the concentration inside the membrane (fbC,,+fdC,J in the presence of 
simultaneous diffusive and convective solute transports, depending on the local ultrafiltration volume 
flux profile UJ. In calculating the weighting factors (fb and f,J and the overall diffusive mass transfer 
coefi1cient (K,J, this model requires an estimation of the resistance of blood (Rb), the resistance of 
dialysate (RJ, and the resistance of membrane (Rm= liP J to diffusion and the solute sieving coefficient 
(Y), so as to detennine the solute clearance in CAVHD. Precise values of the resistance to diffusion of 
blood, membrane and dialysate can hardly be obtained from clinical data. Therefore, depending on 
the membrane condition (MI) and the dialysate flow rate (~J the precise values ofRb, Rd and I/Pm 
have to be determined in ill vitro studies. ''''e therefore made some simplifications (See Chapter 6) in 
the modeling of solute transport in CAV'HD, so as to obtain the overall diffusive mass transfer 
coefficient ~) from clinical data at first and then to analyze the resistances Rb, Rd and liP m under 
diner-ent operational and clinical conditions (See Chapter 9). 
Chapter 6: 
In this chapter, analytical solutions to solute and volume transport in CA VHD are presented in order 
to calculate the diffusive mass transfer coefficient (KJ for a solute when blood, filtrate and dialysate 
flow rates and solute concentrations are known. Next to the assumption we made in Chapter 5, we 
made the following major assumptions: 4) The solute concentration in the blood (C) and in the 
dialysate (Cd) are 'mixing-cup' concentrations: in radial direction the solute concentrations in blood 
and dialysate are homogeneously distributed over the respective compartments. 5) The sieving 
coefficient is I (for small solutes such as urea, creatinine and phosphate). Following the assumptions, 
first we made some simplifications of the ultrafiltration volume flux OJ and solute mass flux GJ 
equations. Then, we introduced analytical solutions to solute and volume transport in CA VHD, so as 
to obtain expressions of the overall diftusive mass transfer coefficient, depending on the ultrafiltration 
volume flux profile under the following conditions: Ko for zero ultrafiltration volume flux U,.=O), Ka 
for a constant (mean) volume flux O,.=Ja=Q-/S) and ~ for a linear decreasing volume flux O,.=a+px). 
The relative weighting (convective concentration) factors for blood (fb) and for dialysate (fJ equal 0.5. 
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TIle overall mass transfer coeflicients are derived from the concentration profiles along the length of 
hemofilter. Further we derived expressions of solute clearance in relation to the overall mass transfer 
coefficients KG! Ka and K.r. By virtue of the expressions of the overall mass transfer coefficients related 
to solute clearance, the model is well suited for the analysis of diffusive transport in CA VHD. This 
model can easily be implemented in any spreadsheet. 
Chapter 7: 
In this chapter, the analytical model is applied to clinical data obtained with 0.6 m2 AN-69 capillaly 
hcmofilters. TIlC model equations, governing the overall mass transfer coefiicients (K", Kd and KJ are 
evaluated by applying them to data of urea clearance measurements. 
TIle Ku proved to depend on the dialysate flow rate (Q!.). As the dialysate flow rate rises from 0.5 IIh 
to 3 IIh, the overall mass transfer coeft1cient (KJ increases cUlvilinearly. At a dialysate flow rate of 
about 5 IIh, the Kd reaches a maximal value (Kdmax). The Kumax, obtained by extrapolation, is not 
dependent on ~i' At relative high values of~i and low rates of ultrafiltration flow (Q), the overall 
mass transfer coefficient (K.J becomes equal to the Ko , which is used for the overall mass transfer 
coefficient for a dialyzer in intermittent hemodialysis. At relatively high values of~i and low values 
ofQ-, the solute concentration profiles along the length ofhemofilter seem to be the same as those in 
the conventional hemodialysis. Also, the calculated mass transfer coefficient Kd shows no significant 
differences when the ultrafiltration volume flux is assumed to be constant along the length ofhemofilter 
if no back filtration occurs in the hemofilter. ''''ith a linear decreasing volume flux model, one can 
observe the occurrence of back filtration, which with a constant volume flux model is not possible. Our 
model is a useful addition to the existing models: of hemodiafiltration, especially because it allows 
calculation of the diffusive mass transfer coefficient fi'om the clinical data ofCAVHD. It may be used 
both as a means to further our insight in the determinants of solute transport in CA VHD and to adjust 
clinical settings, e.g. dialysate flow rate, based on the predicted clearance of uraemic solutes. 
ChapterS: 
In this chapter we studied the determinants of uraemic solute clearance in CA VHD. Clearance and 
its diftusive and convective components of uraemic solutes such as urea, creatinine and phosphate were 
determined in the region of relative low dialysate flow rates (QI;) at varying blood (Q,J and ultra-
filtration flow rates (Q-). TIle degree of conditions in which blood-dialysate solute equilibrium can be 
achieved was investigated. TIle diftusive permeability coefficients (K.:::SKJofurea and phosphate were 
related to diffusive permeability coefticient of creatinine. Further, by running a simple sensitivity 
analysis on the overall diffusive permeability coefficient, we analyzed the dependence of~ on the flow 
rates and on the strength of concentration driving force at the blood inlet of the hemofilter. TIle 
sensith~ty anal)'sis pro\~des information about the reliability of predicting the K, from flow rates and 
solute concentrations. 
Urea clearance increases curvilinearly \\~th ultrafiltration and blood flow rates at relative high rates 
of the dialysate flow. TIle convective contribution to urea clearance decreases: (slightly) with the 
increasing rate of the dial),sate flow. The diffusive clearance on the other hand increases with 
increasing rates of the normalized dialysate flow (Qrn/Q-) in a quadratic fOlm. There is a linear relation 
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between the normalized urea clearance (CIIQ-) and the normalized dialysate flow rate (~/Q) for 
Qru/Q-s3. This indicates that the removal of urea is only due to the ultraftltration when blood-dialysate 
equilibrium is achieved. In contrast to the conventional intermittent hemodialysis, in CA VHD an 
excellent dialysate-blood equilibration may he achieved by manipulating the dialysate and ultra-
filtration flow rates for ~/Q-s;3, Results ofaur measurements show a curvilinear increase of the 
diffi.lSivc urea clearance with the increasing values of the overall diffusive permeability (KJ. 'Ine size 
of this increase depends strongly on the dialysate flow rate, noting that the overall diffusive 
permeability coefficient itself depends also on the dialysate flow rate. Under the same operational 
conditions and hemofilter characteristics, the K, of urea is 32% greater and the Ksofphosphate is 25% 
smaller than the K, of creatinine. 'Vi thin the operational limits ofCA VRD, with the upper values of 
Qr20 mllmin and Qrr=60 mllmin, the effect of ultrafiltration on the predicted value of the 
pemleation coefficient is negligible if the condition ~;/Q.~3 is fulfilled. In the region of flows where 
blood-dial}'sate saturation occurs (especially for ~;:o:;3Q), the relative variations in the predicted values 
ofK, are considerably high (up to 35%). On one side, the sensitivity analysis ofK. shows that 
calculating the K, at relative low rates of the dialysate flow in presence of ultrafiltration is not reliable, 
especially near or at complete blood-dialysate equilibrium. On the other side, the relative low rates of 
dialysate flow make the CAVHD unique for the treatment of hemodynamically unstable acute dialysis 
patients. Keeping this controversial fact and the results of this sensitivity analysis in mind, a dialysate 
flow rate at least 3 times the ultrafiltration flow rate is enough to manipulate the solute removal by 
diffusion without considering the ultrafiltration. 
Chapter 9: 
In this chapter we described a numerical computational method for solving the equations governing 
the mass balance in Chapter 5. The method was applied to the clearance data of uraemic solutes and 
some antibiotic drugs up to 1500 Daltons and to the data ofhemofilter hydraulic condition measured 
during CA VHD, so as to determine the relative weighting factors of blood (fb) and dialysate (f.t) solute 
concentrations contributing the convective uraemic solute transport and the resistances (Rb+~ and 
RJ to diffusion Ii-om the overall diffusive mass transfer coefficient (K.J ,\~thin the operational limits of 
CA VRD. Depending on the hemofilter hydraulic condition (J\H) and the dialysate flow rates (QJ, the 
resistance (Rh +~) of blood and membrane and the resistance (RJ of dialysate to diffusion were 
determined b)' 'Vilson's plots. Further, by making use of the capillary pore theory, the diffusive 
permeation coefficients (K,) of some antibiotic drugs were related to that of the creatinine so as to 
predict the clearance of antibiotic drugs from the clearance of creatinine under the same operational 
conditions and hemofilter characteristics (a prediction model). 
Our results show that the length averaged values of factors fb and fd equal 0.5 \\~th a variation of 
maximal 10%, so that the condition "fb=G=O.5u for the validation of analytical model is fulfilled. The 
'Vilson's plots allows us both to determine Rb +~ and Rd separately and to quantify the influence of 
dialysate flow rate on Rd' 11lere is a fixed relation between the ratio of the ~ of drugs to that of 
creatinine and the molecular weight of the drugs: If the Kd of creatinine is known, the Kd of drugs can 
be predicted. 'Illis allows us further to predict the clearance of drugs from the clearance of creatinine. 
Predicting the clearance of drugs from the clearance of creatinine is accurate enough to be used in the 
clinic. 
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Chapter 10: 
In this chapter, we introduced a mathematical simulation model of sodium kinetic. By means of such 
a simulation model, the changes in the concentration of both urea and sodium, the volume, and the 
osmolality in both the intracellular volume (VU and the extracellular volume (Ve) compartments can 
be predicted during modeled dialysis sessions. \'Ve analyzed the influence of dialysate sodium 
concentration, the rate of ultrafiltration flow, dialysis duration and urea clearance on the transcellular 
fluid shift during treatment with modeled dialysis sessions. 
The simulation results show that the magnitude of intercompartmental fluid shift can be minimized 
by keeping either the rate and amount of ultrafiltration flow low or by keeping the sodium 
concentration in the diai)'sate high and either by prolonging the dialysis treatment time ( slow dialysis) 
or by keeping the rate of urea removal low. Refilling of the intravascular volume is faster at high than 
at low rates of the ultrafiltration flow. To some extend, this reduces the fluid shift fiom the extracellular 
into the intracellular fluid compartment. Increasing the dialysate sodium concentration has therefore 
the greatest effect on the transcellular fluid shift at low rates of ultrafiltration flow. Use of the 
conventional hemodialysis even with a better sodium modeling is contraindicated for the treatment 
of patients of serious hemodynamic instability. ""ith slow dialysis, the size of fluid shift decreases. 
~hnipulating the sodium and ultrafiltration profiles during a long duration of treatment (such as 
CA VlID) is easier than the shorter one. 111is means that the continuous arteria-venous hemo-
diafiltration is a good alternative for patients with serious hemodynamic instability. 
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Hoofdstuk I: 
In dit hoofdstuk wordt cell overzicht gegeven van de historische achtergrond en de beginselen van 
continue arterio-vcneuzc hemofiltratic (CAVI-I), intermitterende hemodialyse (IHD) en continue 
artcrio-veneuze hemodiafiltratie (CA VHD). CA VHD is in 1984- gei"ntroduceerd in het Dijkzigt 
Academisch Ziekenhuis te Rotterdam door Van Geclen en Vincent. De doclstcllingen van de 
onderhavige studie zijn de volgende: het beschrijven van de fysische transportverschijnselen in 
CAVHD, het bepalcn van de determinallten van bloed-, dialysaat- en ultrafiltratiestroomsnelheden 
en de invloed daarvan op de klaringssne1hedcn van meum, kreatinine, rosfaat en drugs tijdens 
CA VHD, het afleiden van wiskundige relaties tussen de hemofilter·karakteristieken en opcrationelc 
groothedenJ hc! bcpalen van de eft1cientie van CA VHD vaal' de behandeling van patienten met 
hemodyuamische instabiliteit in vergelijking met intcrmittcrcude hemodialyse of intermitterende 
hcmodiafiltratie. 
Hoofdstuk 2: 
In dit hoofdstuk is ·een kart ovcrzicht gegeven van de problemen zoals die in dc kIinick kuuucn 
ontstaan tijdens de behandeling met convcntionclc intcrmittercnde hcmodialyse ofhemodiafiltratie. 
De indica ties en contra-indica ties van CA VHD zijn samengevat. De kIinische benodigdheden zijn 
opgcsomd en een leidraad is gcgcven voor het gebruik van CAVHD. De meest voarkomende 
complicatie tijdens de dial}'se is de veroorzaakte hypotensie. De belangrijkste indicatie voor de 
behandeling met CA VHD is de combinatie van nierfalen en circlilatoire instabiliteit. CA VHD is 
contra-geindiceerd als het extracorporcle circuit interfereert met de mobilisatic van dc patient. 
Hoofdstuk 3: 
In dit hoofdstuk is de thearetische voorspelling gedaan van de prestatie van het hemofilter. De 
llitvoerbaarheid van continuc tcchnieken zoals CAVH en CA VHD hangt sterk afvan de werking van 
het hemofilter welke kan falen door technische storingen of door te lage bloedstroomsnelheid (Ot,J. 
Lage bloedstroomstcrkte kan leiden tot excessieve hcmoconcentratie welke tot een toename van de 
bloedstromingsweerstand CRr) kan leiden J met aIs gevoIg een snelle stolling van het hemofilter. De 
theoretische voorspelling van de prestatie van het hemofilter is beschreven aan de hand van de 
bloedstroomsnelheid en ultrafiltratiestroomsnelheid (Q) onder kIinische omstandigheden. Voor 
capillaire- en plaathemofilters kan de Rr worden voorspeld met behulp van de wet van Poiseuille en 
de door de fabrikant opgegeven specificaties. De bloed\~scositeit is berekend uit de waarden van het 
arteriele hematocriet, dc ciwitconccntratie en de temperatuur. Om de stromingsweerstand en de 
hydraulische permeabiliteitsindex (MI) van het hemofilter te kunnen bcpalcn zijn bij patienten dic 
werden behandeld met CAVHD metingen uitgevoerd van de bloedstroomsnelheidJ de blocddruk en 
de ultrafiltratiestroomsnelheid. Gedurende continue hemodialysebchandeling van patienten is de netto 
ultrafiltratiestroomsnelheid gemeten over korte tijdsperioden. De infuusstroomsnelheid van de 
vervangcude vloeistof was daarbij ingesteld rekening houdend met het waterverlies van de patient. 
De waargenomen bloedstromingsweerstand was twee tot drie keer hoger dan de theoretisch voorspelde 
waarde. Als mogelijke oorzaken van deze discrepanrie zijn verondersteld: bloedstolling, onderschatting 
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van de bloedviscositeitJ turbulentie in de bloedstroom, extra dntkverliezen in het hemofilter en 
afwijkingen van de interne diameter van de vezels Lo.v. de specificaties. Vergelijking van de gemctcn 
bloeclviscositeit met de voorspelde waarde tconde aan dat de voorspclde bloedviscositeit veel te laag 
is. Een belangrijk dee! (43%) van de discrepantie tussen de waargenomen en de berekende waarde van 
R f kan hiermee worden vcrklaard. Een cicci van de restercude discrepantie zou kunnen worden 
verklaarcl door aan te nemen dat de interne diameter van de capillaire vczels 8-10% lager is dan de 
door de fabrikant opgegeven waarcle (Zie Hoofdstuk 4). De voorspelling van de bloedstroomsnelheid 
uit de gegcvcns van de patient (arterio-veneuze dmJ...·verschil, ei\\~tconcentratie, hematocriet) en uit de 
specificaties van de componenten van het dialyse circuit is niet betrouwbaar gebleken, voor zover dit 
het hemofilter zelf betreft. Ideaal voor een goede voorspelling is de continue meting van de 
bloedstroomsnelheid. Continue meting van <4" is uit te voeren met een echo-Doppler techniek. Helaas 
is deze apparatuur niet beschikbaar voor de routinematige klinische dialyse. Als altematiefis de Q.a 
bepaald door de snelheid te meten van een luchtbelletie dat gei'njecteerd is in de arteriele bloedlijn. 
Zowel Q- als l\H vertonen als functie van de tijd een logaritmisch verloop. De daling van Q- wordt 
veroorzaakt door de daling van de hydraulische permeabiliteit. Deze daling van de hydraufische 
pelmcabiliteit wordt waarschijnlijk veroorLaakt door de oplopende eiwitadhesie op het mcmbraan en 
door de verkleiningvan het membraan oppervlak als gevolg van bloedstolling. Tach was het hemofiltcr 
pas gehed verstopt door bloedstolling tegen het eind van de bchandelingsduur. Daarom is het 
waarschijnlijk dat de daling van MI vcroorzaakt wordt door de toename van ei\\~tadhcsie gedurende 
de behandelingsduur. Een voldoend hoog Q-indiccert dat het systeem goed functioneert. Een te !age 
Q-kan indiceren dat er bloedstolling aan de veneuze zijde van het hemofilter is opgetreden. 'Vanneer 
de Q- onder 200 ml/h is gedaald dan moet het hemofilter worden vervangen. 
Hoofdstuk 4: 
In dit hoofdstuk worden de resultaten gegeven van de ill vitro metingen aan het hemofilter betreffende 
de weerstand (~) en de hydraulische permeahiliteitsindex (MI). In een illllilro opstelling zijn de Rr 
"laarden van enkde CAVH(D) hcmofiltcrs gemcten. Dc hemofilters zijn geperfuseerd met oplossingen 
met verschillende viscositeit, namelijk zoutoplossing, sucroseoplossing, varkensbloed en mensenbloed. 
Het verloop is gemcten van de permeabiliteitindex (AU) en de weerstalld {Rf} van het hemofilter voor 
mensenbloed gedurende de gebruiksduur van ongeveer 220 uren. 
De gemeten wcerstalld (RJ van cen toevoerslang is in overeenstemming met de berekende waarde. Bij 
perfusie met een zout~ of sucroseoplossing is de weerstand ~) van het hemofilter 40% hager dan de 
berekendc waarde. Bovcndien blcek de Rr (eniger mate) afhankelijk te zijn van de stroomsnelheid. 
Velmoedelijk wordt dit veroorzaakt doordat in de bloedstroom bij de bloedingang van het hemofilter 
turbulenties optreden. Dit kan echter niet de enige verklaring zijn voor de grate afwijking met 40%. 
Op grond van de wet van Bernouilli, is uitgerekend hoe groat het drukverlies is bij een vernau"~ng of 
ven\~jding in de diameters van zowe! bloed in- als uitgang van het hemofilter. Het berekende 
dlUkverlies is slechts in de orde van 1 mmHg. Als de diameter van een vezel 8~ 1 0% minder zou zijn 
dan volgens de door de fablikant opgegeven waarde, dan voorspelt dit een grotere weerstand met 40%. 
De ~ van het hemofilter voor varkensbloed was hager dan de Rr voor zout~ of sucroseoplossing. 
Vaal' varkensbloed is de discrepantie tussen de gcmeten en berekende hemofilter weerstand 156%. 
Vermoedelijk is de viscositeit van het varkensbIoed gemeten met een (Viscomat) viscometer in 
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vergelijking met de bloedviscositeit in het hemofilter lager. De Rr Vaal' varkensbloed is niet anlaukelijk 
van de bloedstroomsnelheid zoals Vaal' zout w of sucroseoplossing, waarschijnlijk doordat bij grote 
viscositeit de bloedstroom geen turbulentie vcrtoont. Bij toevoeging van een hogc dosis heparine aan 
het varkensbloed is de stromingsweerstand praktisch gelijk aan die voor mensenbloed zoals bepaald 
in de kliniek. Vaor de gemiddelde weerstand van het hemofilter (ANw69 capillaire hemofilter) 
geperfuseerd met mensenbloed is 0.16 mmHg/(mllmin) gevonden. 'Vanneer l~ wordt berekend nit 
de gegevens van de fabrikant, waarbij rckening wordt gehouden met cen 8-10% kleinere vezel 
diameter en de gemeten bloedviscositeit (die cen factor 1.43 groter is dan de berekende waarde), dan 
wordt de Q,,, nog altijd met 20% overschat, Evenals in de kliniek verliepen in de vitro metingen met 
varkens- en mensenbloed zowcl de Q. als de 1.H logaritmisch dalend in de tijd, Voor het AN-69 
hemofilter is bij perfusie met zoutoplossing gedurende een periode van I tot 150 uren geen 
vermindering van de hydraulische permeabiliteit gevonden, In de meestc gevallen was de Rr van de 
onderzochte hemofilters laag genoeg om een voldoend hoge bloedstroomsnelheid te verkrijgen, 
Uitgaande van de il1 vitro data van de stromingsweerstand en van eell verbeterde predictie van de 
bloedviscositeit is een redelijk nauwkeurige predictie mogelijk van de bloedstroomsnelheid zoals die 
zich bij klinisch gebruik zal voordoen, 
Hoofdstuk 51 
In dit hoofdstuk wordt een mathematisch model voor het massa- en watertransport in CA VHD 
beschreven, De reeds in de literatuur beschreven mode lIen van het massatranspOlt voor intermitteren-
de hemodialyse ofhemodiafiltratie kunnen niet worden gebruikt voor de analyse van het massatrans-
port voor CA VHD, Belangrijke verschiIlen tussen het massatransport bij CA VHD en conventionele 
hemodialyse zijn: I) Bij CAVHD vindt het massatransport plaats door diffusie en convectie, 2) De 
stroomsnelheden van zowel bloed (Q...=50-350 mllmin) als van dialysaat (Q.,,= 10-60 mllmin) zijn laag 
in vergelijking met de stroomsnelheden (Q,i~200 mllmin, ~1=500 mllmin) in conventionele 
hcmodialyse, 3) Bij CA VHD is de stroomsnelheid van ultrafiltratie niet venvaarloosbaar klein (Qr5-
15 ml/min) zoals dat wei het geval is bij conventionele hemodialyse (Qr<5 mllmin) terwijl deze klein 
is in vergelijking met die bij intermitterende hemodiafiltratie (Qr tot 60 ml/min). 4) CA VHD is een 
continue techniek. Door het langdurig gebruik van het membraan, zal, afhankelijk van de hydraulische 
membraan conditie (MI), de ultrafiltratie-stroomsnelheid (Qr) in de tijd afnemen, als ook de 
permeabiliteit voor diffusie. 
Voor het beschrijven van het massa- en watertranport bij CAVHD is een nieuw model ontwikkeld. 
Bierbij zijn de volgende aannamen gedaan: I) T.a.v. transmembraan massatransport gedragen aile 
vezels van het capillaire hemofilter zich als een enkele capillaire buis. 2) Dc permeabiliteit voor zowel 
ultrafiltratie als voor diffusie is over de gehele lengte van het membraan constant. 3) De stroomsnelhe-
den en concentraties zijn constant (steady statc). 
De totale massabalans is gebaseerd op de massaflux (JJ vergelijking:J,=y J(fbC" +f.,C .J+K,,(C,,-C.J. 
Bij dit model wordt rekening gehouden met zowel de lokaal varierende concentraties in het bloed-
plasmawater (C) en in het dialysaat (C,J als ook de concentratie in het membraan (fbC".+fdC,J. Voor 
de berekening van de gewichtsfactoren (fb en ftil en voor de totale massatransfercoefficient (K,J voor 
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diffusie dienen wij enerzijds de afzonderlijke waarden van de weerstanden (Rb. Rm en Rd) tcgen diffusie 
en anden~ijds de "solute" sievingscoefficient (y) te ken nell. De Rbl Rm en Rd staan respcctievelijk voor 
de weerstand van de bloedlaag, het membraan en de dialysaatlaag voor het massatransport door 
ditlusie. De precieze waarden van RbI ~ and Ru kunnen niet uit de klinische data worden verkregen. 
Dc waarden van Rbi Rd and Rm zijn bepaald in in Ml.'() studies op basis van de membraanpclmeabiliteits 
index (fiH) en de dial),saatstroomsnelheid (<2.J;). Eel'st is cen model ont\\~kkeld voor het massa- en 
volume transport bij CA VHD (Hoofdstuk 6) waarbij de tatale massatransportcoetTicient (Kd) kan 
worden bepaald uit de klinisch verkregen data. Later zijn de afzonderlijke waarden van Rb, Rd and Rm 
onder verschillcnde werk~ en klinische condities bepaald (Hoofdstuk 9). 
Hoofdstuk 6: 
In dit hoofdstuk worden analytische oplossingen van het massatransport in CAVIll) gepresentcerd om 
daaruit de massatransportcoeiTicient (K.J voor diffusie te kunnen afleiden op grand van de stroom~ 
snelheden en concentratics in bloed, filtraat en dialysaat. Vaal' dat vercenvoudigde model zijn naast 
de hierboven genoemde aannamen nag de volgende extra aannamen gedaan: 4) De sievingscoefficient 
is I. 5) De berekeningen worden gcbaseerd op lokale "mixing~cup" concentraties voor de concentratie 
in het bloed (C,,) en die in het dialysaat (CJ zodat de radiale gradienten zowel in het bloed als in het 
dialysaat niet in de beschouwing zijn betrokken. Tencinde de difrerentiaalvergelijkingen van het 
massatransport analytisch te kunnen oplossen en om de formules voor Kd te kunnen afleiden zijn de 
volgende condities gedefinieerd: Ko voor (zero) ultrafiltratie volumeflux (dichtheid),J.=O; K,. voar een 
constante (gemiddelde) volumeflux,l. = Ja=Q/S; Kd voor een lineair afhemende volumeflllx,J ,;=a+px. 
De gewichtsfactoren voor de bloedconcentratic (~.) en voor de dialysaatconcentratie (Ct) zijn gelijk aan 
0.5. De coeflicienten (1(.." ~ en KJ zijn afgeleid uit de concentratieprofielcn in de lengte richting van 
het membraan. Verder worden uit de anal},tische oplossingen relaties afgeleid tussen de klaringssnel~ 
heid en de coefficienten.l(", Ken Kd. Het model is geschikt Vaal' de anai}'sc van het massa~ en water~ 
transport in CA VHD en kan gemakkelijk worden ge"implementeerd in een werkblad voor klinisch 
gebruik. 
Hoofdstuk 7: 
In dit hoofdstuk wordt het analytische model toegepast op de klinische gegevens van ureumklaring, 
verkregen met 0.6 m:.l AN~69 capillaire hemofilters. De vergelijkingen, betreffende de coefficienten 
voor diffusie (Ko, Ku en KJ zijn geevalueerd aan de hand van de ureumklaringssnelheden. 
Ku blijkt afhankelijk te zijn van de dialysaatstroomsnelheid (Qu). Het neemt curvilineair toe met de 
toenemende ~; (van 0.5 tot 41/h). De maximale waarde van Kd (dus Kuma.,,) die door de waarde van 
Kd te extrapoleren op ~i= 5 lIh is berekend. is niet langer afiIankelijk van ~;. Bij grotcre ~; is de 
totale permeabiliteit voor diftusie grater doordat de dialysaatweerstand vaal' de ditfusie kleiner is en 
doordat het ctfcctieve diffusie oppervlak grater is. Analyse van Ku toont aan dat bij hoge waardcn van 
Qru en bij lage waarden van de uitrafiItrate~stroomsnelheid (Q), de Kd van een CA VHD hemofilter 
overeenkomt met de.l(" van een dialyzer in conventionele hemodialyse. Bij \vaarden van relatiefhoge 
Qr;. lage Qen lage bloodstroomsnelheid (Q.,i) lijken de concentratieprofielen gelijk aan die bij inter~ 
mitterende hemodialyse. Oak de berekende waardcn van Kd vertonen geen significante verschillen 
indien de :ECu op basis van een constante volumeflux berekend wordt onder de voorwaarde dat er geen 
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Uback filtration" is. ~\'lct cen lineair afnemende volumeflux wordt het optreden van "back filtration" 
uit de volumefluxgrafieken voorspeld. ,"Vij concluderen dat het ontwikkelde model voor CA VHD 
klinisch bruikbaar is. Het maakt de bcrckening mogelijk van de massatransport~ coefficient (Kd) voor 
diffusie uit de klaringsdata onder verschillende klinische condities. Ons model vcrgroat het inzicht in 
de detcnninantcn van het massatransport in CAVHD. Het hiedt de mogelijkheid om de dialysaat- en 
ultrafiltratiestroomsnelheid in te stcllcn voor cen gewcl1ste ureumklaring. 
Hoofdstuk 8: 
Bij tocpassing van CA VHD is de behandelde patient hemodynamisch instabiel. Het is daarom 
belangrijk het ureum- en watcrniveau van de patient onder controle tc houden door een zo laag 
mogelijke ureumklaring (Cl) en ultrafiltratiesnelheid {Qr) in te stellen. In CAVHD vindt het massa-
transport plaats door gelijktijdige difiusie en ultrafiltratie. Het manipuleren van het massatransport 
door diffusie hangt afvan de concentratics aan de beide zijden van het hemofilter membraan en van 
de grootte van de permeabiliteitscoeiTicient ~::::SKJ voor diffUsie van het totale membraan. In de 
voorgaande hoofdstukken is aangetoond dat vaal' manipulatie van het massatransport door diffusie de 
dialysaatstroomsne1heid (QJ de belangrijkste factor is, De <2.J, wordt ingeste1d op basis van het ureum-
niveau van de individuele patient. Toch is vaak niet bekend hoe groot de <2.Ji moet zijn. Volgens 
klinische ervaring met CAVHD is de snelheid van de dialysaatstroom van I lin toereikend am het 
ureumniveau van de patient onder contrale te houden. Bloedstroomsnelheid (Q.,J en ultrafiltratie-
stroomsnelheid (Q) hangen afvan de patient en van het extracorporele circuit. De Qr kan enigszins 
worden ingesteld door de positie van het hemofiltel' ten opzichte van het bed van de patient te 
veranderen. 
In hit hoofdshlk worden de klaringssnelheden van ureum, krcatinine en fosfaat bestudeerd bij relatief 
lage dialysaatstroomsnelheden met varierende bloed- en ultrafiltratie-stroomsnelheid. VerdeI' wordt 
de invloed van Qu, en OJop de afzonderlijke componenten van ureumklaring door convectie en diffusie 
bcschreven. Ook de condities waaronder een I'bloed-dialysaat saturatie" plaats kan vinden, wordt 
beschreven. De pemleabiliteitscoefficienten (K,'s) voor diffusie van diverse toxische stoffen als meum, 
creatinine en fosf..'lat worden bestudeerd. In dit hoofdstuk wordt ook een gevoeligheidsanalyse van K, 
uitgevoerd voor de variaties in de straomsnelheden en de concentratiegradient in het hemofilter. 
Bij relatiefhoge snelheden van de dialysaatstroom (~J neemt de ureumklaringssnelheid curvilineair 
toe met toenemende bloed- en ultrafiltratiestroomsnelheid. :~\ilet cen toename van de dialysaatstroom-
snelheid ten opzichte van de ultrafiltratiestroomsnelheid (Qu/Q-) neemt de diffusiecomponent van 
ureumklaring curvilineair toe terwijl de convectiecomponent van de ureumklaring enigszins afneemt. 
Voor ~/Q-.-:;;3 is er een lineaire relatie tussen de genormaliseerde klaringssnelheid (CI/Q-) en de 
genonnaliseerde dial}'saatstroomsnelheid (~/Q-). Oit toont aan dat, wanneer een bloed-dialysaat 
evenwicht wordt bereikt, de ureumklaring plaatsvindt door aileen ultrafiltratie. Bij trage dialyse kan 
saturatie van bloed-dialysaat optreden, vooral bij waarden van Qru dat lager zijn dan die van Q-. In 
tegenstelling tot conventionele hemodialyse ofhemodiafiltratie kan in CAVHD bloed-dialysaatsatura-
tie worden bereikt door de dialysaatstroomsnelheid rclatief laag te houden ten opzichte van de 
ultrafiltratiestroomsnelheid, Het massatransport door difiusie wordt niet aileen be'invloed door de <2.Ji 
maar ook door de permeabiliteitscoefficient ~) voor diffusie. Onder dezelfde omstandigheden (met 
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cell hemofilterweer stand van 0.24 mmHg/(mllmin}) is de K, voor ureum 32% grater en de ~ voor 
[osfaat 25% kleiner dan de K, voor kreatinine. VoIgens de resultaten van de gevoe1igheidsanalyse is 
het berekenen van de pcrmeabiliteitscoefficient ~) Vaal' diffusie in cen gebied met een relaticflage 
dialysaatstroomsnelheid (~J bij relatiefhoge ultrafiltratie, onbetrouwbaar. Naarmate de Qn ten 
opzichte van ultrafiltratie grater is, des te kleiner zijn de variaties in de 1<,. De relatieflage ~; bij de 
CA VHD maakt dit tot cell unieke behandelingsmethode Vaal' acute nierpatienten die hemodynamisch 
instabiel zijn. Een dialysaatstroomsnclhcid die 3 maal grater is dan de ultrafiltratiestroomsnelheid 
maakt het mogelijk om het massatransport door diffusie te manipuleren zonder dat met Q rekening 
behoeft te worden gehouden. 
Hoofdstuk 9: 
In dit hoofdstuk wordt een numeriek rekenmodel uitgewerkt om de vergelijkingen van massabalans 
in Hoofdstllk 5 op te lossen. Dc massatransportcoelftcienten (Kd'S) van verschillende stoff en (b.v. 
antibiotica tot 1500 Daltons) als ook de gewichtsfactoren fb van bloed- en fd van dialysaatconcentratie 
zijn berekend uit de klinisch verkregen data. De massatransportcoefficient voor diffusie (K,J is 
gerelatccrd aan de mcmbraanpenneabiliteitsindex (MI) en aan de dialysaatstroomsnelheid (~J. 
VervoIgens zijn de relatieve bijdragen van het membraan (RJ, het bloed (RJ en het dialysaat (RJ aan 
de totale weerstand (1/K,J in afhankelijkheid van de diffusie berekend. Aan de hand van de 
zogenaamde "Vilson-pIots zijn de weerstandswaarde Rb +R.., en de weerstand Rd afzonderlijk bepaald 
en is de invloed van ~i op Rd gekwantificeerd. 
Binnen de grenzen van praktische waarden bij CA VHD wijken de gewichtsfactoren (fb en f.J maximaal 
10% van hun gestelde waarde 0.5 af. Daarmee is de conditie ttfb;::;fd;::;0.511 voor de analytische model-
benadering gerechtvaardigd. Er blijkt een relatie te bestaan tussen de verhouding van de Kd van een 
antibioticllm ten opzichte van de Kd van kreatinine en de verhouding van het molecuulge\\~cht van 
het antibioticum ten opzichte van het molecuulge, .. ~cht van kreatinine. Als de Kd van kreatinine 
bekend is, dan kllnnen de waarden van de Kd van verschillende antibiotica dus worden voorspeld. 
Vervolgens kunnen de klaringssnelheden van de antibiotica worden voorspeld. Het gebruik van de 
voorspellingsformule van de Kd van kreatinine tesamen met de verhouding van de Kd van het 
antibioticum t.o.v. de Kd van kreatinine, levert een klinisch goed bruikbare voorspelling van de 
klaringssnelheden van de antibiotica op. 
Hoofdstuk 10. 
Hypotensie is eell van de meest voorkomende complicaties tijdens intermitterende hemodialyse of 
hemodiafiltratie. Een belangrijke factor bij het ontstaan van hypotensie is de daling van het plasma-
volume dat door zowel ultrafiltratie als door de ondervulling van het intravasculaire volume wordt 
veroorzaakt. De ondervulling van het intravasculaire volume wordt veroorzaakt door een 
waterverschuiving nit het extracellulaire compartiment naar het intracellulaire compartiment. In dit 
hoofdstuk wordt een model beschreven voor het efiect van natriumbehandeling op de waterverschui-
\~ng. Door simulatie met het model kunnen de tijdsveranderingen in volumes en concentraties, zowel 
van natrium als van meum en de osmolaire gradienten in zowcl extracellulaire als intracellulaire 
compartimenten worden gevolgd. l\'let dit simulatiemodel wordt de invloed van de natriumconcentra-
tie in het dialysaat, de ultrafiltratiestroomsnelheid, de klaringssnelheid van ureum en de dialyse 
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behandelingsduur op de intercompartimentele waterverschuiving onderzocht. 
Bij hoge ultrafiltratiesne1heid ont8taat een snellere "refilling" van het intravasculair compartiment, 
waardoor de waterverschuiving naal' intracellulair al enigszins wordt beperkt. Verhoging van de 
natriumconccntratie in het dialysaat hecft dam"om bij cell lage ultrafiltratiesnelheid grate invloed op 
de transcellulaire waterverschuiving. Resultaten met het simulatiemodel tOllen aan cIat de door de 
diai}'se veroorzaakte intercompartimcntele watcrverschuiving kan worden geminimaliseerd door de 
ultrafiltratiestroomsnelheid laag of de natriumconcentratie in het dialysaat haag Ie houden en door 
de dialyse behandelingsduur te verlengen of de ureumklaringssne1heid te verlagen. De conventione1e 
intennitterende hemodialyse en intermitterende hemodiafiltratie worden contra-geYndiceerd als de 
patient hemodynamisch instabiel is. Door de dialyse behande1ingsduur te verlengen ("slow dialysis") 
ncemt de grootte van de \vaterverschuiving af. Om een gewenst profiel tc handhaven is het 
manipuleren van de natriumconccntratie in het dialysaat en de ultrafiltratiesne1heid gemakkelijker bij 
cen lange (zoals in CA VHD) dan bij een korte dialyse behandelingsduur. Dit betekent dat CA VHD 
een goed alternatiefis voor de behandcling van paticnten met hemodynamische instabiliteit voor de 
intermitterende hemodialyse ofhemodiafiltratie. 
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Symbol Explanation 
ARF acute renal failure 
BWG 
BUN 
CAVH 
CAVHD 
Cd 
C", 
Cd, 
C, 
CI 
CI, 
Clc 
Cld 
Cdi,Na 
C,ji,u 
Cdo,i\'a 
Cdo,u 
CID 
C",ll 
CO'"",:!. 
C, 
Cj,u 
Cm 
Cmd 
Cp 
Cp, 
Cpi 
Cpl 
Cpm 
Cpo 
CI'" 
CRF 
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body weight-gain 
blood urea nitrogen 
continuous arteria-venous hemofiltration 
continuous arteria-venous hemodiafiltration 
local solute concentration in dialysate compartment 
solute concentration at dialysate inlet 
solute concentration at dialysate outlet 
solute concentration in ultra filtrate 
solute clearance in general 
convective component of solute clearance in CA VHD 
convective contribution to solute clearance in hemodialysis 
diffusive component of solute clearance in CA VHD 
sodium concentration at the dialysate inlet 
urea concentration at the dialysate inlet 
sodium concentration at the dialysate outlet 
urea concentration at the dialysate outlet 
pure diffusive clearance in the absence of ultrafiltration 
extracellular urea concentration 
extracellular sodium concentration 
intracellular nonurea solute concentration 
intracellular urea concentration 
eflective local solute concentration describing the convective 
contribution to total solute flux ( in membrane) 
local solute concentration at membrane-dialysate interface 
local concentration of plasma proteins 
concentration of arterial plasma proteins 
blood inlet concentration of plasma proteins 
solute concentration in arterial blood plasma 
mean concentration of plasma proteins 
normalized plasma protein concentration 
blood outlet concentration of plasma proteins 
chronic renal failure 
local solute concentration in blood plasma water 
solute concentration in plasma water at blood inlet 
local solute concentration in plasma water at 
blood-membrane interface 
solute concentration in plasma water at blood outlet 
Units 
0] or [Kg] 
[nunolll] 
[mmolll] 
[mmDIII] 
[mmolll] 
[mllmin] 
[mllmin] 
[mllmin] 
[mllmin] 
[mmolll] 
[mmolll] 
[mmolll] 
[mmolll] 
[mllmin] 
[mmolll] 
[mmolll] 
[mmolll] 
[mmolll] 
[mmolll] 
[mmolll] 
[g/dl] 
[g/dl] 
[g/dl] 
[mmolll] 
[g/dl] 
[g/dl] 
[g/dl] 
[nunolll] 
[mmolll] 
[mmol/l] 
[mmolll] 
Symbol 
d 
d~ 
d" 
do< 
db 
dd 
dm 
d," 
ci" 
D 
Db 
Dd 
dr 
d, 
D, 
DNa 
dm 
Dm 
DP 
e,. 
f 
fb 
fd 
If 
Fw 
G, 
h 
h", 
he 
HD 
Ht 
H~ 
Ht, 
Ht, 
IHD 
Abbreviations 
Explanation 
internal diameter of any segment of the CA VI-ID circuit 
internal diameter of arterial access (catheter + tubing) 
internal diaineter of arterial access catheter 
internal diameter of arterial access tubing 
thickness of blood concentration boundalY layer 
thickness of dialysate concentration boundal)' layer 
thickness of membrane 
internal diameter of venous catheter 
internal diameter of venous tubing 
Units 
[m) 
[m) 
[m) 
[m) 
[)lm) 
[)1m) 
[}tm) 
[m) 
[m) 
free diffusion coefficient in water [m2/min] 
effective diffusion coefficient in blood [m2/min] 
effective diffusion coefficient in dialysate [m2/min] 
internal diameter of a fiber (J..tm] 
internal diameter of the segment (i) of any circuit element [m] 
urea dialysance (clearance) [llmin) or [mil min) 
sodium dialysance Ulmin) or [mil min) 
thickness of membrane or fiber wall [}tm] 
effective diffusion coefficient in membrane 
dialysis (dialyzer) performance index 
diameter of venous access (tubing + catheter) 
differential length 
differential time 
friction loss factor 
fractional volume distribution of solute in blood cells 
[m'/min) 
[m) 
[m) 
[min) or Um) 
weighting factor of solute concentration in blood to convective transport 
weighting factor of solute concentration in dialysate to convective transport 
friction factor 
correction factor for plasma water 
urea generation rate 
slope, variation coefficient 
blood channel half-height 
height of fluid column in ultrafiltration line 
conventional hemodialysis 
local hematocrit 
arterial hematocrit 
hematocrit at blood inlet 
hematocrit at blood outlet 
Intermittent hemodialysis 
[mmollmin) 
[m) 
[em) 
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J, 
J, 
J,. 
K, 
Kd 
K,k 
Kdmax 
L" 
L" 
MAP 
MI 
MVP 
MW 
n 
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Explanation Units 
mean (constant) ultrafiltration volume flux (density) [}tm/min] 
local transmembrane solute flux (density) [pmol/(min-m')] 
local ultrafiltration or transmembrane volume flux (density) [}tm/min] 
overall mass transfer coefficient for a constant volume flux !}tm/min] 
overall mass transfer coefficient or effective diffusive permeability [}tm/min] 
overall mass transfer coefficient for creatinine !}tIll/min] 
maximum value of the overall mass transfer coefficient 
whole body ultrafiltration coefficient 
overall mass transfer coefilcient for J" :::: 0 
diffusive permeability coefficient or index:::: SKu 
urea transcellular diffusion coefficient 
length of any CA VHD circuit element 
length of arterial access components 
length of arterial access catheter 
length of arterial access tubing 
effective length of blood channels 
effective length ofhemofilter 
length of i-th segment of extracorporeal circuit 
membrane hydraulic permeability 
length of venous access (tubing + cathetel] 
length of venous access catheter 
length of venous access tubing 
mean arterial blood pressure 
hydraulic permeability index 
mean venous blood pressure 
molecular weight 
number of measurements or number of data points 
number of fibers 
number of blood channels 
[pm/min] 
V·Atm/mmoIOK] 
(fun/min] 
[ml/min] 
[ml/min] 
[m] 
[m] 
[m] 
[m] 
[m] 
[m] 
[m] 
[ ~m/(milrmmHg)] 
[m] 
[m] 
[m] 
[mmHg] 
[ml/(h·mmHg)] 
[mmHg] 
[Daltons] 
local hydrostatic or hydraulic pressure in blood compartment 
eficctive blood pressure in blood compartment 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
prefilter hydrostatic or hydraulic blood pressure 
postfilter hydrostatic or hydraulic pressure 
(average or mean) hydrostatic pressure on dialysate compartment 
dialysate pressure at dialysate inlet 
dialysate pressure at dialysate outlet 
intra-arterial blood pressure 
intra-venous blood pressure 
Symbol 
~rcd 
R 
R' 
I' 
1', 
Abbreviations 
Explanation 
diffusive solute permeability of membrane 
local blood flow rate 
measured arterial blood flow rate 
eflective blood flow rate circulating hemofilter 
blood flow rate at blood inlet = (I-HtJQ"+Q",,d 
blood flow rate at blood outlet = (I-HtjQ"+Q",,d-Q, 
local dialysate flow rate 
flow rate of dialysate at dialysate inlet 
flow rate of dialysate at dialysate outlet =: ~i+Qr 
flow rate of drug administration 
flow rate of desired fluid loss 
(net) flow rate of ultra filtrate 
flow rate of heparin administration 
discriminant 
dummy flow rate (= Q"i for k=1 and = Q"o for k=2) 
flow rate of substitution fluid (predilution) 
flow rate of urine loss 
local flow rate of plasma water 
plasma water flow rate at blood inlet 
plasma water flow rate at blood outlet::: Q,i-Qr 
gas constant 
square of the sum of residues 
measured resistance of arterial access to blood flow 
predicted resistance of arterial access to blood flow 
resistance of blood boundaty layer to diffusion 
resistance of dialysate boundary layer to diffusion 
radial coordinate 
inner radius of fiber 
molecular radius of creatinine 
Reynold number 
measured resistance ofhemofilter to blood flow 
predicted resistance ofhemofiltel' to blood flow 
resistance to blood flow of i-th segment of 
extracorporeal circuit 
molecular radius 
resistance of membrane to diffusion = l/P m 
normalized resistance of arterial access to blood flow 
normalized resistance of venous access to blood flow 
Units 
(flm/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/h] 
[ml/h] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/min] 
[ml/h] 
[ml/min] 
[ml/min] 
[ml/min] 
[mmHg'min/ml] 
[mmHg'min/ml] 
[min/~m] 
[min/pm] 
[m] 
(flm] 
[A] 
[mmHg'min/ml] 
[mmHg'min/ml] 
[mmHg'min/ml] 
[A] 
[min/~m] 
[lOs/ml] 
[IOS/ml] 
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SY'uboi 
Rn,f 
Rn,i 
rp 
R"p 
R, 
R,d 
R",p 
R" 
s 
to 
t,q 
T 
TI\'IP 
TMP; 
TMPm 
v , 
V m 
VUI' 
II' 
x 
)' 
Greek letters 
a 
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Explanation Units 
normalized resistance of hcmofilter to blood flow [10' Iml] 
normalized resistance of segment (i) of dialysis circuit to blood flow [105 Iml] 
radius of membrane pore [A] 
predicted total resistance to blood flow 
measured total resistance to blood flow 
total resistance to diffusion:;::: l/Ku 
predicted resistance of venous access to blood flow 
measured resistance of venous access to blood flow 
urea transcellular sieving coefficient 
effective surface area ofhemofilter 
cross sectional area of wide part of a circuit element 
overall permeation coefficient for a constantlv=Ja :;::: Q/S 
overall permeation coefficient for]\, :;::: ct+px 
overall permeation coefficient forJ.:::: 0 
cross sectional area of narrow part of a circuit element 
treatment time 
duration of dialysis treatment 
equilibrium time 
temperature 
local transmembrane pressure diHerencc or gradient 
transmembrane pressure difference at blood inlet 
mean transmembrane pressure difference 
friction loss factor 
intracellular volume 
extracellular volume 
predialysis patient's volume distribution of urea (at t::::O) 
average longitudinal fluid velocity 
ultrafiltration volume 
membrane width (= SILl 
blood channel width 
axial coordinate or position of hemofilter 01' dialyzer 
dummy length variable or function 
ultrafiltration volume flux at blood inlet 
ratio of measured to the predicted resistance to blood flow 
Donnan factor (ratio) for dialyzer plasma water sodium 
[mmHg'min/ml] 
[mmHg'min/ml] 
[min/~m] 
[mmHg-min/ml] 
[mmHg-min/ml] 
[m~ 
[m~ 
[ml/min] 
[ml/min] 
[ml/min] 
[m~ 
[hour (h, hrl] 
[hour (h, hrl] 
[min]_ or [h] 
[OCeisius] 
[mmHg] 
[mmHg] 
[mmHg] 
~] 
m 
m 
[m/s] 
~] 
[m] 
[m] 
[m] 
IFm/min] 
Symbol 
p 
y 
Lillp 
LiIIp(ld) 
Lie 
LiHI, 
LiHt,(td) 
LiK, 
LiK,/K, 
liM 
dosl11. 
liP 
liP, 
oP,' 
liP,' 
oPd 
LiPd 
ilX 
LiV, 
Li V,(td) 
LiV, 
Li V,(ld) 
Lix 
Abbreviations 
Explanation 
slope or dummy variable 
apparent sieving coef}1cicnt 
change in oncotic pressure 
postdialysis change in oncotic pressure 
local concentration gradient;::: Cw - Cd 
change in arterial hematocrit 
post dialysis change in arterial hematocrit 
variation, error in ~ 
relative variation of K, or relative error in K~ 
difference in mass transfer rate at blood inlet 
net osmolar gradient 
pressure loss 
pressure drop in blood compartment 
total pressure drop in blood compartment per unit length 
total pressure drop in blood compartment 
pressure drop in dialysate compartment per unit length 
pressure drop in dialysate compartment 
variation, errol' in X (X=Q., Q,;, ClJi) C"i! Cdo) 
change in V~ 
postdialysis change in V~ 
fluid shift, change in Vi 
postdial),sis fluid shifl 
diflerence length 
blood viscosity in arterial access 
local blood viscosity 
blood viscosity at blood inlet 
blood viscosity at blood outlet 
local dialysate viscosity 
blood viscosity of i-th segment of extl'acorporeal circuit 
local plasma viscosity 
normal plasma viscosity::: 1.54xlO-7 mmHg min 
blood viscosity in venous access 
local plasma water viscosity 
Peclet number for blood boundary layer 
Peclet number for dialysate boundary layer 
Peclet number for membrane 
observed Peciet number 
total Peclet number 
Units 
[mmHg] 
[mmHg) 
[mmolll) 
[mllmin) 
[pmollmin) 
[mOsm/I) 
[mmHg) 
[mmHg) 
[mmHg) 
[mmHg] 
[mmHg) 
[mmHg) 
[mllmin) 
P) 
P) 
P) 
[I) 
[m) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
[mmHg'min) 
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Symbol 
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Abbreviations 
Explanation 
molar to osmolar concentration conversion factor 
dummy variable 
local colloid osmotic or oncotic pressure 
oncotic pressure at blood inlet 
mean oncotic pressure 
oncotic pressure at blood outlet 
fluid density 
fractional volume distribution of solute in blood cells 
transcellular reflection coefficient for urea 
variation of~ with respect to variable X 
Units 
[mmHg] 
[mmHg] 
[mmHg] 
[mmHg] 
[kg/m'] 
[J/g] 
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